From 5185e5a64bbdd9595e51e06907bb0c89a4bd82a7 Mon Sep 17 00:00:00 2001 From: github-actions <41898282+github-actions[bot]@users.noreply.github.com> Date: Mon, 21 Apr 2025 01:48:42 +0000 Subject: [PATCH] [automated] update diyhrt.market --- diyhrt.market/about.html | 2 +- diyhrt.market/data-privacy.html | 2 +- diyhrt.market/index.html | 329 +-- diyhrt.market/login.html | 4 +- .../media/images/products/LYIIEV8Q.jpeg | Bin 0 -> 103582 bytes diyhrt.market/meds/groups/bicalutamide.html | 90 +- .../meds/groups/combination-minoxidil.html | 45 +- diyhrt.market/meds/groups/cyproterone.html | 28 +- diyhrt.market/meds/groups/dutasteride.html | 32 +- .../meds/groups/estradiol-droppers.html | 2 +- diyhrt.market/meds/groups/estradiol-gels.html | 20 +- .../meds/groups/estradiol-injections.html | 258 +- .../meds/groups/estradiol-patches.html | 10 +- .../meds/groups/estradiol-pills.html | 6 +- .../meds/groups/estradiol-sprays.html | 2 +- diyhrt.market/meds/groups/finasteride.html | 14 +- diyhrt.market/meds/groups/gnrh-agonists.html | 14 +- diyhrt.market/meds/groups/minoxidil-10.html | 4 +- diyhrt.market/meds/groups/minoxidil-2.html | 4 +- diyhrt.market/meds/groups/minoxidil-5.html | 4 +- diyhrt.market/meds/groups/progesterone.html | 10 +- diyhrt.market/meds/groups/spironolactone.html | 4 +- .../astrovials-estradiol-enanthate.html | 104 +- .../astrovials-estradiol-undecylate.html | 104 +- .../astrovials-estradiol-valerate.html | 104 +- .../bicalutamide-binarex-50mg-x28.html | 104 +- .../bicalutamide-calutide-50mg-x10.html | 544 +++-- .../bicalutamide-casodex-50mg-x28.html | 102 +- .../bicalutamide-castramid-50mg-x10.html | 104 +- .../bicalutamide-procalut-50mg-x28.html | 304 +-- .../meds/products/climara-100mcg-x4.html | 604 ++--- .../meds/products/climara-50mcg-x4.html | 604 ++--- ...il-finasteride-3-solution-morr-f-60ml.html | 306 +-- ...-finasteride-brintop-f-solution-100ml.html | 104 +- .../cyproterone-androcur-50mg-x50.html | 304 +-- .../products/cyproterone-procur-50mg-x50.html | 304 +-- .../cyproterone-siterone-100mg-x50.html | 148 +- .../cyproterone-siterone-50mg-x50.html | 510 ++-- .../dutasteride-avodart-0-5mg-x30.html | 434 ++-- .../dutasteride-duprost-0-5mg-x10.html | 612 ++--- .../dutasteride-dutagen-0-5mg-x10.html | 548 +++-- .../dutasteride-dutagen-0-5mg-x30.html | 106 +- .../dutasteride-dutaheal-0-5mg-x10.html | 104 +- .../dutasteride-dutanol-0-5mg-x5.html | 104 +- .../products/dutasteride-dutas-0-5mg-x30.html | 504 ++-- .../dutasteride-dutas-0-5mg-x300.html | 106 +- .../dutasteride-veltride-0-5mg-x10.html | 406 ++-- .../products/estogel-estradiol-0-06-gel.html | 104 +- .../meds/products/estova-2mg-x84.html | 104 +- .../meds/products/estrabet-2mg-x28.html | 104 +- .../estradiol-epic-pharma-usa-2mg-x100.html | 104 +- .../meds/products/estradot-100mcg-x8.html | 404 ++-- .../meds/products/estradot-50mcg-x8.html | 404 ++-- .../meds/products/estradot-75mcg-x8.html | 102 +- .../meds/products/estraheal-2mg-x28.html | 204 +- .../products/estreva-estradiol-0-1-gel.html | 104 +- .../meds/products/estrofem-2mg-x28.html | 506 ++-- .../products/finasteride-finalo-1mg-x10.html | 406 ++-- .../products/finasteride-finalo-1mg-x100.html | 104 +- .../products/finasteride-finast-5mg-x30.html | 606 ++--- .../products/finasteride-finast-5mg-x300.html | 104 +- .../products/finasteride-finax-1mg-x30.html | 406 ++-- .../products/finasteride-fincar-5mg-x10.html | 506 ++-- .../finasteride-finpecia-1mg-x10.html | 308 +-- .../finasteride-finpecia-1mg-x15.html | 104 +- .../finasteride-finpecia-1mg-x150.html | 104 +- .../finasteride-healpecia-1mg-x10.html | 104 +- .../finasteride-healpecia-5mg-x10.html | 204 +- .../finasteride-proscalpin-1mg-x100.html | 104 +- .../finasteride-proscare-5mg-x100.html | 104 +- .../finasteride-prosteride-5mg-x10.html | 104 +- .../meds/products/finasteride-ricit-x100.html | 104 +- .../fiolelabs-estradiol-enanthate.html | 104 +- .../fiolelabs-estradiol-undecylate.html | 104 +- .../meds/products/gynokadin-dosiergel.html | 104 +- .../minoxidil-10-solution-hair4u-10-60ml.html | 346 +-- .../minoxidil-10-solution-tugain-10-60ml.html | 504 ++-- .../minoxidil-2-solution-hair4u-2-60ml.html | 304 +-- .../minoxidil-2-solution-regaine-2-60ml.html | 306 +-- .../minoxidil-5-solution-hair4u-5-60ml.html | 304 +-- ...oxidil-5-solution-mintop-forte-5-60ml.html | 406 ++-- .../minoxidil-5-solution-regaine-5-60ml.html | 2120 ++++++++--------- .../minoxidil-5-solution-tugain-5-60ml.html | 504 ++-- .../open-gate-labs-bicalutamide-x100.html | 55 +- ...s-combination-minoxidil-finasteride-5.html | 596 +++++ .../open-gate-labs-estradiol-cypionate.html | 55 +- .../open-gate-labs-estradiol-dropper.html | 55 +- .../open-gate-labs-estradiol-enanthate.html | 55 +- .../open-gate-labs-estradiol-spray.html | 55 +- .../open-gate-labs-estradiol-undecylate.html | 55 +- .../open-gate-labs-estradiol-valerate.html | 55 +- ...bs-progesterone-suppository-200mg-x60.html | 55 +- .../open-gate-labs-relugolix-x100.html | 99 +- ...noko-estradiol-cypionate-10ml-40mg-ml.html | 104 +- ...noko-estradiol-enanthate-10ml-40mg-ml.html | 104 +- .../otokonoko-estradiol-gel-55ml.html | 164 +- ...onoko-estradiol-valerate-10ml-40mg-ml.html | 104 +- .../panacea-pharma-estradiol-enanthate.html | 104 +- .../panacea-pharma-estradiol-undecylate.html | 104 +- .../panacea-pharma-estradiol-valerate.html | 104 +- .../progesterone-endogest-100mg-x10.html | 304 +-- .../progesterone-endogest-200mg-x10.html | 204 +- .../progesterone-gestheal-200mg-x10.html | 104 +- .../progesterone-microgest-100mg-x50.html | 406 ++-- .../progesterone-microgest-200mg-x50.html | 304 +-- .../progesterone-progestan-100mg-x30.html | 224 +- .../progesterone-progestan-200mg-x30.html | 206 +- .../progesterone-utrogestan-100mg-x30.html | 104 +- .../products/progynova-1mg-3-pack-x72.html | 304 +-- .../meds/products/progynova-1mg-x28.html | 304 +-- .../products/progynova-2mg-3-pack-x72.html | 204 +- .../meds/products/progynova-2mg-x28.html | 604 ++--- .../products/sandrena-gel-sachets-x28.html | 104 +- ...e-labs-estradiol-enanthate-in-mct-oil.html | 104 +- ...silvermaple-labs-estradiol-undecylate.html | 104 +- .../spironolactone-aldactone-100mg-x15.html | 504 ++-- .../spironolactone-aldactone-100mg-x300.html | 104 +- .../spironolactone-aldactone-25mg-x15.html | 306 +-- .../spironolactone-aldactone-25mg-x450.html | 104 +- .../spironolactone-aldactone-50mg-x15.html | 204 +- .../spironolactone-aldactone-50mg-x450.html | 104 +- .../spironolactone-spiractin-100mg-x100.html | 404 ++-- .../spironolactone-spiractin-25mg-x100.html | 304 +-- .../teahrt-bicalutamide-50mg-x100.html | 102 +- .../teahrt-cyproterone-12-5mg-x100.html | 102 +- .../teahrt-estradiol-cypionate-10ml.html | 102 +- .../products/teahrt-estradiol-dropper.html | 102 +- .../teahrt-estradiol-enanthate-10ml.html | 102 +- .../meds/products/teahrt-estradiol-spray.html | 102 +- .../teahrt-estradiol-undecylate-5ml.html | 102 +- .../teahrt-estradiol-valerate-10ml.html | 102 +- ...rt-progesterone-suppository-200mg-x60.html | 102 +- ...arma-estradiol-cypionate-10ml-40mg-ml.html | 104 +- ...arma-estradiol-enanthate-10ml-40mg-ml.html | 104 +- .../vannapharma-estradiol-gel-110ml.html | 104 +- .../vannapharma-estradiol-gel-55ml.html | 104 +- ...rma-estradiol-undecylate-10ml-40mg-ml.html | 104 +- ...harma-estradiol-valerate-10ml-40mg-ml.html | 104 +- ...eleste-estradiol-enanthate-400mg-10ml.html | 104 +- ...eleste-estradiol-enanthate-500mg-10ml.html | 104 +- ...-estradiol-enanthate-in-grapeseed-oil.html | 104 +- ...leste-estradiol-undecylate-500mg-10ml.html | 104 +- ...eleste-estradiol-undecylate-500mg-5ml.html | 104 +- diyhrt.market/profile.html | 4 +- diyhrt.market/qr-codes.html | 2 +- diyhrt.market/register.html | 4 +- diyhrt.market/resources.html | 2 +- diyhrt.market/stores/4nrx-pharmacy-uk.html | 4 +- .../stores/4nrx-pharmacy-uk/reviews.html | 4 +- diyhrt.market/stores/aipctshop.html | 180 +- diyhrt.market/stores/aipctshop/reviews.html | 4 +- diyhrt.market/stores/astrovials.html | 4 +- diyhrt.market/stores/astrovials/reviews.html | 44 +- diyhrt.market/stores/dashpct.html | 2 +- diyhrt.market/stores/dashpct/reviews.html | 4 +- diyhrt.market/stores/felicitas.html | 4 +- diyhrt.market/stores/felicitas/reviews.html | 44 +- diyhrt.market/stores/fiolelabs.html | 2 +- diyhrt.market/stores/fiolelabs/reviews.html | 4 +- diyhrt.market/stores/girlpotion.html | 2 +- diyhrt.market/stores/girlpotion/reviews.html | 4 +- diyhrt.market/stores/inhouse-pharmacy.html | 36 +- .../stores/inhouse-pharmacy/reviews.html | 4 +- diyhrt.market/stores/open-gate-labs.html | 107 +- .../stores/open-gate-labs/reviews.html | 4 +- diyhrt.market/stores/otokonoko-pharmacy.html | 14 +- .../stores/otokonoko-pharmacy/reviews.html | 4 +- diyhrt.market/stores/panacea-pharma.html | 4 +- .../stores/panacea-pharma/reviews.html | 4 +- diyhrt.market/stores/rxaisle.html | 2 +- diyhrt.market/stores/rxaisle/reviews.html | 4 +- diyhrt.market/stores/silhouette-beauty.html | 4 +- .../stores/silhouette-beauty/reviews.html | 46 +- diyhrt.market/stores/silvermaple-labs.html | 2 +- .../stores/silvermaple-labs/reviews.html | 4 +- diyhrt.market/stores/tea-hrt.html | 2 +- diyhrt.market/stores/tea-hrt/reviews.html | 4 +- .../stores/united-pharmacies-nl.html | 28 +- .../stores/united-pharmacies-nl/reviews.html | 4 +- .../stores/united-pharmacies-uk.html | 18 +- .../stores/united-pharmacies-uk/reviews.html | 4 +- .../stores/united-pharmacies-us.html | 6 +- .../stores/united-pharmacies-us/reviews.html | 4 +- diyhrt.market/stores/vanna-pharma.html | 14 +- .../stores/vanna-pharma/reviews.html | 4 +- diyhrt.market/stores/voix-celeste.html | 4 +- .../stores/voix-celeste/reviews.html | 82 +- diyhrt.market/transfem-hrt-guide.html | 2 +- 188 files changed, 15397 insertions(+), 13719 deletions(-) create mode 100644 diyhrt.market/media/images/products/LYIIEV8Q.jpeg create mode 100644 diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html diff --git a/diyhrt.market/about.html b/diyhrt.market/about.html index a516405e5..9ebed31eb 100644 --- a/diyhrt.market/about.html +++ b/diyhrt.market/about.html @@ -141,5 +141,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/data-privacy.html b/diyhrt.market/data-privacy.html index 981d9842d..6db896ff2 100644 --- a/diyhrt.market/data-privacy.html +++ b/diyhrt.market/data-privacy.html @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/index.html b/diyhrt.market/index.html index 4041b802a..b585ce81b 100644 --- a/diyhrt.market/index.html +++ b/diyhrt.market/index.html @@ -256,6 +256,45 @@
+
+

+ +

+ +
+
+
    + + + + + + +
  • + +
    + Added 1 listings at + Open Gate Labs + + + + + 21:32 - 21:32 + +
    + +
  • + + + + +
+
+
+
+
@@ -1486,7 +1525,70 @@
- + +
+
+ Progesterone (Progestan) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $21.00
+ $0.70 per pill +
+ +
+ Out of Stock
+ 18/04/25 19:40 +
Out of Stock
+
+
+
+ + +
+
+ Progesterone (Progestan) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $21.00
+ $0.70 per pill +
+ +
+ In Stock
+ 16/04/25 22:29 +
In Stock
+
+
+
+ + +
+
+ Cyproterone (Siterone) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $105.00
+ $2.10 per pill +
+ +
+ Out of Stock
+ 16/04/25 02:41 +
Out of Stock
+
+
+
+ +
Open Gate Labs Relugolix
@@ -1500,51 +1602,9 @@
- In Stock
- 14/04/25 01:35 -
In Stock
-
-
-
- - -
-
- Dutasteride (Avodart) 0.5mg
- Inhouse Pharmacy - Inhouse Pharmacy -
- -
- $27.90
- $0.93 per pill -
- -
- In Stock
- 14/04/25 00:48 -
In Stock
-
-
-
- - -
-
- Dutasteride (Duprost) 0.5mg
- Inhouse Pharmacy - Inhouse Pharmacy -
- -
- $13.70
- $1.37 per pill -
- -
- In Stock
- 14/04/25 00:47 -
In Stock
+ Out of Stock
+ 16/04/25 01:10 +
Out of Stock
@@ -1564,70 +1624,7 @@
In Stock
- 14/04/25 00:40 -
In Stock
-
-
- - - -
-
- Spironolactone (Aldactone) 25mg
- United Pharmacies UK - United Pharmacies UK -
- -
- £2.34
- £0.16 per pill -
- -
- Out of Stock
- 14/04/25 00:37 -
Out of Stock
-
-
-
- - -
-
- Combination Minoxidil/Finasteride 2% Solution (Brintop F) 100mL
- Inhouse Pharmacy - Inhouse Pharmacy -
- -
- $42.00
- $0.01 per mg -
- -
- In Stock
- 14/04/25 00:26 -
In Stock
-
-
-
- - -
-
- Otokonoko Estradiol Gel (55ml)
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $100.00
- $0.18 per mg -
- -
- In Stock
- 13/04/25 22:55 + 16/04/25 00:41
In Stock
@@ -1648,49 +1645,49 @@
Out of Stock
- 13/04/25 19:40 + 15/04/25 20:30
Out of Stock
- +
- Voix Céleste Estradiol Undecylate 500mg/5mL
- Voix Céleste - Voix Céleste + Otokonoko Estradiol Gel (55ml)
+ Otokonoko Pharmacy + Otokonoko Pharmacy
- €70.00
- €0.14 per mg + $100.00
+ $0.18 per mg
In Stock
- 13/04/25 18:45 + 15/04/25 04:17
In Stock
- +
- Dutasteride (Dutagen) 0.5mg
- United Pharmacies UK - United Pharmacies UK + Otokonoko Estradiol Gel (55ml)
+ Otokonoko Pharmacy + Otokonoko Pharmacy
- £7.62
- £0.76 per pill + $100.00
+ $0.18 per mg
Out of Stock
- 13/04/25 08:46 + 15/04/25 03:47
Out of Stock
@@ -1711,12 +1708,33 @@
Preorders
- 13/04/25 08:46 + 15/04/25 02:48
Preorders
+ +
+
+ Dutasteride (Dutagen) 0.5mg
+ United Pharmacies UK + United Pharmacies UK +
+ +
+ £7.62
+ £0.76 per pill +
+ +
+ Out of Stock
+ 15/04/25 02:47 +
Out of Stock
+
+
+
+
@@ -1732,7 +1750,7 @@
Out of Stock
- 13/04/25 08:25 + 15/04/25 02:27
Out of Stock
@@ -1753,50 +1771,71 @@
Preorders
- 13/04/25 08:25 + 15/04/25 02:27
Preorders
- +
- Bicalutamide (Calutide) 50mg
- United Pharmacies UK - United Pharmacies UK + Cyproterone (Siterone) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy
- £17.61
- £1.76 per pill + $105.00
+ $2.10 per pill
Out of Stock
- 13/04/25 04:41 + 15/04/25 00:40
Out of Stock
- +
- Bicalutamide (Calutide) 50mg
- 4NRX Pharmacy UK - 4NRX Pharmacy UK + Open Gate Labs Relugolix
+ Open Gate Labs + Open Gate Labs
- £18.56
- £1.86 per pill + $125.00
+ $1.25 per pill
- Preorders
- 13/04/25 04:41 -
Preorders
+ In Stock
+ 14/04/25 21:30 +
In Stock
+
+
+
+ + +
+
+ Dutasteride (Avodart) 0.5mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $27.90
+ $0.93 per pill +
+ +
+ Out of Stock
+ 14/04/25 20:49 +
Out of Stock
@@ -1845,5 +1884,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/login.html b/diyhrt.market/login.html index 71b0c2a08..b3df0efd6 100644 --- a/diyhrt.market/login.html +++ b/diyhrt.market/login.html @@ -95,7 +95,7 @@
- +
@@ -142,5 +142,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/media/images/products/LYIIEV8Q.jpeg b/diyhrt.market/media/images/products/LYIIEV8Q.jpeg new file mode 100644 index 0000000000000000000000000000000000000000..33613aa842240fa8e491fce845429d851eeec060 GIT binary patch literal 103582 zcmb5Wc|26n|37|a%rK2))QAuxl@TJ@vrH|IG(C|R?lu|-M9mR(6n z6xp|^>`C@5@jF-V&-e5B{qgxe9^Y5Zz2}~D?zzi(o!9I6TCR<*jX^*%m*kKy}_PWE1!NeaPuPc! zmfiLBj=}OpSf<+jkFwSOC|kR^qy58RA0=leFZ5a{p?AF1#>L<)+!NrB4|o7QpaIm- z=ZD9TTvGv%UjTq9;=k*x;sGcL0f4*bzw7og0ARlXK=J4QuKVwI;&#FP!sc)|xW(Gq z0x+8i0NXhLb~FP(G~H~2oB!qBD6okS-j^%s~9qi=YJOcc?dHDD!dk+dz_J|4b@loYO#3T<% zOG^s~D=5oLDIGj4Erkw(*|KHJR@SZDY;4?8f_#Ef|If5h12_l-z|72q*#oc~7$y$P z##{IRkO`SEkpAmw0S3#2!!xrGV5>R_V6gy?#o=&F%*+@jEDLPqV8RI=I*Q+}d*N~r z^Nu|a$Wkf!La(P;I1j6}eA_FnXXQS#lk3>^$bI`|&U)xaeSzcfpcg>t|6JrhSAlJZ zI56-c7$!(KES3rF0`GtWw_Whij-$F{sl)g^m*J=vgo4x_a2`vs+UNmWVJ~T7Jc0c} z4cPKQy&MNPS3{H$eoOx9NqInl%mn}*;}2jj{##fCfc0X40BleO_Kr4!jezHdQkdt7 z04wMXFhnc^06`i%2_R*YfPD`cGOiu~0SHhI>4IG$k;?CZ<5Ubiz4v+qjo2W}3+qt! z1|WTN`(GQD7d4wj92TL85NS*ifQ%5;BA5{}qZwU(Br*aoE=WWC;3HD85eOK{V$Z|S zx!Oo)XhVKvl^Spu>_QhIz*NJHQ7Hh-Psd_>5VQ(DQ)dlAq`?CE3=G)mB>!7HP>UcE z^bi0zQ>aAv@I<5yFercyLI8_UgfszQQ)mQC?kysq-@3D4X%s;sV=!0oL_zgIAc8I* zKQdUP!M&i`RzSv4vDhG@+UgA&9AR^A)Mf$cavl}lJ6MD@dYt#^*rv&Roz;ffZD>yodK?RT#APvDGj3`i+G^0mk z#OysBA{}hL9-!-u4sru1@FIY0VM*f%@C0}<5(5=bbPNMt1w9A;a3Du(q6Uf{rU<6{ zXeH(;Ed)+bI($^BAI1{HIt6FH5Hj#vjAR)K``ZEC35ctyIe7L|l zKMw3aF~A(}GG-F;DiFluM2@-uN(cpe1D;IycXxm_4}e#_o3EwF1YlTaF~z|VKwOyy z2qwHiL;_xTp%j)u`T-!#L}Q{sZoyF(u;dU5pow5kQ2+w3PGt)^NdXKDK?G0%;V`g> z-1FE9eWpRbpkW4lbFgT33vMvE@V#QE)q-FdCGj94O_wIf)Q^p9z*lXl2Msz_K}40> zJCJua`PvPD?cJ~=e+|44RgX-dG610Hk-;B7_`)!t8J)xOh$>DRjjjv(4RXL|Ws7(z z@@!C&C`ilk(x(A3x9~p9Yoc-%frWzK0H*;h@cLS4-e8uKGL6XYiAPs=ADKtEIzR9& zU|M|nx2i_Rl86%_;(!}Gn|aWeM8#ODMKEZ}4Y)sKdM}M4N`a5@=Nuq106Ps{_CLhZ z1-c+l3^G|q+`?0+a5~`HWyMh$Y`1XKR7B7RONO&Upes;G#WaDEEP$}SCW5n;2%Ncb zbE^j2f!;aiiZpkG)UHy2HYt6{+1V zCq@$iscZ)Vo(GXaE&`<*pyy-?!k#tiCZygzdfZG=1otbYcf^F;AnZ((dNxf)-rO~6 zIQ&ch%-f?O+vAIl8V=LVDGr(|EIXYpYfd?b<%v${QAZ{tbOTwelFykvl|J&aPu;>@ zH2mq=oQBkip0wO*(Y_Z_>^nr@RICqPzEb({SIp##lDvdnO9Sun3X)Kam*YPRqMji)AsGw>S2}{3OV=K za+2~UWY^-oFJVVC>>pqHMYHZX(<+4t;huH2*UgEb=>ZXG3Ap0Wx5&`3#FJU_aM*J+ zj#U6I#rAk}k{G+-%Y%G62{&IVY8(*sh@T-pioVpdU4S%*<7Sh+xB%Il&Kht_4=yY! zdyy{|VbUnjX@N5UEa4A|AeWjYDhc2z;0-)~5YfI1a%Ao0Igl*4(vQ@`LqF#!+!=m3M0fZd#snK)6A&2OwqF-YI%#05#y9~P6N*KE zFre0em--K3r*IeqHX;9n10TW%fH5$-i2VZfI)q)=2R@KZA>qi_Xf*`!CZn=c8OmUR z2&_ASBtpgG9aCXDF)U0s4$yAb6EgNt4RBQTi~w7!ERVQPSx{fvKffEDaYW zqudlJBbjwfe5)F4y-p_3wE$?QIt90NINf}n)fb;2lbZRI`OSkvmi#vkCQQ)4_8Mj; z=}??sboh1y%n1?=-WVAH{EhH-2JtI_3>1S9=oCB_?6&_=51&aB$o`W;ZD7m(BJ??y z@(6%k?Rv`qg&EHLPFQn7P_v$nMJ!RKHAf(KZab+*CTcsSW9so(V;mV)9ULN|=fd{~ zRSmEOQVbpsO9%v@L9$5{5x~`g837a;m1$|S1_KzZv*^W#*yR890W#P-086A1#ZeiD z++m>*Pqi_KYN&JtB&I213b4dOF-XRd=|}NcGaFz&4)*D-yMOy`-Mx;$ zGgaafF1d%QRtcotS zO?jN|Bb6hDZ`pW0tkd25{27zXA5gDIXKic$xB4yV_)B zrssp$rHnFFA&VVyX5AG{KK8a1I=5{z_H7-psdFe#H`6Sc6i|_lvYsJb8&Ta6_cnfM z#iKM_HsGDWTHMoj;(>=bEy5Bxwmbj1_9^tQ*0mkB{L)uc*)6tv8Ht|jv&(Rl81fok z7n;Z^|D;p0crd+pG50ZU!DgjpMpZD>eBw^jCmo$51$IjtK+iMT)^u!*<#b|T$?~n7 zo|8%)JR3mq&*Mm~oYA4`ktdJY4)NzCMRguh7WjL7T=uV_*)jaJN2(qIzr|QGeN_*d zot65f#dD^A%B6O~xO3%k3HE^VYVl67%R=@&hgIypJ)g`kPubtoZ$A3vf&TR+JUI*t zl_EsYn}kJJ3D91FTnPv={4~hy@CUZhFf~l{&D9Q%HVJ{64`3OBCzT~8K{}Ph2pp!t z1~Q-ED+*A%!wm=uaPdbFnCm!6SO^7RZ=&Ei2>37$nHHo{h#*Ax74|y7LtD%e04xq# zGa$$(6{2f63V`EXht?Fpk^z$~y!`0rx3HEE&_OyWt<9Y&LWu@7F*tfkE$Aqb&iJcJ zCm@i|!Il$v?9Nc$pq&h8140XhN=2R{TWkg*-Hu`adFAmPJNlgg^#GCC0nRerN@+2n zZ-+8mKh_UNCnz3z+_t2UQT$$8>UGJr{JT-ErrUd-zulVjjI$(U%+cLGvwDmtM_w{6 zmT^HrrE}zRgUgDdUBT7ir|-pi?G;ITXKZ8K?p;;(fAPG*?^2J9*%6!Mu@B!bXFoBx zwI(N{nc?U)(vVmwv$UsJ?8KiSs7#CMm5@9a>plUYkkXqla~x1w7K z)8zWjN49%nCbIqreOKXfouSXEbRSMC{CJ&wgNy^w=uAMB&SVGM=NTV+V3pr-gInUw>4ZF6YZ+Jv2^yt zCltP{_Sea&fIl%pqo7Z@m0FJcn!H{Ie`lqht)H$As& z;ia|x(MqE)V@Z~y5Gx?`I|C9f75wMqf=Quruh=psN2DXX8Ss?zT zqZ6VQggLp1&|o+);SKu83KRyT>hER`zpCks*1y9l`umVodD+n$C z7JCP}J+|bbB1g6jfRq}@3V)&roA|{Ya!mxd133VzjY#w%PMAH{F+LP%8ZbpdgVOBw zuhknCub67xvM@A+On`>1FolRm_z-FIiU90^ECfLusG7&Y!W+<_F>;3vI5=JO4$M&L zZgRk!0Qn4>fhMafWF$4}dISPR$t?_R2@h0;XWN2FaW5VAftX)3t5Wqo`Kuoe$WUKQIV~!x>&z(JdiTg(kpJg3Rnci+}nCU zGFR>5Y|HC6VPyM#ulrIOPCMOv_3fExt@%g~=lYOg96tY5<*!v^E6GI<^k=L!b8!}XmAs#6-4~KM-~D3C?`(7C zuJ+jzwvVPOV|E>IH2w2Xf=gRSy6Ec)wU_N#({!s%&Lxlcp02go`kV_EY^uu@GUp%r zW$yH6uPw8kE?Ij&AoQr>IdyCD;z>?`7{Dp#y8#5;p8U33#Q3tk;fqL%*guSexQ@B% zBI<|%0ON0p?f?@X!gPj)sq6O*t){@^!GQG|xC0n41Ggx&bwdvUeJFj9Sg$ge%Fw<; z<9&b)Itc+6*VNG|0uS1Zfj*#gETUxy%gn%j5KtRxnDx;X5x|B(FB%aC-AAkW^?wj? zdrzHL&{u|m{xGz6G$1k1j*waY?a(b855jImanu*aag=CaHbB`XYq`aroJ3L?l!68i zIUPDX!6q|{5Sf+)vVeNjw}4v>^_au{f?*Z$4DKV}#!YX{s_fvM z^GkZ!(%l|5p&=I8(UI#>Anxz;uyQd?*g*YY;WQL6{a@7C4eEGzo96g8xqlOF!8~y( z%(TFvlmDukT;^y*_ep*#6hh5+R~P)1^|UaM?(-FL`g2SE`Ea zmZjEfQ-Pt=$vkGtMa~MBGxLm^)tK8N)i2*nRFwMF9IV6395ZYC-TRS|LefXO*=29} zgKkkJm-3YF%nF51H!_kUomG!Pg?aR|{H4#T3US5{^$cGB)Z}~BQuvXuw(3~Gf7z%s z!L@cO>!W<+XR92&DVJwqXNx^{0VWoJEtgFqM_uk`iOTrN9I!S zgbHu;DN4o zEU@UKo>~wG2nE!j(*scj(ueLaO)Df&HjPK&2*CPD{jFh{BA8+^s|dz|>(~^){Da^` z8eZ_|af!YV3X*6(h>nB60pXTs8JkVP#6a!?XBUA>4XCKWMpOh5 zw*)dUCKU2xH;^uH%_<1GG-pKs`>Q4VAnLY)rLAxb2K=$VA_F$Atx)^^htfspBE%D> z6g)X70;vH||LN;NXCOvp7|>WyLksv~z(wNyK7@m5Smoea-n?D=W8oP``wL?e$xl)Q zSi`FtN8*0HZojk8o%GUSQRBFSpSyLouU~xSni5CORMA4tn?2bk=WgVB$UgE=-+uM4 zF^_FkT(*hJ<&S=fGyDljx#~;)5%!6#9*_0E_^<5dzN_6kr;r@(FfSrDJ>V4cQ)9q? z_rrVpO}sB#=sj4OYc*Ag`xdtP(JuPn51DF2;K_UIg9B&Hx9v&d22Sh zJuMgTf##@tvM6(3s+L;X`Pc+Gjctw`$B5ch+deeJtO&?-77U1Db#*3u_tdOB_dgMy zSeM*X+3`d-qb}jXf}{F?=|E`p7_-*Z^(T(+iVn4}?$T)Zxk&w_GOEr$*20_ZIO$s3 z$DXn5RbBV3^Zt>?DfvAn2<}fb4lYk7xR7B0?0Oh9Oi>~ojNJfP{0Ku0Dg;2!If#$~8UTVHNeD!HU@M?y z2$=>0JxU?4J7hx4u?yymfEstA8b#HT`b;qosyftGgsN%^xU)>c3qKF#0ViM;R9}Ei z0T@)FPVOD%42X>wi3niO^!zX<=`iGgjbNY*^Z&!-@H|LlQU*369lD*le?dfY0_tMu zXhk;f0f2hw3R!|f3JHk{5tAaY6o_)NPs+aXe{B3YYPq!2Iwy{hr}gb}az)aYc3+>} z^1ZVjT5sYzb~(oV{1EKV6wz{}p*Bg@+zg^?LW|NHqk@Lis+o{b%v6DaF z8kQ>TyTXyZ!){3-QQJOH*7b2r!o~L1ygh%}mUl$&&)C^|W?o?fG-NLvuJtNL0%N8( zfay&~32rM*G2>^BD~~m{x(wS5DfoBnH{CIE;bT$m;h%~|Z1WO z)Z8=ld1$7=zWso1LS}yTjN6DsmeE<;?Fpy4KPU|eL4E7vGgTB4%(Wo8z?7S1mlnj_ z`=vrBcw+alnfT)0<9EM=8ce*3@0PDCV(v6)SZW7f- z=kEUynaQjf#tJ^Gx??n7N=(uOE>Gxf!j;V)>3~jPYGWW!==>w4qmToc+5&2>kEMe; zKm%1gkS8w^)u=2`xS?K46yxwSz#!V68IXe`pvHn-APLe)fa54@4V|ORu$u;JO^h+c z2-*S(Pr*iCuc=^DuEAm>SZR*_(FfQ|PvT+73k`>v;HYOKFu;BU9JdvZKUo)I1qg1C zqsp!*U-1(-_j#xwS~^*v_b{>UtZ% zn(M`HU7?+8o|2Kpm0nVZVw)T%Ii6gLNs1h3{`uBKnL6az`v;Ti=WxlP-SEBo{`+Q4 z>;~COgm;S416g-2Yo67*Zg{UD%3S4!(ecE|7`I~E48O=jezp7T zp%C))%*D9iBW_iKP0#cmrPX@v*qz&1bIGr(-;w|FwK`q%Ey-67Uj81S7nK+&%vqc~ zR<@Y!8@}zywemHMfQhQr~GS|2?Ec{-i7ISfiBTx zVczuIL*=TB($&+hMfN7#FKa0zsZxheR;&);jZaGl={$Po|Wi}F=jG9QX=78i^Uf;~yIfIwoTVv+sBFq{ef+(mE_AQ6y%$aM3-hiyrahMxi)2tenQnE`+S za)4(g0&~?82n9lCNxFChVA9S)F$|n(l#p}`;~PTb1005fh^Sz3BC4Fk&=v~(vA+Tq zd!UGbMYBR^ze5Ou!D#eB<2nLRM-agBR0awPDwII%KP_RW{}BE-(9db+uYsD8aY+W6 z|Il2gLr$kcmpRnBmV`!u_^3lM9gm-K!ZRN(XU}SAHLu$Gzpp!(#;$Ix>AzpGQ{Vm5 z^NIKUzbD<#EZY0-z7Sh7xHQ*SYm#RDVuz%!Q`I+a>7UK72bkYg#iitAm{6p@i*Gw8 ze&%Tof2de#bMTpiw>#EDm0nbyNiv#Gnky@eS&4SM*7+crFR&{VQ7Yv&O=}CupozJ?u;G`}>E_%YE}pjMb>Jpm6Vn?W1LVE%lXow|Q8I=;KumIo>4DqT3UCV(^v=AspP`5E87C5~? z8b$_aa1RxN3EV-m1w%xSA&Dqwp+f(<4>{EhqekIpkAOk}5}K8eG6_gr5l1(V@#-`t z@y!x*)gV|e1b}B5K!YBDa?&+JD&RLna}uE04xMuK*jdOL+W_*^0x+kGfOP2fht9oC zVuDi)r47_Hi-I)HXTA|YA|DV_BN)oa{H8qy#TT@qoE9HL z_V)CAexl;|{l-^5uhwYD7dsVK;~Umuc6Gkb%g8ThD;`%hl~zya z?ylnPMEKupZh(ii#Xn1(0u$Lk2ppSJiMnMGx4UKfV&?9Q!=NLn2; zeCIe30@!v6u52_o1Y=#$B|=0+0#3Qc7o7%-VGU5|LQ9Zv!_k}840;-BJL>uI4WZ8>F zneT5U4Mv{uObA4#ghlEOOF&MF#=txX!IPjI0qn;CXvVr&z%W0=&U8T9WE2?g;OPR) zgJAj?g5DX-V?pTnF%0=FV^bjE00UuV@PM5JaCn#Zgwf(5Kc^GcHix7-Bet$o->%;4 zt_t7rp|mZaXE z=^a?v6%)F(v#rN>w;123wxO!q&K)t34F-Q-JD8(Wu4 z$GypknlDBrrA=%VGBb*j(y_5cl>}w#r3&r*YF=~otfG;)r^VuBMNie6c&`45e<3fE zv$Z3H*Sb2WjL<5;BX?oqO=WV_3oF*fzoNusz5w8>@bM7jr4>+=aq0 zQ`d+KX;FKvUMvQ_JDF7IbbL-MeZT*I1wmFW3{AVps+arwGHaT0h=aI#m}rCjevs21Vo6?dm_I9XyTXD zW{LoXAGNk%q>My7ItiX3`^NBH!EG2?GeSp=blgh>rdd7;^1lV)4Htv01~BK^WC6o0 zn5G2X*EqOA$@~hAfiPew4reQ2^-}qkq{uC&1N~{Ef%`T9QPKM`ZFtas1H6q{_U>Pe z<(M{xi*Up@_i*;EYaB%-@l6suipRwDo)lR;&B^icDox6c2^=Z!RIj#5Jya673fSCchnY#)Ljm~=uY3Ua~o0j{Y-Tb9J zN3}1Q<;CP!L+;b=&z=i9U+#sy$m#6D=f3rxaItsjesaj-maEyKqKu=hrUU;Ksb6p7 z=48sXbV^GO1*{tNwJo?rp1A0!-f_2ae^g7Z#Gwl1)lN) z%`H5`yx%HY_f+1CT32#?`&XFdG*x16pyQW*TcN7aaqffD7sjkUvV9!_4KGiaw%n1r zH)snL1C0pSPV$Anr!Z=|TuVui1)!CJsl^eoibBAaz^!(~a?X$X6Z0PHN*sD^~`q!TXZLGc2x_=q(3TTqXIJL#}v8bvLh4mIDV zklKVXm{;f^Xbof2L_&9D1c*qOJ%sfbpBXGU7@<;z01P(wAt|&mSj*%F+=w(@1QubJ z8n|KZ12CQu4Xi1h`}y5gaxl?d? zg{D)QKXt5LOWc3A_I__w{6`gq3HPWnC!fy zvvLuo<<`8*f&!1>Z-b^s9^IAxpVX66c=GKJa`M=?x3Ayq)9={;XZ2sXcBPq?t-5M& zOUekichzgHyEUe>`MT)J=cX~w!^sC{66X|mw0cOj$$Kb%4q)3|G3{yl^aI~I^?Aec ztlX&c7RT7qt`7&aEcC)7a*7<=#$Hbsd%QL|J^p&Fo?V08rlhY|fN1;Bw=<~Jg4iFF ze<{1B$za)+`~4l?l`-R02LtDuzuzp&9rM-fPL(jNY-%ydCM+siKfjc_Gw?RD0fKMB zbQFz|zbXddT%OPW?vS|46%?9N)#gz^|EVWsQlMvRA8+Uo_M>b@=80_ylO=@;XOc)E zE&>K~6^(*o3Q7oN_5gz216_6iM(N=cKqw=q38e?Xy3>Il4&o62U`83b1Ah@fGTjE) zx}m4nlmfx2-=^Or7+lWR2P7~`Lo>k~Xn1e~Cf#ADY5D+WFhS8}a1s28M-5y6MF;LL z)S8g~!-^;~DgcTspt4Xl>ji0>J7^U{en2R2&w8<#E~se&s03%UjTeta1r~I`WWK_Z z>Cm2r&}e@}ldH9YlcOJpiS2~!XHn(0Kz);Yqei;#yw5qB%aqQRhK;thiU~D*UO4?p z`mslh`R(NM9>#e|Ilrspe_DUHwE7b5Ri&V`GMqPTuetAaE4{IF^dYpUJ+u;BJ#6D(mt)3VwN!gySBdkIY3J*N;ctPprR{DPM3lMgnYr() z-_vyHRTP%UG%&Xl^{t%TdPu2B>W6lz?Dr#s?czRxHP$A%Bc8)oycQK4&59J=do}a+ zI*wL~nl_J>*s1WYi!L;eRc`%A|Is8n9PoVPYMEkzmj3VhkzWo6+Qq~7t{6OPSL}5w zTuuIZI?>VOvRcRQD{thE*;rJwoZ0$lDr-3SiEGWYl07e1#_w;<3Hao7Yx#83DVL{yK`mU4_xt*{*bn|aW3cs{mSNPFckd6$o*-IaUMak*AJ)Nw-5%`J~HHTfvC$MZ$rocy7cgv0%B65@nw zZ3+(6-l6N?&l=wqdMC-W?2u%eviBS`;S#KzO&^#-#e$*vB2Z!Rr-+~AI7z4Niw>d@ zACYMoRD$sj@|Q`%xdy5^TP7hS(e+eYtwfKZ!b2w?Fu$ol;0}fu0PCkADrN`;RpyYx zAaKHM0~9in0rR+dNZIa$B{c2|&(lZc;!y@Sv7WTcfWMqXvY?+DDkG~!m`&mVwA7%$ z!inHS0RytrQyMxrJG8hU$3o#$k8Yu2yM*o`aovO7$orN|Zu$uHOW%QpmxU#Xe-J~| zfr-EHp%9EF8atr@?$6fx#a-P(=Zp7LRORqCXbNy7RgFGfGSfCUG=0pLoIN)$qaT+j z`}^4Ge4Z~&uaYXAS|s*9AD{fV>(h$llpphN2U|8XH@v&#WgV{<>(@<{#g#=KRD^bSiP4G4yzk<&MnOYD&C(alGZDh;k8O+($_Df`lx4!QJph` zn!iX*Wc^(q_X*|oQI$W%o|XsVviM{9jwIh~zY(R~lF2rf*!(qdhS-(Dsb2Rn-J$)( zr4N@ao%OD&JGeHsC2W9}$ayAD+sS^Gr=N0`v*q4=OzDq{>$smgrn{O{aX;dtM2=Iy zeKixU)~M}yOI8cA?>&xRmD4bh%&A(h@e4i)0OE0if+aHu7OzNf+TawzA4&pl08pBl zQBaLt-OOOZ<6t$$i-NY2HvIH0a4xLnKlFo!yND+b~R9liHiP8{3+q2F{)@rVLITn0?u4{r&K> zzDGIiB@;5s=YDI{F0l1L=8L)2k*QP>zML$cus6Z(xIdzx{*Z*4Lf4bk%Xm4+kwJ*HoMsiF^eo}(@{_WGlH|&!iEXsc!HQ(2fxwl$&&@uVz{@8i- zKCR2s3(`xDMo$)tu%`@ak4Sa)jPv=Gz+8{np4y^_VD|GGW%IIQ51wqBDJhqe?wLC* zuHYfwqu}>!ytg|oQ|6jZu)@=cyIb~6bkvqTcJ80-`EzHBX;;<g}qhc~7jZ(Cg07}Zthts8T|E8mLwRE6uiuy29u>cp_l zn^k*x_cTpQzi&xQ8C{LOG7OV~R6eI{fSUskW_+A4-Y*!tzby9lx$>(i=ew&9o=BYa zG%XCvb`v~>Fh$_N9gHOexlGqLKVsNqgkx};lr^XDkWGM@EQ)Xd%-~=>js{iTVV=$= zy(A-C!H^q(EEFl2aTF|Jjv*Kj0`oEHI6#)=Pk>b@XJNJh0e32}Ii71t=cN4$m_qwa z5B`UVZou3z(s(Bxhk@B6S^#!eLlsnW#&Qy+jH#7+8_`vVOOWb+VO2ng!5&|`Ol z=nAc4#bKkMdx^cC?D)2?bHClK@ihJ7!$Nmeev8Z4y|wHA>^HCSKFca2c<+k7zl+!3 zGbJ+m1r2Y_6BC5f{4RNZ=lfFN_VIkl3;(TqD;mE(VSoFqZp^CxT7F`SOW5wQqjy_v zQeK#3ek*V8TIk&Xwrp~rLhiG07w)yxPUn{)&7TkXF4ogWXIJaLR% zHB8}l_FX;K9a|k&Ip%KgrR7nn&Aj)DH^+sr?JFfl>dQJW9Spp_hua63#>?829CQ%X z$h~=MWae4M_a#LS!=G>N*}n2M?`Wv+kFo#WX!vaT+cKx<`EK1f(Nl_&s_~y+I*r#1 zLfmD+IpKQhOY0*UnG3lYGSv&~Pli(m=+9%9?0w_KV@pP?IlryO=S=3^dHiTsE@%E7 zTm2V3y>)n}J5}1#(i%~LyBSB^$4v?YLXTg2b7^_4pk2VAWk%n#^7IFG#?6tj@=K#{ zB3(UFkEF55MI%`-FZ!hNx&P=92(N}IKv`9H3Mw0j$@6L`As|(fl|gd41A^hq7~({f zYuGP0oMfl54)l=`s0g9c_%0MF8W8KC#yu1!cc)=8Hvb872$W4&sPdp8SPr=j0-}?6 z=zyRC8vhMEnS=@&24J1ifh@L+hgKh*J z2oetZxxj)Y7(x$1;P7;`06&1J!PG4A4-yHeMTh}utJyeg*Al=t1BTi?fB@<5>lf`4 zvkF`!Mx?Duy2ctRwq=I(C7tbBsc3@{i>}WfmI^6XG&?EQ(qPIZ~4B}1Olg@-QR zoo#i$C#KUd5cK|V%e(8k<*oDb`wZu|7Jfb>aYkEQ-}6+~SaSBUv*s9+sgf&RaEaGu zp|COvL=0n3uEEi!|{L8vj;qpx@Isz*#aU zb0JeV-BbNl`zoiU&Z(gfhILxjcCKG~h_yB))wdJA^}ck@PiWqn+R3I{#=~Rf67u!i z?uXl-iYhnWlyizQ;b-3Y^K5&=sb}%=#sRS=W;18z(_To_CA*%98O+f+;o#xihL}?9 zBPt^PO$op#qiGRbZ783RFhnRxB&;GxM730e4+hTfLwy8x(z!_hVMR}18kmP@8&zz= z`(OjyvqK5Ojk(w#ojj-q5jolk4hUfqBvN*L(1bD?Kt;fvdM7ld0VN!e2vV+D0uZb7 zOe)vFD)a_Csxr8aL-8U>6?AQcUTXxc2bfPcFjFwHE=Ut^pF}I*NzhY9qxN?zf3$=# z4rnZF|2U;wk6&WygFY(lqc9c{U*WaHiIJisB_Nm^2-09YRx$)_ae$`C7?OUa6 zVfy;o&ECVjmC4CRJ9kPS3@*_ce5d`Y{iViEdSUW?MEb|Nq0cY#D&Z@l&WG=p8@bLC zT4mHr4Ez&EUsS26KQ$0`sF)|b&ShDYv&`X-Uh}an?|eHDTtIxSKEr=EkR#4v(lfV9 zI(p!CLhqHVyKLM~i?ffNP_+&`(B1uXbz-}5k*{$sZ~DcrA1(HtTCGr0+alz$^B#0i zgvd`NRPS)v-uWquU5oYjqnZ5XN9`)!3VHK)zO^*xh@Ug$33__ua`?w_f{t_aG5+w%q>l5HB)(gAz?}OZL5Hehi8DAqFeha|C6&`FGAyPBu7rq zD4)+9={zfyx0?LOLPT_4nL6`yXvn7bW>oY11=*fwX^A?=kmK_wq>&|bhO)RuAdvZ9 z1Ir|cwSjW|Eh14EKS%;xFNUH2JCENo*^&jMqdAJGXo5*-nBgqI+XA?9_-Z%mwEeO z)XM7O%;RPIx%q-viS${uG$J0Zh?RsLeBu(VTElcVRn z71xUOeG0l=M{P^aCua_}r9M6I?I0_E;_X{iNwW1y3H{PPt*;PU9W?BgJi?0Zo`KeY zZ@m^fo5Io78NaBD$C`4Vf2w-4tCKIWeA2NqYG1V1bBjl1dq3(N<}`|wUg0m^uUYs^ zZpz+ge{B1dv8{Q4)IM`_1C8|AfU;K;)l+R9(-(G`4m|Qc*d!nAXp(k?cxCAiub*Vc zqw1$gN5lgTRB-R+*38Q7PW+zT^?uu_*jxQ`d)l>%D|mQ~gUoz|#WSwenM#5+BcMer)c=_|dwC zLUY@$CAq5W29ty9+llL?@86C6e%)mAP5XpKT{81Fo-e<0&vtyUd@jr4N>Nk^u=y*@N+bAR!A5ARr7G+I0y^a`dX(UIF|) z0zH)A2Izi4A5cXNKjQ){uh{ig;Q2HO6Oe?EKln=__B%8E%jBJ$+N3*6p&>>KaAA|7AOVSnTp;DUSgn zeeP~SvbT?>aPM9DvXTAq&-@ZD_Vg!yaV|UOB)8%r?{4nP^Ht9vJ@xNi%O`);qIr8N znbS3*-}z>hN^m|^F&8~`I9MlqYv!)^6Gr>K-`>(xa>nt~n?fapi3Hosoym>!RTnQ) z%J={27_V$P=yK-qq^$j@)rlfaIolnVYYeo%%PcA@)LnRA`f5pqNB&7p`7d|ha+6q& zS|uOps?5o;x{*T%sxEe>*?WBD9EM1%?tcMMgWoKdn9p7OG?NpdYCuYG+YijjWokjpFl zYWQuPOK;Ni<{4hUf~s>4tuH0a0@FBSb#D18aPlcH@J=~9*8lE&?2&IXnBE$uD{7m4i0U^LicKs@ZGHQBdZA*lvPnSdOz8o4 zo81p;UhAGQZmHheUCw4BRGzf<>>gpsd(7od>y@KFzgZ76TJLRjC`l|oBB^+D_rZ3@ zH-s5U$sdkd%3+0ijt;ZOTedH{zgq74IQBZ@hpewLx486-aK8jT|9zBKa3%kZy@}_2 zxt+(4&89xAofQ%~ojeGb+Jo{iQ=496$i?N5n;+Ex0=|4F4Xz@vgoed2zK#rtEB-?Y zTz`#$0uPkxFf}5eX5JG0A{eHYibhaI-OzFJWcr}>451E%Iz)h(fPDb*qreYd5t#9O z{T94HuNyNAe88TNqZxn+;KU&OCV?(86CTT+$2kHu6jKCt0b9>xiLJT>?Qi&PGX8`x z%p3%lWb!}=paE>eb2#)eUicM_i~x+$)PH=UAZydza{{4I2}rt2Oo;jy!>^(I2Ln00 z*v`FA`lQfQr<%ccP4b)5qlIln@4F|S>pTkmTG_;XJF9q6dT``N==>+MD)!(j`(<3W zEo=aNFPWXUHJ{hke(LnQTKfG*hPc>j(s{Au3yaSUwy5xjCO#aCihXrf&!|lC*!Gp% zm1aD9eOHpB5^AH?dF>wEjjgNoqH6l_-nKhql-)UhD9}G~-_92;!G$Yg*t%H${1~4t zKR(f)jH_%h_ygL);<93;hJUvnaR$+aLv6#F>(&=L z?tFb$d~0|6ck47?arGeAQhL#q$O2nl?Nx50dr!J9add}j?`^449Dka*rK;V}mp3xQ zqF#p7AgXgrT({wIoVP6$1&td+7v+ZxjyNpGY&R-fI)Qq|1Ih*RyB@@@`ik{hVQQhmo>?pl5m5P2pl`-tSsg}c0AQ7Wz@%DtWS-68St zBj7Y~-COl-E%V4|gY8b0-E$wBuioyBeuv_c<4`vLhqFaSL6xaQLUcqkLxhGd2ojaVt~ZN=^?>KT z`wbePLk^#ViUflx!xIqzT(HpmM8n5e3Y8efaMP#Jk1D{=%^7r{3%_OuAp;lk02N5v zX7t7-&dMc~E_N6?Z}%7T@t-;<+~&BFY%BkJ!Zt=|_-pI-rH*{bagV(G%aQ}rqtsQN z=&&yZk8>nDGq*SRlpHbcq9@G!YU}j5dT{LXjx7T#=L&|;@t-Zf=y~sa?T+hvjpJi> zP8U>uJsaMgxr0}+TE$2rEO+fi;nL8Dq00x`AFlKAA855R9?>Y@@ow3^Zbh&9(U+MW zj^^*}`0^AD_pIi5aGMM)`|+n=)qj8Wtn}w^YhSLCGsgD@92x&BUI+u7scU*^a$m~ye=Yu~tNh9FOpY(1iHb9HEZqneh^49}rBHM5o#Gb70;KZWkxtjq>q z*=2veRoN?wYw;Ukb=Na9AvuAj(7kJX=T@Z^x5<=EEPuGXkOo5(0*#eM25&F-^xPG0 zJ3BP*JiS)?Cs(@Pza)_CbYHtMtBui_ziPJuxF@#9x&L%Cv7g_Qd$a7i#RiZL-2gws zqb5XVlVcvoYh{jjWvQMzwEnws+}q`Ak3fc%ze0zgxMD1{VoBz#JvEz5q-{9}jPB%>HxNBlp<8FNg1+2$mbW-@;Ywrb9c>wx5I^hd~Jyw->ss! zXeDRzSIvjKVqAMIG_q{3wb@DqA+x&O*73>3ydMjr(@zywy$agT@!fEKPtC6BXOCm< zlgcv}(7Zi-b~u1l>6VS}`8^p*{^x!gaVyR%=1IQXZV(*#{;mCZf2y6;RAfew)(0VB zr8>RvgB-VqTe5z1KV#>re7-F)glLht-Ox+TrwHGFJ2>QfYWTKYp%u4h57|^CDtwm8 zdCz0EyTxeE)we zTXSibWZSHWRUf?Pk!+JyNAiDX{JHV*Eh*6j3M&kAKu42(PQ4jR1j$`Kr3OkD6gL8< z{@69>Y=B+@Y$|ke)}x9Tfc9vcn~a6xPJaP#q#qLk zvoGx~yl<->K9}fivf}?vb;M3pSY7u2W9luyqI%wj;j>7INH>TmjdVAwAl)S)ElYO@ zNGu4Vq;!XLh=7!UNOuV=B`6^wsnYE`%kTeu*Eg4*+Bw18Id{$4%hhLlXM%r5IKNZa zy=h`iAE{cPa0&gj_NJay?8#G>MsW*CY0H+eb_z$eleDjgq;2tMdF5Zf({UzvE|oaw#y!Y^i(GpXux% zAtr|VQvzx__Aj?o_u@~hN6D>bEbFl@oT_FQIUuC^uW8Qny+gi#(6WidYoXmhHxM&k zGvn?o_St$16g-fMbws!xZ&F5X*?2-d&?zwfBH-#2zbM}G~4xjvS(U?|}(YL(1 z-OrWakRihy^i845UE@lu=z<~Ir}fUo!_VrqT)tOB|7~+85{%zc z!qdu0mmISxcInqw%r5fZTPmxYCe}=Qp(YY7vg^IL=0-E6w&j=1XZFK5QtnH=p=yL~A*CsH zO7ftBL5l_@A$`!HK%QuP#UNR#NptoStetl+`$h`!k-|#eI@bqv9G`F>jC<8yQt#*rKOg4iG<-HoJEv zD5X(4m#|^}=PzOpnY+7;%niXnQv=LCBo`13j2g`Nkl=tG4hX8h_zfJZ8V?v(ppe7) z<_HW7pub`e@+0rbce*nCVTYQ4V-?-7kziA8YL1H))CdQ?fx8M5og;HYlMJnLLytmW zc$8^!z~&6mLgz0z%H1I>25=pF@dXl#zU>hb9HX1-e>)-cj@Ab#&@lNn@T`ys3_1t{ ziMBjCUiZL-9mC)-&0}&|Kk3_nYTL$)H|6&(?z@mM0+1r_jBG+ zH6@WKye0JMc6o#WpFa(AXnp?IMB53rO_Lh#yD6&Wx9@N>?a;~-2Tx#HQDs<=@>gxP z8Pg{d^kU=99JqS(em8LyH}_b|&%==r7m*vLS$33XHY75n#^#)66n2O!p;@tytCugO z1z#7=;?BGBTR}o%Pv$4!$OX0Yr%z)~sw+u1Po$Fx2`O9{pxtF(d$s}whh;FQ0YxFs z!yr&=gP4j9FOe`YkxFC|fQw29g!P532%7 zT9m|-YzsYRTLb}&M4ti5V37Gi02?s=fZTFMbM(*y5LNQxB0&^bF32u#XUh+Hjl%#W z!UJ9yxgr;+j0F$-2(kU2;TQDRWPqT#c;xN3wNU0Mm_=oOXn|w={RFOpCiz?QdJjBb z<`COriZur1S8PmR@`c!R+3smVJ`mY|ely^>3dIA(qj2tO{ezO?rrf=5`5IC;yeePa z`}7Y=OIJHN&%DTCWlb5&f2LL~BsWJo%w6@J)KQI3xT~w&UO=8$K#n>ujvCiGk~c1c z&lbg~8cizx%ww1)xL>F-&vr9iQ0dM+=6*rDMD<2S)wqgk?!XBlQt1iiJ9R8mR7WHR z_R;;e3bfqQ>g;V}Y*`b*d2ZaZDYS1$M3jXbJL>S?&|2J4wT%8FXW-JI5J=EVPlDR% zFrsq4qiG{Y;B$wFkE_0Gm`ZM#O7EVkF+&spvIV22(4duWbi9z_Jfm)um_S@OtDo5H z_qcx$1>w+HcUjFUKl%QAg!&1?PoqRYDbs#DM8`N{jyB_xy2&0z)?W6{dqGcq8 zv!)h!mMEZLIV?F%Q&U&9v9M3?KV1X6&)2(Kzzgg1Enb^}uc^^FIiW za#zg(2)hZ(t#izhS_*Z|ycT$TpAFvKgplV%@lSFY<{?gLiflbp$Cy09e`n%6#YrZY zxQe`wsJQsY`Ai{gZ>=9D85PC&%Xul$u)O47i5IFX9b>YyHV+YJh$fo<70hfg_R8CW zF4cCcgMVH;*CjX)`y@4ash-8QothEveboCXeCn6N0>+%T-GvnA7Up)CIfRmn{^9LOE%kA0&a*TD43^GANtXg!}&UYrMyBJhXS_n)%AeU%P`DwEfT|3>qFTF55k2aDW8IkB|%y z_GctOEY?N^23##GwBmN}5$pXnFu|ngLl;ZSeF<1N76Wbp8(tVDZZ5`~^UT@r{51#S z>W({-?~iAOKMT>LftEJniICwN@z2aQdz4N69}AY;+qyj_EH_E&sO~=TOzrhFsU<() z$83EiQQc_*6!ydw=?Lezvd5twLlaCcX+;W(@^5Hn>*X67wO&8Yr64EIBfIV7Y@h!1 zJCj|S_S1dSpm(LcvYydS!}*XQBl=AjgFdTG5G(OY;q~po;4#@)w+YfG!ZQP{DG+9+bHQ(dPiJ zAjA(M!UBO-m}2`mdjMJl{_7XDmp7$pVtEpJFM7o$QZI(qq}9!M-oR`KwzVj`$R7ebjMduKf(elz zBI81Gt36|wI_K1PtDUu@H>H1#5_KpR^L}*AhHvlVX#jp8H4tq;m65FXel_zSki_gh zvUEATsivl`z>m^;gw5HXTB8{a*wOs3wh-kz#{RCH+*4 zg4T~5Bjg`O3e^ak55uP!p9104hhnNz>`h>&nkx3=L@KG55 zdE(>YYvKs`(P_AoAt9brFbV|zud%L20*nP21d$iNg+#8$3pjtl$cX(fcc0S$2I>v| zU%S}@>evC}5=H{3Q^f|AL0m8@x*1%uTX@L8MFu=@ADa4rVsbzD7kC zC3^A+O_sRYIJChZ5&@foY~gGW5+|1pf;?p1ZEGKcn_*xIGy}foKQLl~1JF2c!^7a{ zkNoe;3P3ak_=Q#wVfKgRbM#tf?+NLFfHcKjRy6g9*U)B$4-Bpz@SWHI$)qLRwQu;1 z*3#)s8Ou!OYEfSXaRn`LTsk}PTR8+8Op5IQD2P(D3R)(=LG#QWJK20Ve!e|j9wV|4 z$xf}{d zhF292paaoTP#_L8To5%05E=|M5{xKBhqD3^y#sjd4kv~)=-pEU)T9Z979y;=7A0Wl zkZ4mQ8~%NdTpBkkBo+gRE{328T#QnP0c#WVgkO&!fQBx>e;4I@Nz&bm5XLW%r-Xh1 zfXze*Ov#$){UQWUo~t4ifF>7-cb!}XN`;~Eg6LKt#PPaO_SGwcx1Woa7J|cp8a20mS?` zAg|l}yoi39Z$h~3AxKPX27S)S*8rGFX|{3E)csURN%FSswD%v@X$+{bpHdCYdmVmmmeXSRnnauuJI3|r!Pk3@JzJ! zzTB72MRU6F|2Q3lRRyRBgA9y01TYg1~qA$QP$+!53{L*SR8LkdAdOF7UmUl@=P zT=TAWIH=VJY(I)<1SkL$2_Eyd09}g+2%*ora4b3`CKdx4G8(7l9cWY(eUThVkbvyi_@tI=nmfG z;-dMnHcRsj_5Qw5#{DSE=+{KE05TJ#fz-6&a<|9iOK9^vk~4_oBKY|+t)E#K)L~Wp~Jw2@n9x0x0I!IqzZjKq$Q?ED2pY!v}N)4C=a+6dD=O4D`Qp3+O$%!C_UJ z5LUwq{Q3-h0CdA#3V92J{s6_>9@qc?t)d&-_-j1+MGOXY_>BaKxXuyTCv!rz@zO3L z6Z_OQ9xs8lsMJ381A^aV%#Y69BC=_MbMmjq!8c(G<+0Vni>K47qn5pRN}aFk3hABA zmWS{q)#rQ6NMw#5rJMG?WTp7~gTBe;{g)<|nQZwd9}b34&93{YCX)dlJ%N*TvNO?! zYbBGWwd^e((&M#MiXRX_v7#)lja`uUddiC-9Lc}aHebZdg zqFEZOH@&YI3ADd_i);w&tw`D+88KI&@QEcL(ND7XV-Gnx@~AiJ9IzjGU#vESSapka z6w9nN+YP`rE3)Q4n4(Ec5kPI{&&5W6IP$H`38Xt!&8F8Ntfy)CoWuH1i}0D8oISl^ zRta$Q0Bk@vygo3U0$L{=3WdrFFkX&FHiF=+|F|w;73iRj2jR%R1x`vb^t>6G?*8va zkadOK`S$t|VYsl>K0H`u5=QQ$w-LESCAk4eOdVFYk?a*Zjsj;Ow}tU8JTxC;CO#m4t z_eL|9Gk?!o;e%eHV$4)l|DZ`D8BLj+Ll;9hhZf&lbiA>j--Z2yaQGs_m>Zsblb$H| z7l=(x&}l#O@xLn)JHC4Bj6E%V%D+=ffFP=&JHU!N{=%xulqyc+)Nph4N^+!|CnvG3 z+mtuq<(19AD7&PXiyF;5ABlQOT941C_1SR&!!ruApWB%!fA@S&f=+Z>zaF@L;s2F7 z@B?9>y=rNp^rYp;nZP zz)OfMMRRE5r|^&l$=I%6)ul!6*A7h?PVdJu8JZb8D8{N&%>r=80CRKO`U zc#}F?DE;u>nMZJ}#cAa~Nb_v?!?t9`gjt?4AT8$0{6oR`Y#p`>qg}J1gx^-Ky*Xx&_BpeyU)6AX*i4TYFxlb%yS;Q@x6X)oOA|j`m5YhWQ$l_pDnsTaqcV04zIrM@sBM zAbaYR2Gw>`%7}l^*H*QZ#ly1m>6a@S2`hmCcXxQCT&`|#E?l|5TWd{=#hxp$Cu%K; zu$UG1|H-Z}%k__c&$z#SnR{p_#p@ntN^tuhB)};X0Cm3;ThmX3S7E)D;D6CRt zsYpZ??5FMlPnTQfOzOu>GyhEB;q$f^_0HkX{w!nAwb>%UGhgj-YWr#Ti)F2=mA~=V zKQh9BB!N_J9+z>aR^9Injf`ERo!v7(tJf{|er_CPTso7M>HW@6QRV7E75!j}L#A1B zsQ2h)G)S|!6&I?rPT_PFd8rYhtYQ7GiP~SOh1}a~+3U#*#vlEj{;G~X&-P{IR}EfpIa`FcFcighSCe8DU2=wM#|yV3kbrHpuHX_)~3cPmGM8PdeN0}+vXXL0*8 zvzbTa7ein0L7MRchg15zk!6b?6+A2s-9w!MuYS7iKAqmRDgBW0_AHUR+I>H|+;fNa z9_r(p1&`PW2g~JEw>np?^o0No8A<}Tl<8m%C!NQef``0kF~$^1oVGlA`kuW4!4g`T z%*Lpcvm7Bd3nk;u_`e{44p8YJOUjM@?}uduYE!R;LMCnf<0Cax6%c(t5sY~~@zXs$ zxtl4d&vXy;r@q7K{?ci0L#a9Der#D)lkz$ zyC*tBmBaWVLGNC$K3CrOBHH>c(f!VcxyXsO)vJSEBT2U6?)x9gqesYGP%SY#Cs`5% zM)K@36m|jkcmGQ6Mp5eb?oQ+3mzS;?>xJR{t(UknN2#pLvG(n+;)s+KOC_m>tn6m$ zu>&6AK;K!mRr6k3`Wq4MnP*jp4L14|#}Y_pG!Qf_f9fnX#YXvGLLPz31n|ixGDK)&4#~i zk5HSGHbQx^sx-5Pzf27u($S3Y`>auXEQNU%h)vs-%^x38U-i>*pSRkTH)A^-)o35F zjz49E#~(^&+=vPiDJ{t===>#pr|m@s7r~01OJrA zgTQ7+F6QtiQsld&!t(4s=&3fy6_KtRU+_t~?ftEp|IMcUBUOqkIGSGX14=}qsZhn( zClRS-4lMVObT`C-w$n0TzlI=NGAJPAMhs-yh64&W{zun^7_!28K+KO8R;}^{h>#{i8a; zos_CqpGm)!@K=n_ZT;r2`+EtBz8d#p($9=PXhl`=y?cIhV~G^y+gR8xL-AvS=8&{- z<&zrAmqOrdwXE#+(W5We2d;~J9pj-#8hcl-n%-qeo_Vb(Y!w$~M|5>0Of~R(bf`>3 za8GCmWc`C49W_rhckX3X@&%LEO!N(i4YkJpGKsmHBD^7QN=t6-_RT9?WZRE-)cUvl zLiGgQ3Q4V{Q&C>CFY(4{TF_BZi`v%>!|YA3-BEq2%Pl#l&IE7uMuP&$%H5~VHkgPe zI;(X4~V^=%dxjwncf{r~gjrQpXRo(u2@5(&_rz!5|Mpcj4tCtyOu^VI4Z*XC0 zJR*Y_P@v2yF4{2A3!aSrgzE-7!X>N%GD8y&W)3YvSaWSiXwD46pbbTn5SuA35-hc% z2#5rY;+SB&;(BdMA_9-V#6w>O0xL`ohP;QTas>DP-7UIH?ekD7NO*l+Y=cvcDelOO z!s>WU!WkuaEX~Nryhavrz|OK!W2Hr}*L?kQD9y9T?3N)+h+(k48S z*Gh1^==XbLUhbEErBke6Fp=@VZgRfWgOzozoG*qn$tT~Tv!q$%Qz+{5wgRh2X*QkR zPH9uTi%V6^#mxk@69fB-EWViu!Xl2-nFR{pozy2pTcooIhi;p$;?8j`zO+9bHQ3&FTM0X?LW{TR+rJ z)uisNUsw5m-{$Abe+IIkzV>{>&quJ$B$3(|9$~Sd;JFdqoz1eNz3uTC0nP4yB%U#J zj)uL&1%2_WU6D#gh{iiEG}BWDVnx5T8TFXU%WEN2_OBWiXR#2{YQEH%PTF$|~Mf_K;r~5QDwmzMOPIB^ub{gTmfc@jQRWX6; z7{2hKACu?OqdL(!wayx>W0sh08J%#>530XAWoM1aoA`Gov`B?%Y?Z!~|FThTH@A}K z*Bu(V^P@Y|eD;I(BrPJwQHhz$#QdfJRc zYs-&jF+jB~aIp&b%^^;Jr)YH=ls*8LK+}W_Fs@Zn{#-cp^6immO^Yny1DuM{(1*#- z#ln+1+!LO3NK=;CSjR@P59qIWdeIki+VwXYE+Y7hYe;SEC;L-VJYLWVi1Q)b8--(Z zxa08Y*BWh|5cPHZrFU*u|KXjbL98u||7x0T5pOTXxkXCi_OiQtH9wz{Ju;=s$HV(V zK?#*f>i%9#T4fKR#yz8y?JU_EF{(g95`kJtCcqZVTC;jJ?y?z~FE06Mm5Xic^@4NM zEc3T-wHITNd5kg6PTQUe4fRKQrPkyhddd^MZ48oG$Spn_K9_gmdO3i4ni(ZgxboKL zLxWK5gi(8lcU-(moBzy7{@v6{`LwieN1hhjj?T&9f=uTnKMLl{qEv-QcKUzR`w`g? z=ySCYFTAQnDTFybcGCY4@-WPy#V~#*LU5@3Yd%GoEiDCcX!1I}a6(OEehNM1ojURH z7uB}g2TjtipUhE43EjOT5FhJNCW( z99J?XZi;t*hEF^GcV**N9I#Tqz@q>p%)tO@lOf?${{c%23Aj!!I7Zt=(3wYQxB{`$ z4kj4Rnq;DML=eVF?%k<2DA?@qon%WJ1Zg4Btcu`K=*N&;Abij~sQ}ni831F0p*`Xt z6}XQMJfjs3OOgU!3~ioI7`wO_V1XPs8=b9?IqX&+FzGEK4IVQ9e-xWG6ajF17g)eK zLICm|qw$Pz{+>n3j%fj&E3l=W69Jp;8A-?1s8kS}vngfRFWQY#63An8{_$=yKa3JzxH8$l=(!B1{9MvW=IQ6HjPjb{ zY@W0c8|S*R<)30EHIWofd)9AWd#G#lbqyBCQVXa?t$KdT*9l~yvAk4O?yyhKef>R7 zLDPoJo_I1LDu|e1=l#Zryjeujj|{Wm-Y{0|bk9*6JYX2PZ82I;wYArJHu$9{JCM#x zTvzaZdol%M)K6^<-I1iwm5fIWK9`S=ESjEXV+)oV{yt3a2-%HS8O{-t^s!|9wqruK zv-+II{x>S-SvjBegoL5QO8XcsulrZjBPZinCn+TZ`$rDbN@{nC@y}Z!kJD%(OYAD;?NrwQ?j)XhCD)A%DXBp=(~IQ?{_4_rRzz zfm*M!06mS1Jv+_%K}v#{B%NrfvI=p_@+UlNSLSGEwMVynrQ-NrkbQgUEX|XElbV=6 zljF!^g}p;&{Lw^!meDD=PJ*{9x=8NVxAb^=oU{-0LZ{nDQlGPVMmsdss~O9lG)cZ6 z!OR-QuNUZyx7)0@$*cL~yF-&Qbuf}I`Gv`3eC2#MWy&HJx0ga?Kw)*pAd+6{PoZdK z8Eff8Q|KS2#O$zdc4r-Sn`IIH(<)n1rSdM#gh$emge0P$>|NvI{qqVsc_BF3IT8j{ zKLdyd-EKoK)&#Kh@Y+X$eDMb)a$;Vapn*yg$c&qT3DAfEGTV9t>(jgqzcx36{*4EMt(;u&;r9WgKfs=2iYL4fVy{Y61o$H3GF`Vqpx=GKk*l&vFvz$gXLr`PuF zTm9UTpCCBdL|*|L;LZ>~5_2B#Rw*Rt03HQMt+)kEa4^!HZDa5Q2pNLeR|oFD#8O%^U2WmX+g#kU6w-G(yC6Bwfkjk;?NXWxv}JpZxp##n#Nuc+)~(dr{yq>L2v+s+!YuI(Z{Y<2KI-s3P>{ zDtyq3aJxo?VqV-ud(e{UD(qEt?j@b!>g8YYR6ilZnDL9k`Y76`Icg|r(oJgiehv2Y z$e0QZ45dn|p6-qPmuKnCvsrmmslMa!73o3~wg(h?EtE9Wos42UMOJ+&#yZ&Mn4nd7gO7LrXV3o^KK;-_~_*HuYoafHPoi&!6y)+F8dMMXeH$%m3*V(V7zY-n3|Xx4p8r`%|MN%WF6rA%o%Z-d)}7@5 zQx%!8%uaRg;sHdScUMoAIe~u!T0JfR~Du;RC1ItHW6+781FW0gqcKo=VY?p`G8rY0Q{ zh|4@AC=Jla&;n-i3}P5ZZZPKnl8E_QP$#vWw}%nw$A z?tylZfwd$sJ;~uPz^v~0MEn6U<8!y$u9ZI+MA^mwyj%~7;XoEb$YYES^AUO zn&8q`QUnB?kr0&UxRDDC>0^)XDOyP?F0~J+F*RTeD0BRHJ;k;81u-hi`oKDUc4vl}r6zZ<1OdzMPJ4~m741qX~; z)LeTE;?$%RS6ox_ZmJBm_iM3=&t}fdY|;qZ7>g8bXsF#L?aI$Kobkz5tbWQjTP#V+$4lXQ?)G~x%V%E|A;xY$ zMm#-r{9%PvUvRwMb;g}C?P2J9F~qKcLoT7ykq~*F?ayCj%$P@|%qsKb+nxLA0c#59 znkNYl=tLDtEk$LOyFzUOE6SyY8jc31t5&Wo`+xTQgGNJtnjr#>YWWiU3AObtna^LT zoI7Yo<>zehC1)&Jjt7qO4F}n^-bDPQjQlg?hNyEOC7_WpLR~1V>HmJDK}jr}H!59>T)1JTHQfgdR^+$u#VoBxGWUXHbQ8S3 zWRMgAODRuPW)6<3lzPqIySiJ3jR=p^AxD4tW@q;?9?Z{#cjhyae+L*oOLr1dWvlaJ z%p5AedHe(?DNSQtLZMoUamAOq!KbqC(?yMqSf=($XM$j5NAg)#s!TytK1Y&Su9tDD zZObDG-m8k|(`Jm*0~SXQBvm<;gkCt5Zm#Z^J*am(wC!H@nr+f}UJ^A{L=_kRsdnrm z=i=^2-JWoVn$++UgwmK+11*Nw>v_*~QK8UG>wE=IK01?`A#(-#J732YH&pB*rvqkI z|IR-(nJ^ZZZSRc{|I=k$NxFv0rb|x_cQ)hy$y{!Vzr|O7-%KeumQy&PX-`TrMLU^5 zs6$WVm5->w7O_MAN?fm7m)DE5_Y{G}6HP_*?l*-Kw|4y~OHXq&Hc2|tOZ~KtS_H~^ zc@z1}COiKMuN}6{6G7%>K-_~^Knz^$-0Sdg2&2tan;a;zfQ;MVynwu5>wTa!Ehk2> zQXd1%9HPLZI|DHo+7Q>w$3Q@fNWcpKDbwwWc;XUqz0HMQKy+WxmL3d8kns$bAO@TV z+GBm^3)_a9g5H$5=Y();knUfF#jpTp`v|e);I~$$YQi4g`U>=4BJ@(JAoCwRy8~J; zgv0}SHSE!bAJL0YF#iVXFIcn|rfWa}feV_rU@0T?MPN#@g=5?Z1S&KhUE(XMgc!P~ z1(OV~xH(;OS6LGEcXA#~HuVlU^CdlYjGXdoc;OaV!WA1ojL4jG3Ql$qUYo1;o%uA~ zAHyxQ7xSFuM~KmDL!|+pUDr|K??rJ@K zWxkZ^vr&`ZEq&(u69n^5M-sD(DY!YlkCE;+EqL1{RurC*FsigvO>Xg^x|@vje8_(# zF_|CEj%h{OrS@+WEmht{$&>hTofZ&>ou;pHOiqaFn-TvFESaMVZDjg!ujKvUa8iA3 z?Z{J=-C~6=XMTvJiF*`tlV?uwAhLh_3 z@4tT4sC{IUAypj|VOf14!$^_dVEtU4Br$&0P`a1&Mcx)|>WO6(qn|g^eNjo+^>gT1phxqJ{uqfG!eV)&-EzyL zhPHV5@zcPv#r0%k67i#7-jQ;R!w9UUx~=M$hsJ4aO7+cVY0nBOU#ybjQ)-JR1eBEr zn9#X-G5g)&i*Igm(BKvSss?5T1w)VBpc){Tt(#eRr8S1d?Vn&dwDyH zmdh}HiW+E{fD?u`8sPHzS1%pZb49bjP6!e|3@0Rx705Of`KhE!K( z0|Zk58G~7`-XEv{&>>qrE_e{STsd^>4AjY3yk5Z@UEA}g(#P^d;520&TJ)ZEF{w2(oyKJsd0Aq3oaK+_egkdlk_IKC54u{ z-ffhq9J88hcj3b;t=eclXTRAxq2jnmm5O^=zbu#vX@cw-lk-L-ye3A57A1w;E-JIN zy4i()d%uV;D&361?~$MIab9?7qr7sIB4Ksn`!PdJXBs8%H|KpCXz7~xY$95wx_rWf zprvrIGfyD2LFqiH6I*4!pRS^1;g?zJ?vL`XBPq^9k{{@@F1ju~#VwLUDH46liKTP| z3~C|^*%`CSxu(7z>XIx`#7p+A{iQs8o9yTCWN!07OdYJy^I7U~3JyJSj!Le~_>=bF!DHyl}Hshvbu(1;HU{t8d#V3#GopAKtj_hq%Rxd+|=c zY^a)7ri+QP+z+d2#u7_iy%fkTH+>ELxlFQS=w48~LR8aJdT_2*e~A95@37;P_U+Am z@jn7?b~H!gvivbO<2oej5NdVpp#_^I?{j!=@4jBbtUpg*S?@UJRepYW^QCiW!sC#s zXg4+5C3@95{AR^`wG&$Huj@n0pV^9%Ha)U;dJ!&oob9X2CxWsPFEXssBfStpwkBP% z4{$p80%UGB@5rAlvp7Xf9CDftP7q25JirKAbr{PW--z$@x@ok(cobz~IL`l#I@8OC zq$82}+fTg}M1@BKYh`pWzT)O`&YS)dw#O4g4|!zk++7BvCe&@W`qPc(lqzrdbqq3J z39hPNrM5guHloqZ`c)@1S?~G%WvYRF`Z+Cg`V%F4x52x&#g%BD?zEQms;VZ~=nT(i zwM0}~b2QkHhPeM$F*?tvvR){3SoD1T+Qx(XvuLAsWRp#GO6RGl*Og7?&Oa~cU&_%($79g`6s(|7utk{3tpv+{&MQ< zN+ydB?0rHVm^Ri_))nRI#{3V8v}tKSeI+ZtJUyxK{UAG^ZVKOmJ-{wtjChmPSQx|* zGoVS~zlK3E=l78e3yF5EBMTs1V0cDi9>a8r$e~;Q!T^$JfNJVT(ZvrL59is{pO(h#_CaQnsT$lTJVd!1 zhYOo}W_#66AKashA>|&UQ4*>P-SDN_u;w3cct#;|zs|~fDXL6me!sfO^PPL=SxU(K zVQ|?G`{7cO)BX<4FDny&`~-~aC%y%@sdqq|6t~z>b z?=iD%NPLaZJr=Ka7oD+hrb~$sdrG6%@M|RFjR&fuv_+7yYkaDwvAEDDu&7b3P`{2P zy4t7O<%wBclCs2e#%%4gAN46n^~SGu-kTB8S0ADhtr`ak?IvENJ#QX=>hNrQXATQ* za=N)(>5)6MV!~YAHtxQ`!=!x>x_*NI{*z zN$sdMVd=-3Q_R>>NsINy=Va@kBR;95bem)l*?MM>bCqndZ)}ztv(n(HxXEIEA?;;$&9DKF zK>hET>y-g1HF-V)o#Sphf%t2^A@Nf&HmJ;cGjDe*8@H#XrFZTpD}5GTwqDLEN@>h< zYQM6bj?Rpw(XL+^l9)Vc)hW;pn8}bW6Px8qKTivkp?wwC^H*@zx4>%uOR?_d;Mm=p zliaIWy-CGVlAr=owdn^BukOqosi}osgP#(W_4#=OrQW4Y-_JiD`}$=rNT3E=`W>fB zKfUt)b^6AskuEbku{K}Z`@o2Dvv%`BO^(06q5DNehf1R~DtoGtKZ^McN9fa>5QXC8 z4V|utWTwRX$1&RpKCutT)7%!VtNCmU><V6 zwqw@y#vk>rsk;YNe1+kH8AY)L8vzfOM!1wqPNi59j4QZm8raiZ<27~=tKnO|l0zN_ z#OZ!}F)vrdDRs6pbyCI;Y^GV#Yje1@+u!Jr5J#&fc6J+t&xUJO1;;>_`bR?S z^s5lYJka3bfXF@Cu)!WQn8?aI;DE#0haL_CM}83!eKB|!hF2zI4v(ycFv3lrfn2dm zWLO><5cFsb-^34nA7rhYjOB~0f+%NF)Z!8bHE-b23~(- z5X{ZNLVY4U3?MlPloNlO3zJet@~HgBXwV-8Vf6h7rZdqH{y1wWah6^X=!>dR_el6& zAAr;4ySr`L*K*(A)Pb_GnJ3A^%F@^dn}xZ?S#YN&$JbTk)}1NAtUAt z%Z_!Ix8ufa-D{im1qb@g>Av6N$gUkwW>3OtH;NqBC-qP9H1Ci=B%-r*m(yMhW0g}K% zr}3t0FDNow2Se29x$<41=iR=4T>2-Ze-Bpel{Ro68c)(PCME93w`k8_(z0G=cxA4U zc6Ih!ihe8FF#2n%P!oI^c{n?H5hXPDxmrf;=J&?lN}m4ww;6WI@%xCAXU*R0Lzgdb z&WSd&;**74xW0GYW36mfFeN-<&(um>&uou0Qn=k;d-<6AJ1Unrs&_Q6JPiaKF2pXQvPtyo zT4m2zf@W+y5TcI-8J3P!b4DZp`si7n8F6-FZ6c zuoC;tFZ@UdMLx)ka%HJh73(fDEgo8L{rLO!-hkaIYt)GkPb1&hpXRxJRrM^aFU$h5 zcOT5YXIg7iJZ?&n8-32OXKOSI-d#G#{BZXl zk>$KTcw#q|E$Sa6ATES6r?GsF^eRQ?Mt z;xhe%79SCsRr-}<@u{afw;TP9J%5yJ?Anzocr~u}n4~89QF&-bC^&r@k{Zd#bW1eJ zd3WHrJYnFVJAjs-{Nr?~p-M_DO?bPBYJ-0KZ0@EPBKR-1E7lEJnd-!f2s8u9f;R8!l7 zK1T6~=oaIdfod3Y2c{keE==ViIV7)y85K{X9o4KHS1o62o@>4L{yV<#iNxM_5rI@Y zS!|7w$cfsy-mXD01*_p~(#|BofPyBKQ0c~!`prhk?9%vGw4sIcJKrmBF^%0HaS0cf z*a~>g{`U8&1BKsUzx~$GrN>fGupejBf?nIOxeAS#STCsQCv-=zp_p}*n!Y$Zq1WIO z?{iAm<(!!C>g_4pfY0{1*#%?`BJ>xv>aC$5@<$%EIT<4dlwgb+(74wi)V{hbT#X(_6A%4A8Yw7@P zVDVyQiCWq8uI2trHsh2OTOf!zsmE_l|Bxoy*<(<)P~9)H6G?NGoe&1}ouJFuZc`89 z@Qkz^qbC#L+woU39y*=zF$%W`oG!Tr#{WTD$ybwS>Hi?o8|<+_Ve7tH|H&gFL((h3 zG%-HSI9WaRWH<8MG?dqDWJ5HP_H~b4_j%Gk$T3ZQsz**@ zEP1m$KwaR$=k5l_I*Fkl?`{b59Si+xHqvhpu&pp$76- zQq{&x_UWi^hamfT1Yzyj!B_98fS;-<{_{5GqdK-Ud6vmrJWe$7cbf3>txUU&gNe9E zAH5!nlt(ZJN6O>RTtpcO;n%g^)3=r@eBNJcA!j>FPW$}bOZ(`q8s633$U3$^VCkN< zsT9SJ5r_u2NmsA;jYf9{Ovbd0vMbewMAhtlPN-rWOw=>kk1QW}#x#3O96G;AkC8U6 zNv$B%J&6tX7$qd3Q;@gD7wLoFctr44X`UGOso@Of16%-mcC)1h|R8Q2;e6RZ(%c`r+z9jp4*GK<2p<~@lcx%&nhLu0?pnuz z$Y841X+LgOBVkC;3$P=CM?fQj7^J}G(j%3cUfQ%BZugG%bla7gO@)8+!Vii|%-qeg z4YZr&JFjN`kbI9`T{5v)ZM{#y%ALNT9&i)_rapW0^Ek^Q}Tj+8W)0IZF^ zm7f9)K1fWkEChsKTPXL~*q4EW?Xes=HItk*xw&q1T%?O^K6_l(Q2kHk2fj+<3W0PV z??`I}v__^IZE3ZttI079rZ7)b@5cvm%cwq2@JuO}_&KrX8@QS_^0?oHj`{nM4U0{w z<(e5$>?N^ot87kV|D5;WtVByt*Gd&rwi)-@&)Vuc3t6|RPK6?~I%f56! zmUr41T^FBVPiN#msF6!uk8F9tU9a~IXV+v&ioCSe(xq#_j0?gpLfGQxz|De#7x~`w zWPJGtEX7O9Hf2_WMkltoA0s1+(hnJabZgrVkT@HqlG}DE?zSt{lv?-*q`t@4GJ4=C6#c^@}QX|6a5) z(kFCx*VnBj;$sx>G#~C@th|AZ7&0u8XF|y3YeqdV8P-{_@(mq#P!ZQRs1;fqZ6NLY zJyx(KJLFJza_7{}e~7!c{6Inui02=1soUK#O*w@J7eP6Rp&!2Kj`s5#7=Kf4j>o6r#aLlV6=g3++_s&VapQg0r=G|UB!P7F4zPP)&{zD zH=TyZjG&SM7WTUz;lZ7-g!e#o9)hsE?L~#5t4$$nA58(MZoR}Rk=t)|rO4SbA_RYrkha$y=qvwq{b?zH|c`qu~Nl<;S zmamf?$`l_-9?wpmL~I$IfFaIFIM>EGeJ6C6oHb#Utm)WZ{zb`b+9$5bv~*MFDB(T@ z{ca9%H}&vad8a`g&lEj)VBO-7`zSt=K&L%sGyuyW6g z{DqXD>Cjx1d?;7XZQFRXO{lC8ZcqF-gE&GN{vW;5!VyWmEbsp~<8Nu=iDlJhGwPRb;knjpR6iY+P~h#FvUAOp?s{^W z<}Zr!f;%w*YE865#qG@niU`sKGV#C$fZLXWpD}cjKqRH5Zeby}h6HKlhd^wuZ`Z&k zh^b@+`oC3F?z75Hu!enWJyO^VpKEV7Q$V1mw`FcoEFDHHXg?H86Z>GXYoGmZ|40G6rR?F{H-DElh~ zT?6C65}0*@mdySaoWkBelfq_%eis4!L{#QtZ*ec)MDV?=A@eibxLBO5bGR~Yidaca zK6ki`_HwmR*7)(krZ?l+Am*>Cql;^bjoRHs2O0kP%6=2R!lQHkT(;^L{7RALQJvJ> zQO%5ZnC2p+2B!THk~WoeB1pOO$*JQ3;SIc7I-U>n=&n5K38(mK z^^eU${lv3Zd4z%r{(;oVla{7wNm(Q+N^?| znY7-uyRo^DUQkz4;p3WffAUJ@&#_1#%E62I%Y`3V3+wvVS08oZZ(YEQoz@(f3;bWq z&j@a&WaRCL`Ou>pte?Sxf$SYv0gH1>E+hkj&BoxkCy9phYnA81PC-2({-;^zeN$X) zIxyD=;R5vz1Y}GS4K3V*oIwNS&e%TQCKnJ6hz)KoT_tv!h6_aMz9}5~i~zJrBXy9s zcy8dT?zofO$wJ?@I#U*PLV)4WperE@L7jjL1sq*f4g4Bdj6)bgs5Zb{^_%$M`>$o zP75a1%HDRB{53kXR>s!t249Wx-a_AUU~fx=Rm0g~_=CZ5_V!-o9 z(cKADnZBe+LkhkV!1korAuG=hw$XP}4#2Gdr^JP{ciyIY_WK(UsLq!~GIR6;>*t4H z3$dR;lIUDwIxG?oqmyThhCIY3H*+@4z4IF+h<=P<@MD7nhirifX7>whc#id5Mq?-x z`wWuZ2?TYPf+^8=X4AnZfuVu1-qM=g|LGdp4|J(ar6A;#lQz#U(BKP(m{_Dd{mB-& zyUUwUu(2yYnM2Q8@$ zxOzk7l*QVeC|*4bnph3H-!sav%nTZ&Zi?v&Q8lrS=k-i~Iq#1ZPqg0|xMoA2%%(L= zTj8-C^R?X6dE}4R|H;YbPWmO&HbvU^vaVHDmc{;YF8ZXl@FA$@1-(EqmQ*nI1Lf=# zEULs1h_An=$2l^5X zUJ3mnP+3z=eTWGFKQ5R<`(dugeN*r*;AMeWvF3tZE6~95p#JW%|AjY@W`JaX?yFF1 zc49+|aUqZpChjPPQXxtBoXDz=HsNJN}S4f8LA1w^;u57K`C zLQdNQAF8sw)06qNuQ^X%GQ7l;Mv3WsUY+0D9C;J`_r472T_VRfI7*FtJTao|rKZ#M zt!kJs#@{vvwY9a@a7#``jUr)fX_aU%^2%9iN*P*C-yjEraHdZuu-+g~3N^VPhnTo# zKE`h9Ng@NKr7Ws{A&Fa}1|=Fg)H>7Ij~vB?6&nwTf&QkHSZ-%{_6IE`wZ-QeecMlN5n6u@_j1u zkk?ga34Y7xP{cJxRqa$K+otrEnL-{(O?xjy3QZ2d^W8&^rVsmvQ5BZ^WoZPAsT{kh zw+I>EJH=e;!D^ORBHtZZE;;!6ycr-1=9}LB)j4M{O}F>QIi#cSc<KA+Waqv`>KW(^xkJ2_ar11fK*7h8PW4$g|r?bYYO?g+TrSITebC z!l*wGh88q9=)V*au=%6CgK~3$5}2tV*!W}-yg*>SK~i&jx1=LLKnIc!5q+EsDQWLS zBajVPC%COJpjAjB^*j;mDTRg{SGk0Jq=S_KQSb~1{@GM84CwXB0bvzvw%f^hb_in& z3=13U3>!}R6$*l1?2lOF!La-}2ne}>9dEmO(DUoJham?i-)tN`JF)^+QP*eRb22|+ zF}6$MOloL1LcQl!Q~0t5)kehCtmM5eJ`3e~ua_h>1Qde&4!xgTulp5)LIt$#UNnwc zVEq;y^0Ig6{zjF@md8q1>{5doD`KT|*!#*eS2mn#ty9g6A-LQ0vwEaK{9(jgh&!sY zFQCyEv1=B(;x@jwutY7>QfI(o)IeTZiv5=2H|gLrxCP#TWb_Z=q*UGFAeQ<9+sdK! zNW~UUYx!I%#zIEM{QlWb&jGX~Ccbl+-pBdth`1Q2lP4}o6f`GLn5H@G->dm#z?F=A zF-ObikY7VFV9oDTTP{>!Wm!YZ=bFDGJkoEmC>|$=!-Fz#eja(cetM6?*@%Q1xoOU` zxA_K)HmeMF-K~QOtJy^~ESiRgGjI>H?KPXvD1m%hOoae%?Sb+`pW z+%ESYZcAZfeFw&+*rnJB-G;#a0JIZuJ8rj1QHr}bm3!DwF+W&1?mdD%P=n}@lFC!~ z$OIvC!skC^9wQD$KQBXzz~0rphrl}Ju#TZha-fG3jGBzn0MLoW&iw2R7HHPrDp1I7u9TOshgAt!{m7VOZh*bA5HmimgiH?;jk8&XPzQh&1 zX!e+0Tz)JBMHhq`M)5hknYioR>yp@-S{mn(S?~E=!gHPBnC8dw-W@sG=5Z0nxbd@J zBe;=ix&$s?Sgctz=0Z<}G9J&c>e3RH>Bd`Q5aq-l!iTv9g}G!??(%oHtLCuGY#~;t zdoS+E7Ss!V!M;fQN~-L}F>@U6ORe@mKAf{n1!!cd5N}v=E{0-%N=*!6rX_nURPf5G z1|sNKEl|aC^EPy(wPWMSi-Qc0bE2O@%b|~5y%u9j>kodxge|OFjepR@Zhotu9(q~s z%KFEHSukqJH+A+CIc3vwD0f`*R*)1LZO9SG%Dt=oH995D+xJ^c5~q}1cg(1h+69LK z4_zSU1MbHstC)Q8^1m^}v)eI<;+Gla6afvNzb3ByEuMJrH78qlc2{B^zohi0c-^NNOTmwRt^xhy& zpU<)FZzMJj%h|^=Jc~VSEXqPGLjVH+BtcxQAnAbzZnWW}LHEf&(w3A1V}HorBjw&h z75y|GRAXaNARUOIQUHu=zk!W~MbQOCDn%=iD~_guvO3eDF!LYqAFNA(NGX`$7?ydt za`{rOuD5Dzc_j`b`azGx2YT7=wE2$pT;#Q=LSBZ+mz>hBh`O61t{pwD5ua^$bFDf< zjO>t@jGUbU{k?L{XVo~#(KHzMxG1GMIU0MTNGoI6Di|)dopvjlVn0ctf8hD_che}{ z=t+tY4g6j?{xfDP&e;O05>}Js=&?K4Vem6vrz>jj#K>Ckb*LD$b)6jj67~IeySB60vH1m`kWp*1urz%Y@7*q4EdP7M6f6TW&9O6y z(MhFRLdt9`HS)ezo@3SY85CU69e85At6PmUab}UfEF229$3GTj_nn8a5t8J1rcXu} z^5*7n*auh8DY~$d(p970UoWe;||Fd_AL^|q%15QF9pCV<5{B#VsUxOT!*x$v>9-?@A(&#dvpQ$du#|?$r|ijF?S-E) zeJrYbY%|A$J7Em5%SYDC_fO|h%@i+|eF!NUDjzftPY!*-D}~L$R~yg0V@quL-V|Fi zpNA(p9GfK(_c}5N3D1W^Ii=+aJ5j_++;E`ZHl~&EsP#$amfm{ z)j!VNv%B4jbv9eUVux?U3VrE0dROcZdr)7^Z41jKCweYkzxk~GdDK~}JRHQ=7UnMG zQf#yM3>o~W?~f?}O_&U$vj%n>ZYR_dI1U)`?G1$WV><*7m}&y9uwyKiASsqhs5EbX zC7MEc3=Dykfl!=6IGWhV!8ZY|!JRsbJE%$Qhi&8o>z9_MWsuU4Kb>7g=sUrGsOFH*zYc6bT5FbEdX5<+N@bI7voC}d6Q zt+}q+dGYefPF=~XYu)@{)UBkdv{^#M=ybNHxjWuE!eRL2Tbq#Ji$TYi3BhgKq1t{_ zb^g>VdG8oauXhJt3JCwjGc`{lQo;|$wb7PBkrS8P4Wabf5aGb*j&3}8h=jCaK?-G| zYEn2-5Nz&zz)vZqg-A_%$Smme+4>*H?l;H?J4$j_Tf;1oD4DG79@62TWG1ZrKgn=# z_;q94oxV?=b3LjCtkIfqZ7sMZ^gS%sV&KI&XvD_tA8dkr-v7p)CNzxoOCCzjRG=BG z`z`**b56tjASI;&D>-@O;u2PjM)~9dtsytTo#OizHLzzrk(h-0Z(F!JqEk-9bVf#N zxAC|#>#r9Xdb3UB>f-$Z9pAm!UTZM#ht%Uz!HM;CsssN4U1!qP?4dYPeSLcbrf34w zx9<_nte-pU@l3&b05N#py`ggPzgdEk-U};FnDWE~>wn~D0l<>*vpbv==5x-dje8N6 z-=PkqOT_qfa(vaMmLR!^YTS4mPvD6QX?aH~sUw&QyCm#5Q=Wa@o~!X3`o7~i0c@6K zn^%K_@B?n0JJ-F2hs22d0gS!lZSt2Vzx-|93{|2R*HG*Ek9`%kEasKXK1bczY_YS9 zvt#Typ*CV+UK}!|i}H{kS@I;`z$t?}?$b9zKeUF>ir=*Xq+|{CUu@)?S!l(T=W&{6 z`Xe-Ntd|$)3w7JS$&XC!ic8`OA#LX7#ieGRNB>clrrD+y*VxCOk;OPWHOCG^rsOcM zoZs&q-!Xc#r5_JoXPe_ebJMxDpqUU&=3$8IR*sM$rf8}*}KEJG-6d*dq zey9@y!GZx(#ns@z;!ULt#*jV2u^AB)!1~ScEj2mozJBJ3_DHyRL^%m5g?`s`uu>W` zhCfxFwW-Xyo4S(Vj)oPpU^oPqnko_S+UEO_B*md0zJLN9CcLi7`dW;u(1=(Od7@F? zjRkE{x&SJdmQw(gDw+0pvl7dZonq5jxkg6B!QCwL2t`jU7#nWqWu@u8V9-mbmTIm5 zRVOc0wkQ-IOuBxWk+;@rTor{oq7xE!$|LkN_43Wz!@%f1vx#iZCV^c)wT2kAOmoi= zZXbO95*dzTI1ZOvwT;#x%uTAT{c~_0brNY+_bkrxBmO*Tjgb8@4XKbK1TMkzRtZv2}HD8cilRj6bbQ(c}EqzDCr%H=W=;vYkJLWr>wb@S2T z4k$QQi!Qbu#0V-~es%&e!tM2e+|lUt!;;saG)+W7a4?Gyh7t`~p7w$l%{$+Nqwj)z zmH0*FE-qvbn5Kh6p1e*~ttTx)L%#jntV5nO>W_bzbKIvo@?4rf?!2~H_;*Zf{oDoe z$7ovogJav}zrt}ENM;>w|5mWAZIE8}W zAHK~yT`s3pI>l1)|~%^wA)qIsqmjyopK@Ar>|J(JN>^Wv(B2*QB& z&3$1_7HCy%H|YZzcXwncM*(R+k$;X|ohe2{-m2B(}e ze&+}#g17**8_2_v5O`^7iaJCfNxL#GdV&f}B@vpzwR_P;e5V`+%ZNGCzIBwY_{+S5Y%?7I0m{SE*L%HPa2kMH?skw-QIT8 zdbpLOh8&Uy!@?48LcdR=RDTT|oNc=eoRc3;&25OQ){3hLPR)uFwzbRDGV9rjyFc-~ zBpR!fOpje*b_;)fN8Rd>PQ?1)+d?Ca_+8tUhJMeW^4hFqC*V=^KkL1w$zFQ71#88eru`qB(~kR+&_MDc1c!?0Ut|ssa@t%D$UDVGj6H>;&_OY z-8JvHcg%sN@$;ZBI+*&dHYVhmP`flM4gn`uT>{=x5>vZ0FaAQXBzEccVuX?vo*6GC z!kl_(S`_D<_t}8!&Z+#-rC>uMDqMb{EC45y;|q8Hb5JbB{1TdzipN{G6f@DupjiAjRzs z5xQ^B4OfDraG8*D@L)LddG1VS`)71^XC114*M@7(4uWJ*u|t+Fzg&0aAMaCfi!Q&5Fiy)# z|3L@Ov!(6!O~)p|?8NrMhU&Zlb8VCor5&e*6a5N)tIh*uN}9$$qbX6WJ`FbRW{>I% zd_`@}&7VuwFKE9L<3{W*xd!NJ9saz3hYw!x2kyR_5SNfoNhnr$8bCm3_FYl4&XA#( z!9+U7igkW!&`(mUx2=T*pFbBzkn?$RIA1<8iO3VCVN;9GmnW}{3to(A@e$zPij4Z;zW?2vhgO06#z(?sn253ANLe_tqZA7}7YiGrCM_+Si$pWkWJ(o5t_TQb7jhZ~a51YSs-g#qf77-E= zn&QtwJ3sv+`NG-c@voOjIi%h3@fF3~V$$x04GtlUO#cvTM!kUJJ&!ISAq|$xFCdTP zrihZUpkbjN%XctOVFGtzwl7L9e~jvzCLtVGGE##D4k#9|m>SrY$nYNCEk#YfrE0c{ zpX}WROq+sIJ-zwK6@=!I_$(B_RwAVGax0{hNb;G8TVoyK8B zihblQnPq@opzyWv^1~?Ox)W}h$%LM+w;tg~B1#-dseu9%yxY;H*~1DZO}oYT6Xzm^ z3HpaC$FJF+FwE8kjJw;%KE3y7ZDuGXqrh#D)VpqlUG;MCjHIRR(S(V`+`9-RpMw*V zID2nr?*VqZN!s@Qy=d*0cweo#^tE%v?d*yLte<{Il6*9W>znT19M<*?T8Pw;%h$uN zON9@vD;De89vnP!?w%@at1P)<$ej89Xz8y=H45|NP^;GO^6tM7toWH0YP;kw8F92> z4rEK`ZKU)~Sj!Epd%s7YVK{bX19|?1xP8NP^K9cIf`JEQT_Em9OQ9f2w@whQfy0tN z1_KV&28SsUa_dHsJ`miQ_dt;b$e9$t@F#2kbBa=}Xhv>)7&!hRq91ru8?>}so|GCk z1sYhbv_@k6%49zps3tPOoz57Mi2m$N!U#Etv>YuIYNG+%EEM8c_`9kRe-hS>W~$Cjw;BP!;%{Hb&_Lc01qXQ4Tgfm`MI#1XGx?VgtlQ}(0C&g7zI`K44qGDx zN({$V!p?uM1g5cp0s%hxy;qmianS(8%k-48;$O%+Ns5>p-q<>i`X7_0h58rCRl5G| zW&!G|(SwCAMba}BwSJ$AzoxjRi{%W_$@}eX;?UZf^Z2vw%%(G#0h*B{^HOTy&$Qi6 z&d{M!9Jed~Tyoah-_WrT-@vnit-BZS^3Np+=nI)>cpo9_o?h5qG$e5&$hcPhGCyb2 z>09t0z4XV|ljl{M>Tj6qMJu>o6viYO-Z(s&A6j%Jy>4u5R9%@6EHtqgjn0UX6I-2n zHi>dJ5WIHQ$~punOQ$Ah6Vl%~>OFS+UAnsf5LRZZoTobQ4&db=_?{S;{8_vbEc zt6K=3qz={{A8r1#Hr4RRr2!{l%?OiZb6i@cDmf@W;GyC(Fi37@-u&$=$C3|*GV|-; ziPfT)bG^==Y@hFj^G4-^Rjm(I)}!Kk6xrAMUKS;AxqLjL)fh4>Xv)|ZS%`?2%wmpH zPj2SDtML7`rW*g}o;D7uh}1#OclZaN)7z2^`dpU5E-ZnlI2*xLr5q-|DxIc}te+*Sil>OmhpkNgQ2u`;^k|^shK_VjOjh~kS zG!-a#wT9R2B}UjRYp<-Q{>B=7_)%dVKP3q?WM$gCh2HV6OO*RbnxwrC4jUR8QBy7Y znAgxE6exgaE)){P+UOm>` zD6hE?#VpqVqS)OPqAEmxrrdKC9jZo!d^eObL%A{!RPKD5sF|vlW(cjV&W$)YB%fe& zm+XuB+PCKfk1q>*WK+85-ufI3X{fX;c#<_Wfap8|DFbt%mLd)M&jWxKmszxw202tp z78|NTnE@q!3_&6W;~_9K*yDC53N$g&CJ~|m{L1YQ5Jm+j%hkXlFAe;RM(2aj3Divy z{YW_y%^+#`Ln&Eq8^r(Iix2`-O96NkOa)0Hpf*gf_xS)m2L{zM5I1h*=EKGqGhp#( z*cgI1H<$tq0mW1}2Mi5_yBN7)`95Inzj2p(heFPu7p0Thqu!gto2DZippH^LqRO-z zO&NMraDFbp^Zw+B;!kFbbNR$?aqDucD>}ES4&FQ4F0IOgUrz{KjTv~g@Ha+GH2vn^ zxEThjdQa{8Wy=$m3@SVBOa zHWc|pU5=NfGvJ%54%^6QMV6uD`Jy4ME0kj4XK6~Ws_74{%Kt)=-|gRQH9cC0E}cP? z8C4%#HB9Y*CLF>PHO1|V>Fw&F^;JcYwE^AqX8D40xldaS@|ty$%ct#KM#`l>NWD@M z*5=z9g%!%TD*Nnlj7F7%7xsL9B|XY+u(dN#Tl8yCcl;M(u4;c+Ex^FC@^|CL#NksT zui?SI?cX6xPN#-F8GD&ug?v`F;dq7)+rJRIze9g2B^gdztl7xf=FHD7eP?|}ve(@@ zzntnv{l#+gp*D0GlJgdsh_1w{m-f16~TE zA$qE{-`12AZRe*h(?sidepK2huCAGs3>=@X)8UC-8{e&Z4R^^be9&vUGhEa6t)aQF zu3^gvURvl`_bGsawY}(<9hF9g$q^NvP)l6KV3(wuKKc40pqxI;ER|~<57ha~48O6= zpR`LpZ@iL_J$5>4arskzM8!MWBFlVC$G!E@uVZKO=%vNh_^i0Am*H;fmv3w8r7ery zu~?PLqQU8?LdSeXtF;dXLmbOf*YfhBIh>DZp-2 zpiN9!yUt{fe1-PFj!#oEH8VNKtMKnp`s@9$fwyILBK9WYf}^F@M~okD{MRWzMeU2~ zlyIoatyz#e@zk|UC3ET@;R&amaF0^2^&P$DV;D4O`0HZvp?{`CiPOVb>P)#iv_fS5?f6g4 zlAlE}&mfeKPJNa4ln)McZbF(pJ{@m(c{acPCP_u07O#EgX|!B!@&JbVR_Pql(=`m%1rjJ&zO+Q(qP@{su;pS@I3fSU;3p_cE&qPeOs5{pqD*O;2=T zRMd*7q2Jsu%g4nbT;w8kiy6xORv$2)$4S{&@9vLXx$f^=5Zv^5(72i$>p#1|_-r}k zf;n|4$kL&5P+|lOe+HnDL5DR0k_!Q9dBCxw3!u5VB0&EVVu;p3+{S;mZk-}R`Zgl` zX=RBE#M%JFRqY;{G{lJtV5ze^3v%HAH~^$mVA!M}6@Z1xNtuknEfJyevfL1IY&aGb z-8cJ5aMVK|c4BCk=R?{2M38sU20_la!N4R%iUx;+>mX_&|GV045`EiXm5bDdI&Q%r zwTQ^ut3uGZ0NY5cq5WL>xQ3b9LC*h~A$S-Qf9d+y+Xkq+?KaPwMD$D~`+s(YeYmWTQW^HmSJJ|eDVR#MeR zRjSXlx(Ccke;m53xLdGSCeLTz)8F@1{iNV1+2o9xXG%D@dfE|v+{Bwg(Gg)c#Vz@y z%1vD*R9!s&b7wZ)Ys=ilmdbJUE}C}s9y@ApQQ>*rDlNTk# z)#0DqmJO$T1}+|%1^klFk)JcL+9iuuU!ATHf`lT&-D6P&JvN&V>vgk*zpsA0A9Z2 zzEHY&*92s2jLG6>AFdHf-)vg#x`j(xi}arE(F%WquWBL@f0h2&?gbdD^F`!*Ri{v| z=TC@?^04nK*-1%CAhfraKl`C3$vaGRC4(K$#&e{S+Z%8`x4*8?2+uKtm#*6TkJ7AJ|%fC-s#-l z{ghnOE)n%3zw%O0(+2=>UCQ7a^!Lm5iwnSrF1O`PO2S*D{)bd&5>TZm%Mh0b{oqZk*fRk6$zZB z6CA2KK6&{o_7*S7J2ost7IPfjSCOoGDw#>V#Zi@?3&xE`R+`?8ZyczNPiNhPI4e0X zr8x9(FI-tEUm8TGPph%(rq|}=Y3-vpRp(F69_sQnc)0M^_{xM&E;Oc0v zT95NY(~iA-dK@EZ{xfT;W44cDzGz{sfzz(E(El-LC&jP_^oEqUk$6(zq>o)=tF7mTx zwJMW4kCqBmYdh5MOx_%P89k*_!N#@P$SugfoRD=&c`-0pJYr8WC=?Q~Z@=4iU$RL% z#&KTcEG6k}%8<| zv*&{~0sXk1_%|w)T!+4sMTX9U3p?|ZG2ZqA-xcoQS-TMzwmx1yezWZhT#riME10I; zCbdm%fp=$uMsEenP`3^5ICgIBq@z*(E4tVM^ExAvZ)--G}Kj& z-psSD*AJqe>IoI3rMZXYgg1<>rY|E`vWTu#vog6Cd;`PAzF(xIB<#%yxqqmb(W}7d zc-08_8i^~v9pAp7qMDt3Kh)fvNb^Qhp^E#8Q`qNdqHNxWP^*$N#V`AZ+-{@j3ni+! z96+7<%!B2M_H{dbcVARb|JLJaS`TswW&6E4iPjm#A*;uMPC~q8@rv2vo4o^7^4D!b zUlItLYqx)r3`%@im3 zk2AXWi{?8VRhx3c%~A)I3CM^v4|Li`zgRqt${4UbR-=x#`;{{VK$sJ5KQ#Hx*VIJI z7wk2!!)ulG6h~z4lx(^1QQBqZ*cT2;`nOAOUWHl+gzi!eG%#%4ls$b_wz_Inlk@Bj z0}oZqfV@yKjc)(d)1=7`>O{>}1&K%dFS80qe!t!@OP94O?nqHFV44tYsM+BAj!BD8 z5*1x)j(Roe{&EuY?d1{6VxDJ9me6YcQxob^>uRgeS~uVEqo)}~merpE$oRryTYk(g z@$4@2p8=lN;JTauiEEo$%i3-yFP5MweswaO$C`Glk18*V7HYy)Cl7yQboU;-?Jl3H znw=OExbQKMs2AM8g#V5&R=XYzG!WrZ>2t!n9+Ep1X<+>gMr@hxc*kHi!dCULqB!a| z8}E2ShSZx~T@{6Q8>UA~F9KGTi#+8uFF&Y0aqf1HJC2W3MXZ*5oxd)dJ2iOGjd8Dw ziEOt#qB&4(yC!G238)L@WU$&?n+`BYHX^iU;qtcVP!(Q)Ky|3Vsiz5JW5>o=);e?GtpP>>#0;GZ^Ft-=tk6^^w0d@(U4b}c|H z7Zh5TzMrY7^ehjv+A2CI$@QXKBgQ^|W$22!Qnc~JzAu~0BibjQQ{3ZPInhnud)8Kn zTuUQqeBENp;?ggxSH}_a^yH2}NOtH`EHlJ)Q=<~^uBvz0slt~p%Bz!pi()4A9Ex9xEqsynGU;FiYS6tL) za)VrnPI!{0%gfCVc#p{J%Z#(Ch%Zd22ym%%v9KBtB294CK=tV>vXQC!ptXUsq zolSK;on9X7IrsHa+xaVl{p5r>3j35(@tIvsRoQPUbF(#T*Q`M@17&nz~Nd? zvZrfg-~UlovkW({gST9Dd$~A zqv@orVd7FC=2_UkkOwjA%WF#~ze;}_krCV{U|v}`o$;b+7YdACI$j_ms`9aJ{F%Vh zmicUHjws_ToyvlKLRA^xkEKg08NP2vEOb;GF4OQV(FJD{afzWDv-MYefH{e~S<~;$ ziyu*HI?n2_iFXc(yLByvHFDe&By+!BwLjSFzMKxo3s8SPG)P-0E!uu9Dsr@2=leil%JmoTWcA0%mR-FMdz*cOKDDc@7tX?BJ@QIz z*V#BS;%}G2-ck*_#yfZW{*9#*{YsD07x8hxX1yu?P=4vhV4^gc6^JLy{17JGPdm803U^LN%;iAYWOx1V^W zdit>Sk(*Y90o#YTo3^N|p*4%G*KFY%8Gb@2Z@N=%%?ag0-<#sGwWGD9D0Lt2ldZHY z8H!!iy5EZ ztX@w)81nJA=>{n4xXSvegI0szRP?UGAKj>^OjwmwdCFHTMm`TJlz6b+!^-<-#X~{K z_%5B#FS4fvcC-VLZOv>>xOLnqQ@)qf{!PQ$E=PRq_8K+YhpvCw$mll;Q+yW#o%Y)$ zg{?;buUfmkWQupzS5l;BcC&3Dt*iO0|ZN_x#JHyr1 z3h;caD|IqrXxlsyDz6#;ok2X~Lb%mn(Ju-cj9PyLG7}YNHhrxd_YM!-b zp}So|Fd`z1NRwKHPC~_f+Jaj3x`M^FZp*_%;#t<)xV}qdcaIw~Im1Zo?}&eq2^m45 z#IlZ>L8gk@Fy*GPu{gbv7TM-e4?)m2pq^>S^%MkTs@mKj%S$4O$az4T~yzmgGW*^{L=+{WnwIRaCpqg&Mn#pF2Kx&(!_m z`?}KZ+^ycOr>!+v51-`oFxPr4+-yli)IJb*eZ)g_>yUxqEz*0$bGhWZRzUf#-BY}O zAxyR=N*?Zwk|GyLl~?^VPWL+)by>#*6)V)!zH@ItO&Yvw{+?k|&bvrg7C${(< z1IO@>M{RloeEJ1qF7dV5=^%Yp?|FB~ag#XFK`Vi4;;PUv{tL|VWi)BMQhC3ruyeuj z5s*ei3RA5XAFl`Eyc)^j)dUq_1S3Eam75OYDyO|*!dbzDQpCUBo&b_h|UjYMBt<0xKB4BB>1q~*boh%GFbWOlK%-gVS~OJ z2qFZ6##h*Y)4`)5bcsxW(|s`)PbwFI0ATmqUcdh>R09EAgTczjK}V9WjbD*gxorxF z*ZdUQN{d$4+H^w!$%_|0vr+P+lJ$jb?ZtUfH4-~d7N-gtC$C;UAU!?~NF8Wk^ZYe5 zNB0U{JYV@$s7ch#P@&7!F2V1obFaXhcSMZxFj?v1)2QOLH8XcQe-%-YH5QKe@md9j zHzHSI%H8^L2YuaH-hW!e_+2}~YW&7E1KGFVF|$ywzj~Z#5ip@Ti99+quPXO@6WyMz zk^nCZG}|?Ej}BGlKDkQf;mC|H`CRJ5V}KF*c04=xDs^W(5!8!ABxE;@l`7_rScSG8 zuTqyqwl7bX@431=EPlG&6KP<J2E;A{z)T(G@3rN`?ys?Q)lU;MGyD|1 zHXM@;A8=FBy<`iWpJ{UNlXT{#E7l0L7EvskEGU}@{LzpyBJ-eF`SD?k%koh)MS0Io zphGWbe05`r*wGvJ=~r6!LtIrGsO?QoQLl_;BqQR#T*gJ!FZIrAgQBe7!>LbHHG^hn z7L^p04ZF!{`L_hi=m>0XK|(83hY5Kn|pCw$LE1RfA>9X?)Mm*9Hk{)f%?!sZ4A4`3^ zWu~_%d3eO3$5yw1z`?H(i3&H;WOWsqiR-e_f*nZ(0?D9b0kWG%w%V0mS2_vl>9>xBfZ$LQoLpd3r=T}x-O|o2k}}o>ufI#)&_bUW;$k^>_SXl7g_eu! z_v?!DpT1qK;7y5mck=kguw>AYzT-^LqvA$SoKBSIG$OPiq5KR*pT-;h>8MLzKh@}y zvhif){=n{r36Bb2*`-glZqnfLOG$C@u*9GGM;T633Gp)~GCN1vCiuJph%Qw*$#GYc zrlY3oWs?Vj#mS&*rN=J3KhUmLVcaHRoWPZ#`Ooj@m-GRgW2*^Ke!Y(RH%6t|b!icv z?*2a3&FvPny9e=p_QrSb_PkNoL@l^PIkq^zxl@dhC{hyu0t77-^dER6OZ`4wOLN7V zDG1!NK7l7h223~HSkS48B1`s+m%Q0ryH|^roiqX_r^|kxoeB9Xh6D1PkdQL_`%N7C zOD8{Uvx}b(nr$3DOwSh7<(g3SGS1*8Y|~;+80`{W=aSHu+3{HL+~-{!QHeXvLhTd0 zbo)K;?{1m6DspbiqMmX36jQm@^gFtq>D}~v%4FTi;l@cbt8sHSb5EqkKSt-8Gmdiy zKaMXX6&}((>(Pobs^i(e{u|rc8s{(>@$TO1Qoh)w#U-|Kv-R)YoKd`M3i`#|4;t8v zag^`#=JfW4jaM6&T`oAg`&+fP+fC+g;yJIqtKN|`7QKF!5^*hBIXzQI=hJF$5z+pP zbf<5a@^8b*{e)4)?ox}-+%K(vg#^C1ij9g8{oSZ|V^d69rsLV+*16l{-$x|g*Bfsl z)Lh)rP&zRtmdL+!K{eY}o#fe2=-WX!DsPjSX|waXmrv!SAuaoJPxr`LpG$m-C(t5& zG4``1Nj+irDn+?__cV3TqE9laZormeI{n0t!O|D&aFI`dDlV4HePhYavum)bn8caK z$NTJOmbdQ%qSaQ3e~v6T05NA(2)l}Mb9er(MK|zXAReBfc)e4wILMIR)2nYy)(0kKSq{B$BL29H%gb+fNK6D`z z>AfV7&_XZ%*ZKatRxaV@A(zDh&e{9yy`OYFUse6LTXQvthc8|z*X+Ygyef=^zk-Jb z4Uu+{lj&4~$S6gvmZNl0>fVAvp?AJ(Jx}56?sc>D55{+NThf#8p2%Y^A4NA0I+F9y znA}j*-8+TNAL(4TD^;w~L)U@%C1&!?#W~PSMrJ8xEV z`@h}1S?fN|sX^(=ei$`#rXf5|%kDeGN-#fw!rMz-@q!LEOeJo0)yGN60i);Fr^Sj2Y-4q}v8X2We^y5;- zE;rUUShXCwG^Nwx2W6@WM2b!M=2@_=dut1n$hYQ^6dIkfW)juT6zU$;NU1q9#RLZw z4Cy;V0&)Vyzk4^@?5@2WQk6&?;!Wtcva&*5W+N!ktm7#MM9vYJxsbba){v#UK0X*L zctn|ABU8Ix4Gk?1i#4pKXKqZbM2+nEDVXc?T)uhx+Ih5sd*ZOUALpZtCHMF&PxS83 z2)ZlH*{Pb>xvh9Qb+Ee7;#Ti>#I%joaH;%Ml5jWTC_vK<^|Ia^Ro*BX-(y#fmRgJu4Ak*%`&w}aiM$EH*Aya7$`G&XjE(-=qqR0ZLlwk>&>ScOrlx_Wj!CX-hJIULBw2Q<>_nH zfu(!Y#TJqepx4;ML;vy?H8?TEI1<7#l?E%8j+og7c%F+eA|7DwZqxrvYCu3p?meL| z{6I%^{vBY`Wr_esEx>r?gVnoxIq&WP#FjA7&?F!>g|FPpi4b~+ufF#VnA^X*H|wTz zU#QXb3FKnwxeFIB-eSH5v{N7#mUEwh$q~>;o!1fiau1mFgRVEdWz0MN``vpU;u8bz z{4b2E=boGg$S}VI&=U~QUIG0Z=-jh+Kp6fx^(*g65&)?HK$)F?e=cbD$~C~Pu?^A* z0X>WU1%g4J+`9;vk#m4=Na#G1>D~WWvfci}|5_@G^!PQUjgvmX!tK=3v2c&#zSaTN zJ(W>sQb#Mj+{@2oWw_K@a5Yfk=7gl6XpdAv{=`K4kx8^gBq>foSXp;b8C+RYx+Jvf_}n9@XIRhdI-%R*%5_TC7LD+}!5))E3w1h9$kKKnCW8 z;UlGPMRnVI4Vaaj(il$ci@tuf+D*ah3f(3Ow7O56<*{7lGd&Wo+yg%Q9oIJSM1_B_EkYo;vg;3WJ~N z)eIER$EJ`?BsZ?FyOiIT__ts(?#!-s>#`g9n+}|tzOmy)Hq(u5p3%@}6w?A)QLj2$P+N!kFz_K-QAz`h*`7;RG1_?<({ER5xByZ15^=KEouGNI?0oKhE-)vo_>Aj&gb3&bph_U>NUA57iU7ogCp#_KEXZD#R>$?e+0sV#;o zWqh7ffEZ5N3=fkyE-T(Q<$;bUHQ0$pZr=|Hb&ZBH=@R8}f<17z_{>fMx_9gQ1ixRw z-G0d6c(^#RGQG@e$UD%`aJh{jIFnoYz;>>zDA9aiMrVQerb3|_MYzdoFD@+qqP1tf z&z#hn>^5L}Ds!v3HDfN61%^&8q*tp73jfn(Wo>u=y5kFSVgHM2gSuFGUI7)=W#w+t zr_@JY;nbVSRSVigWZ}0h+kJNjocF0umTp`#S&<02bJypY>o8xfKGMJ9-?*+||LTRO zntv&+H*YQIXDZ6n<7GE)z&MQL3F*_v8MUSWk0zcvYYpKs;1`nHhm~fThQyIg!oYKu zl5+$$Z6Z!O^|gnI;_I(!Yk9QaAg!o=xg=^qZsgkyLT^8}Px;Xzo&K=Q2|E|y&)oH77i)}zrsLk6rikbU}%l$W9=JS+R`kpZMiKx+Hs>phXFP1 z88-ATu%>NgFhwvnGGf$YiQnV%?%f`S&+j8SIbYprVcdWuO#^|TXYZ3+Ta1a?xlFqF zYxxA4J5Ka^53H`nG&b&me}i=m)vRi)d}{o-lv-os>T)ttZJ9@XyU}{2TDiH;Suus&WlDfNF@o^jHFq+#_(|&b?G(6AE>Mb6U zO#LWO&TpvXXYsjjN!W1Q6`{xEHJO(dz$$4jj;!j>ewl*vjv1e^L`|^%0`~Rtocr>@ zzHHn(*FG4*BCHQHT((cJKeG$EQ3a!T5VZZon1~7lyu4jwBKc5EE%QT0&wihzk3{g# zg=BG8O>cyCM*P=+qoe%scx;ijpL9lTT!Lvx{!R*cbx{mFOjgL=%e?s))1)e%QVl2Q`HrWw{J>{$Mr1785^S^0RGrj z`ku+Z?0zT3IP+%`v*)PYf+qI8Si9xY!iS3=5<-U(61^WkuewPnUe5GFB1Oq_ls-jY zLU>9j!nL@xyE7I>9_+Hc|8Xfi@&m(03T0v&dCB--u+xL{%JYVsT#8-8ekQnr&N_*l z$>alxc-s?|4ebuHZ-7|8JBDE(5)icgiXW}l_7NSRj*W@<#>BIx2Zv<2*X!Af_h)7# zYN*QXA|4!KIX>veogu*w~eo0t5MDKh~kIu=!_2E4i*>n^DlP#*NNQ(jvGpUa;e zC1VObm6bCZH^NpSZFM3msrJN)ZFbDnVPgISv~@JG%X(RP>B=fTp&F@Kp6Go0B46C0 zOLH=1ecNtPT~LQ^*(SFkUVZD6{*74$Y&hT2WL5~K1M1q=yA(g%L7>I*5^b_Sq=UhG z`8OZm9$AfTR1FbCHMn}j@>@BpqQ_*7$)T$#YY{%f2PyZy01W}K+wC8E2$-e;1G)FY zfB$ptkB&tM*iryciwOPcXcGQ7wLz6v?g6sqy$kn1BFunM4`_1!iO5Je|3yPb9bl0F zf%AW45zrTbfZ?4fNOSqx6W#~!H2!A3061Hoy#oQQ2;k*-|DUe${GV~%`JcCdy9*fr ztQ3&90^C1=`Qm+@i(j6edt&hV%e_=cuax%^%THGqm~> zdikBQOh(O@%Wo$1x|v=Rg?f^^;&d-M+=9iuCX zdsk%dULS-ow#An@#}fNURKLN!p{8M9WDPG{8`L)xvWWM8QDNM_EC#mfuAw$;P-4F} zAB2iWfBYu35X~k7h!JpmYA|_7*(qd-UlufZ_sT5NIyEcV$p5nV`=})N z?FMd#;?q}0M*1AmnC3%Q(oIT2`i$YMi^kxH*5LNgde^Q>-_yq}-2@`Os)Q&U3@vET zOD*r+-$6&uZ3?}|(Ii)+A0=7W3wmtvGXDm7IbVL@ zvJmCVTc>E#Mlmg`Segqu_Z#GW_DE01J&qcR3he1Fu(65FYHra*Pt_V`uK^v@M)&JE zn+*1k4PV=}_71pCISQWhek{*en2AUAmpUEc1qMX z=H}Wul?Uq>)M^tBrlz#&FaLbwE~-p|yGPj& z9B_*PHS@iHizfNEOby3M8uBpeB`o-O)->=;9zFi_Z6Wl!nGxPy2XVaBG`sBb_(p8_ zrv<)vdv9b-*7MDFZZ&SsWtxI>t`@ck zb)*?JRA~XPtyK*U8?qkCb)hDF$w=ko$?CTWbfCgOD!T8ux;$ zOi1q$@Iy>OT;s3r@oA=OS}ujb_b0}LHO*yycHkA?l2uFgUeLHrqG9PSuH3A0oWo?9 zenRiu-14@2^T)X>kRnW-AwMNR!}Qwn^8Fh;{@}(N0sZ=4J9u*J)R33t1Un7K%SZ+R z(`X*O;V{gGH=7{VBz3c#oO+g?*3#Pa8zhP%+@OrgC5JDsxGSU_o|u8>R0M^AJym&3 z2L0M4f-m{#AGzMIhz!=lNjejEPW{Ecr>?)!PAw48KdKyB>gblv%H{KRmX(bx!fgs&QwV2rbisZR8 z-JX1UaZEVk=eB#GHrrPrVl_EOcYt^3z}CE&i*LFd&J_?n6RS{NF}!S2_O`)iFhKo7 ztQhTj_NOh*FUNY(D8ja8aWbuQktrRm`@z0*G>dyhj3dK9OruJ>=rmxnf2WcuJ{rEqm&nd%zHzB_K2 zLJo^$#A9_S(^37ot$Ew3_2ZuF?W`!#gRnMrRqtV!)q{rY4Bw1pnaOmtL2Th_wSFk{ z@79fv`KT%=igd^$I#lB&@tkdGp|RHu@(4={2)by0x0L57kil%+^###fT~#d&v1x+_ zzoilQ^u3bHj-~naBY+KpUGQoXOZfH#4@fd4YKTj2ekdT3g>TI$kNy+zD)9W%)a26C z`LwTiS=LE93EFEb%Yjae^iBTEtsfs0c~r5seV}O8@ud5?l*r$ZrKyP`H4WO}6fIDL zoBNXW+{ty}Wmc|Y=az|I+d0n7(x4F1~ix8Wx?=}#1{9Cc@MIh_o#Icxbs9Y z#cSLM*oKqjd6dQyU*#K*jmw+pT3ZHy3LF;P6raS&DvF|4?^ zol^%Jn(v2Um-M*ekPX zvBBn+Ooi<}?_P+;5-MgS^Lg@R2EA6@kEU)U^~U$3(Q$3vuV?4yyBVO2aw! zvuA2dO)v$N@Q$!^aq(&2^<{xe0@{+v%~6vN7b*H)i@s}J8L1CMHWZXl(h`$p0s=g9 zF1ezSEeQo#Y2L>iZWYGB*h8O?VAS&{HG}24aPy4?&A&QsH)(cEE_`|r!_8;E56kub zu0ronl$4gJ@F}%yyvg{r>`?AYmc!&xY$)3a@*;YXpxO0QKCrNnckPS=JM@s1FqOaU z@63pxa69z$G(LsC(5YI)_WJ=O2}t6Z(ao&lWCmG^(Y7h(;$`1HwzXYYV?7J!QZoF2Dz%;oL@^vpS6 z@m>G(e~aioxe@}nz<@U9)|bm5Q1;dHz*7)F7J=TKdkg4zzx+q@gk2Q^d>i3E{@8)v z0m@vE4*!44^uo?Pd6)gq6VQ36HK5Y{aRB5~%@+g|prC3MILU+5EaB9Vok4 z8-zI^XsNI6`f(jLq;5Y{-rO1y`!d?oQXl;MRSnwqj_AYf?IhMX{mtXBUT`$kDPnhh z(L!BVYZ$fiGErU?6*#f|s72fF$e`BTF+`5!=543dT3-0!FPT~^0-^>tsR9-}#3Jm2 zS0P^~Ai|F0i*V1q)gltQr`IZ=xvfA&tXzuotYE_%>fZQ2oZaSZT#v-KF0>qh!mliZ8?r7!Y)4rR@EOWJm%e>)QjedDt9 zL0D)t!^TjvPY`-CS{pDH=`^n}f>8;=0zZ!Fa+6Im%#f@c`qO$BnVK;wm6$NyS*Uj^ zHWNDH2c$6i7#q7bADMp@cRFm)PNC^RfEsWktkh6d&Z&$c__>zHMui33S;?ezZMgmT!@c8iEYlfC1eZcI=gpvF2GD8jXWRHXZx7}ku7z1OeM)Q zcOT}nc^Dt+u#x6TrTC1MOk2nge=Ebjzw0>cUbuKN2K5?;4A;sMWyXz&Gr{E@JXfuD z;&zChjUoc&kPf@aS*thS?rnaPx_@0}G7Z7I?0$Hsg^f)*BsGTbHqE0r_?pV7Aajuc zCi?B(Lwh~+P#s-@fvX(pT-n(fIf{LiM>bR#eEO@5U7^GR z5>A_UX#(y{AUZFbqD|$}1`iZ9uL@+c?s*&$BVV)8H4FNR%UONujS#m=ZqaCbEPN`8v5pw7JkSzQqqr zDXISQJmHib&y5-c8{~Tz9J!b8XcY?TIw7NDcf7sUJPXO)?PbO>IJ@hb^Bnmt;JJ@?qpKbP%wo&W~C+dcRF|#D3tn{QGL@rRRbP} zRk*s-3JUOGqXs$Ov5Yi)t~2x7sW={9v>aS8eRZJi$B*^aPmdyX2k>2VmA&Ob0dwnE`_QaJvM=zD!?J^1 z4AcIA6TNHcQI;J#q5m-#<)?|ZQgmd<<+Sg`B{JuJs?vxGSaf}q`J4?uRQ`~X=-?}f zIaKlS6OO3F&`Jufe>WzYh`~eN1Kf})Tz=Kv)-1TTf~nc?uI-X@ph#ay>!Xy|YpOe> zmKb*J8*ZcT7v^mXHo4DJjnQaGc<7DqrbVxkOL;5CeM`g|+{Je?=b%F07QgJNtWV2v z3rM2RC%9PW>CX(!Eop)G#Y_6c3pL{MvMx6QAqUi<9SfCl8M;xRSOGWkj!v|QyJ;uq zCS1Z?^_6wmXkpD?Q@Z1o5eIIR)NRU-sjAf7nd{*0udfI5FpbuWo0Vym{bdIlESb$_ zqNABHiUClM?PI!*{z|>jRXL$|c|e8wQwYBRBaZX$?n#1j&i{P{0PE+&4Bi2Or~i3O z05{BEKg0oqfALS$E>H$TKqBWO9sn|tk3v^~gxrf)Kj!=$CiJh{)0pN6RlqQ_cV0C@ z5A^dY=#6T`6~HhL3_^f03+M|l2>Ak>01@(s*E+y+&{cSZ(79XZ|M}y*R0rLE`a%d` z2N)+m#&wO(FKN55b zj($JtK79E2d{vsE#L9v{`$tRj;hL=-4}*;tm1ecPW@OcCT}Q|or>A=2g_;_5Op8aj z#P}AnuZgXMgl>eJmbpMcC9jk0BA|3!3;rMH{);X^8_3O~?$tn{&mLM7!gA_Qr_XNI zn$>t&NbPKWtI&yWg^1oXSAClrlbqJpfFSaYPTjs`CT$4`dUfdoeghWs6*jy>ti1txg7pu~g z3`tG0yEqTKGb6#Z>AWj98=#%m0#OW^Vmm`lkIX3Zdhaj8d|--EIZ<|^1Ky@v!)f9D zMxHU2EBytt+J&%dtlwDKTWL!gF=FjZG15A;)(~M07&({n&GiWF&1$TZkdEQ$q8f7S ztNEAMEF|}dUCA3^W};2e*66AMFm+sfK_6$7Y^hTA3Yg^ZFmPlfv5={r-8nMgzM`m8 z*#vqxL@&yQ3ou>;%J<*4S63L#d4@)MRcZfd1Mk0`rWHTyD>jF-;`T2v9~%hN%Q8XY zBjEEAu-atz>G8*nMXK;(+tjbSKd=%&9;XjHl^)H%mbf?dhk0$heN*QJdHgK zWoOuB?p~vbRP+3Xn00dZqU+Wc_C4Db6=0Ym2-Yo@PHgQ0YXoL~ABKp!>&8{6N(sxP zMB`OnR3|4=;sw(8RoTKhh8^astSAdbq~P0V$3nhi`*s+qzV11=dnYKwA+OSKp+ZV; zSgRP@b!Nj@4H#Rif~%8-yFPOh=#;GNI4#N|`G8TotJE7F$&VN?BD@)p73_;eUZ+6S z^F__Rg;COqoYtNSS2vJ@%x}NtpK4Q7WuG;rRZW+ruvVh*W%{%7ratyf2((sU@Bz}Xi+%9ot*At{u?Bc%QAWRvu9j%$*Mw)vrt&x zkgaCaot!Id)4=hg?cTS z9v&Jy!_9Eg#i9zoL0eG1}z(pmEg2~v^M<fVxe_Ru!N2bMQz0(9?totz2^1A;*S?v6o zcUZ==`E$zNZee4?Wfi)PrT8Wy2c)3|yJ$+JQ&He}Df~TM%5^Qar6XRpr2EF+3|oEu z074JnH4^oD9EL;Rtx`jMsCypOH!P^D9skBYxI8kSWljUEHx?KnZ#n2akB%JG8px4f z@Js(PnNcs)Q=+uV<}rs9oH!BX=x@S*_uNwxm1NBiHOujd%$Y1jmRg-Fr2p zZW`$F`_=#c@dHIb7bJe`4+{-IG9Y>R32+&xJLh!)X!qpSmp>=wcVYnL3=;ZNB6LE4 z(ffPmca`c-gf4*oqoIK@{C}(dbKNrob9o@(19-bHKwN#!^aUEUG^z zdlggW8|9Ms)XJBT{$Ff1lO(${1@acBvUo3YQxH4FLr0F2X$Q{#D-U!iMT&O@o{v|E%>f-!U}zc!xhF_C!Os8$V6Oo&Zpvp)Vvg zu)a|OLbcSuZ##;iKc`WXBw)81chm{vGcoNrT3@12_3LFsh7FXg3tu9(qeyC-YpgS^ zHQV)Uf*(?wJGz(ijuA&@yUt_W7Oif-LHp`sT6?CR%ZGNs+N*j$`k(oj{A=~>2Eu5{ zpEH=T<2Pt(Z~)0YeRYaszVA@Yt1r+`jhjEOj^A%B_=|n5e#il0beEkd&phFu7m@1| zZG_YKyf?RPoR@qUPcrwS^HEXeHTKzwnpJsJ^z_*>6E&%@-pll%h@nxYY}v9FzmN=d zG(?w`j4kMoEB4MO`K?}Xfwlm=#-2KtnG=7#&(%WZ(FB5s`CwI{TbNCuR;b^y_sXAJcboS>7o@q-2G`ck zz**-L(~SfRcMGfp{8bg{8IFBW{wuvtE!Bl57J^~< z7;ZWDhS_qir&w6M;^d~^G_%`bm}OHbZx@z0McU?qU;g^cxbqp$GSPxtBR0%wC0C9D zQ}#ujt-!=f*XTXej4kdY`WB%&kGipFbLUiU7=_y;2klOmTckI;L3AcsQeC}M(s3MQcfdiDd5{{3Tr?bq zanuZ#dU2IU`M=IWcl`#Lt3#`%>v37cgn60{I^F2q=Ocu3km)Hy54t$Dqv=quZ2+Bw z(c}oM01K5-g&$0i+E;r9t1xS&#ha55tNTW8$_2;9a43H{ho~~xVtlFS2U%8 zCLoxD^=1F#%Q^ld(p|5}-ms$hTDC1;zHr~eG^20RRNn*6`T$Ry(Min_JeAayP?Sim zs!MIIHPuU;QoZRcnAkPzQ75*n#*r|TDfr!f)%Q*e@Y@>qx1q42giv*bhDoN+$Ib|Q z#ww|ZLHw3&8&ngOb=!2<-g)%7_{fC4W_DXS+zHhv@b8pBw2Q^=TPH~FQq6-Zk-Wl@ z<<+;;2bQm`tOWV8-mnlBJr*oA|Ho?VI#|@uu9VwiF3ngqS?7=CA?{oJ)pjP;c+7LT zd8yP&Lc8%mJ(%0sq8k~SB_H}K$O5Tz^V-i40LTE8-Pfx>Zh;Iy!mNL`1-b>`58%)N z_`?vO3j9GD!0`om`~fSsE`nIjy$$RNyZRmo>3a`C0AL8X3KWiuw^;sp2V_;9dvg8# z(+j}HMmj7&Wn%URasL3_R|jasKl@2tPzCD86N4{0i~tp>>jQcM(gD)1uU@zax`Mc< z7xd1F>eh1)P%+V*tk6O26j5*#{c-PF6ESs zS5emk*+SR{P9@>auvan>n>*4TRi%i1sl2$Y;{@e36VWZ~Srfrt*k3iQs39|1&RQH{ z7?j7Nj`a+RI#TIs{Pa-YRMjI$GJbhJ-C>vD$D~raTnAlf+)RFfT6v|z@EtkJ4h{y!wnP2($e9n$ z+TC-@?!Oe=(;_yi1`SSPvs)>5Qivz8tjJGGf63ozW`Fw|^m!)!Upkd#WOCDTt)y>S zUZcI;f zrbzyN4__M>|4nzsw!b~aJtOy22mZ}lYfO%D8JF9MJMxGeiazz&D@ZHS%zi(x;~RBl zVQ#iDi3CtN>nknf!=5)wp&yqxs6n<1vT7!D>gJNJYaw6Or{sNc!~jmSzdXIE)wof- z*)?riWh^RJMSen|OWb9co$|@g<^d)eVLvr`6j8MwF!;i4!=OsLt8=o9TrXoYDUhF7 zJfkJHtMorzijHe_H@;{`C7*9Pn&3~(rg*?5J6iD2hD@cG3;&*YopF5&+@w+TDI|(< zu|WCsRr}Q`RR--=&kT7XAuFQ3nes7Ly>*ebjo&8$R?cxMLSO>1?Isx}9p6|c3}1qt z-i!}rS^g|#-tg&FVx+^H6K~^|WRGlFMRWoSb))IyQLIU{m6o-jL3+!XfelYsh3IzQ z!@ON%hpC-!$;h6{B}0Bbd`!bl{XEOY11Uw(vllhV@Z{0Qm}3AAghJPO^eMk;zFGsF zwAUcd%&%YWw795JXHoPSoyVemL+@*!h((fj&S~W8#EJe;?6$`n=_yT~$DyGLvZ2DK zo-9z zUbNTBr&+o5v{DxUYSyS~y&VDfG#&qph?eYK$`AS&=MksHN2s7S=sJaaKK7dPvhU$tJ8taQYRk)pxeu$qq*ifK z6Ek6RGY%(>iShZ*j8!>gV`dvl>#{4xypM(!}*wW2Gnu!3u*8 zN-25F? zX=r?|b+0v4obzVN2&ehpL4}@^MwQ>duEH-n7F+(Eoi}SKHh#5MO4vC>qWRn5VJWWK zvP2*5=sIee&@kmhUWt`~kJDPHHV!82!@l{@RcbPUMV4VD=*sTqCdPtgfwz7TF%C*;SIX@$LZxc1$<<+ z@g<-dX9HL37|vf1x(Y%7x%L2^2uPp-dhjX`o~wBEUCDc(IA7gnzI71*ZTAhBbr^w6 zoG-v#fOi58phoB3b^O1Qxpufc`h0N*Y82><#I<$@#wPTX9{d4g#)Mg4pW=h>TC&b< z++`BEtLj~k^q(Ix6KKy&$>9|TIv4g1A@Q=J-_KYt<)@VSC;QY7>W6q$W&A{T24S4j68l1l<*e1%^rMg?QB%#z`Z|%_ zS1pSVw*)_gVQ+BydglU)Q*Cw!%<(@ z=RA_}01&NPcUP|W6gQ0qV2=0A)aEuHcNi1Zo-&y@v#om4i0FRyIIQi5ULQZiVS|1e zW7gl|o1sK)`$#)WsT$v%UC4q^?gsKFv_i;TQUe^Fj-1inw&lq;D}wa7Y?Wx-YSdno zB-&(`Sdu5L)7G54oCbyZ0cMgmI)Q)4h51`ST$(lnjyk<*QMOW%8bIT8DR)gUQ}8ZA z_X|q0At5Brdd`4M89eT$>9ssd%kE3|y(%28ZU~$>Opyl&1AUFM&I5D99z6`=&p9$Ui&+myW!UVd~T+Z_gb;N##UXNO@Z@Ct<33 zfBBY_dbPV4=8O6tKQI+|yCF3h<+C!iec1DIWxIO&P{HR>Q|4Z~s9}&MjN5`YsdLt5 z=Z=Ci53A}_7ghZTv+t$P_;@qn%@kG!H)ay`-9*JPKt=Nk#Kl6}(TiRY41XJw8vZE= zQ=uH%?Qw#+;7&}jE`(k_hZs$+>OfoE6y+R&vk75^<^^k)xJLw@i^g7msouG-6d#r4 zjvKf;yY&6=)t$NL3`1VV@mk%#QWcXb#eD{t4xPi|W8oRz>tOgU1(r3CB*Pz@)|PZ# zWIhh?_1hui&h`R-IhXTg%GK*DOWj^meSGb*V5CC-UtV?cHM`EF=VN!BV5*+9?IX`B zQ>P_QiBz$?1~iYyCYRS5S`AiZmqH30DLfdX9}s;!rbARX1JqSaz~GL?nye$;od_v+ zHz)nkz_X6x@VL>Ejj@%*K~dGrdilKhU16e7iOQWI`_AFU3m(fy%r2YUa{7SW27xMiEkc;22g$B#-44iXWULkoQ0vu? zWhd8X5*p0yP8Cr{zGukm!{lQ1_;_sy>FB4Z+jJeKhLvPE0XKYk6noxlgtLq=##l8a zNT1TLGI^YfciSEQT&o-4)VO-Vh=B0@xKwZNX$w&uz?qLlp@B&$zUp76phBxaExtso zKa&jJnOJ`Zq2)l{$bOTa6i)KfD0(L`L>hstRmzOxcy2S}i=7A-`jsD0pUQTJL`4fq zku`Y|@C81?OJOf^%PAy{wvrCrztZ_kFJDW(3QJVWBDuKLZ@0#`+Cwmz4JsI>L_T7D z*NURt@e(fUIODr@`kFo#f)ri8@tPEwS9de_z>Z1!M@Lh9d|X_xp0-xw&qJ*L;Aj%2 zV4X9-tnSU`l2GTV_@RHw;@qxlFMCTosZoC@$@({Fo-JHpVIo{>coo)|5@RP7dPOE-F@#FpNbA*p*?_gS2#oUq}7a!M~cn#{Z_JC0o}+x1aP&HDLHlIKNC zu>r-Z>wOo#DfKMGf4rCb_k?b=K;uvge|(qC(Hr-afelyB@jd5L2C3d~oPkoHY)$3% zHy4Zq-)njT-6$5yk*j%`H!{Vzo5@&m?V|~$`Hs)2rg+Ln1Ngr_c=V zot%L6W$_OxNg{{U&KE7toTh(+Mmo|XQ5>pRPjWgXg}vqKKu=m!&5&b6F16~=5TgNqg7C)8ZV^rFNz`k zxlvH)<{&mKuIT0A^}L6h-x4gD^9rFo$2UK*w;KNn_u*}eJIkY~D7Puyr$70!{1vFk zl|X%Kc+i zg8Uie0UI3x=Zjyisy_jN5a(`v0d&QTS1$rR!=EDl2TT813_Jmt*LOfK0l@4($5maR z(6gMs0*Ge*dH%C~x`(lvS1S6ik$3QWw*Qj#GDzA3dB zBV`LEglS_rWgdf+s~#L5IpUtaIVHh~t76ZJthl(;xN7?wq&)Cg|1!AVQ!TwkjAeD# zsb2PmKtg^6@&cBPZ~>3we*q;3*@FnU`CsPa2@!F$rUJMp_&Vt!s%cD~~ z@Xyp>hR!Z+idLZ3;LxFDVXeo+g8tffsaQbhmSBHE6h~;~t^{T8!4CoY*X|(TqfJzqf$DRPtGX_2ajsrfLjwo{Ly>`+02;WBlEoNrUp$X&XKVGXHn5Xb zC}Z?nNG z^@#zmW;t31bw2XENZJzkR^gGC3nQ)f6sL$w`PE%_+oQrX9)+_7h&f2R)% z%tR|S@~WsTtFfc+L<<}^?gpy)96Rp#{VMPuUbQ}v$27;IeRM)k_2RT}>V-Lhm%q00 zb5<^)z#0-+wX$=buSSse&!ut<8yd5R8t(N8KTZ|W5)Y~kCI%Ok_=ACb@&4p%oy*^* z0#Z#)#VtZF6}Cu+25zR6D%U#H_d7hky==5)URD|1u_qtA{Yrp@f!=65sthIyN;vz8 zS$8yy1nji81In1oew3M2yMwweRFxax{f4bHs@49}?k!f@Ng-+FALaBv9&q)y5vxn{ zDCB3sR{V^|1aIdev)VAXDJBU(Dt97a@AS_+6)m)NmHsDcafx+J-OfAsMbg#yPn@@> zMYv{)b903m;>wc*U|_2$uiB(KvPaBack9*6fl+SdT}_(LZx9nW*cU>P#0$&zO82z% zSkHm?dYgvHox5XwvGKjuC+jZ>iXzysoQ6)5Tp&e!k+XJKRun%OcdE&g96Jy(ep{0J zEN`5Dd#9(LJ@BBy-5E;2<~(%9^D~cE1)3fNWBV4%5m5Bdl#jax@kBNuu}dK(CMjHP z<#=FP@xY!v%#FatkF8zabids_-@(LCK$wpP#K7&Ajj4)S(`ov4KY236jI*FtqzXF75pqY5(mU6=by%<{tuzpO! zfvO5m=r+;O*jhuY`^LUTpf;`lzhqiW$DUI~>>I)uC{(!?cNs8Q;G# zQ8t1%W6>WYZ3fe1sZOOvz4f1WXQbrfcCnM>i&K2L%tiZFaq;em`tTfR#CYRSgjc=c zM%jX~#Nu$NO4mej-iC#qR~s1arfqICYeccoI{Zn6={VdZPB7vH(iY-mi#!tGiSG=G zv}8?Vi}A|A>CU%uCu?zJ5m%H3ZMWC-TLeqHxgDRZ0T>f_U z>b`Oj^53;qpD{-jdihooAN!$?F21z!My%?gT(koh>ThN0yyjKCZYwMDVUdWok%Oy! z^+=(kchF@vSs|NEc4|xPu!Lm)2N+6N<&$z#`*3?YHn$#jP%*MYYM{Y8WNAkXq2VF# z2lIsyXS`F0k?1?Od|#cp-@c(C$)Ia^Q_ebZbgsm1A{ZGBgalaVC2_M}GG$`?805vr zFW(n-c=y3{X^!d)Bq=7MzqzZi!SztLTQzxi-fh0D|C38l(a|n}Vx2}&Fb=ff;AV8! zZ$9)s>6gDPAE|N$&{j7i@-?xsZI!LBs+anWQ~jJ(ua{Y47t{rE-z|hQA1GE3fxodp z#*dbv-V-dfDwG<}JTEbep~X^i*RTE2Xh`4bw5eTXdo~fQikNX%or%S#mGXNR9CIDq z<+NWMvHqUy7GYRc7DK3a?eG>Eai06c>5sj`4|CE`!w%S3CpR5d`$*Qf{;l6&p5YUR z(O+s=QV&S&C|6yX?~5|)yXjcY%JH$>(vZb0OJ2a=CQ~z%z^YKNY(Cgl0&be|NIT}S z-poV&k8PL-^Ln1RoUlyOgX+_@LwJ9Ku7&gab-TO2ER|`UDeBL;c)#fj5cGZVJTm~0 zfh`08s0*CV0fR-LkX<4XfL{K0cX`?h8QQt*?RYfZ2tZ*;05>bwUkB8uNQsrin8rxS zWxrpw7^JdZJ1R?h?8k9_MUX@dg?W4jirk&wL{B`s&CwW3F8 zylrj%)EvC{YNt4R(wPB@W-ohJZtpFDm4?Zf5J=3c8jwp(eQKf9$k$&)E_Ywm*FtCV z71ggFsyoeWt5p;To_0i{H0YIu{g(5FPEC{EP?~Ikl`q2{TXggA-p4s&0iyOxO%dTr;kJ|m6oc+%XI%- zr9LmR8H{vuhhebr*3Mv`xf<+PQH_5iM{Zq?g z3-aTJ;&x7d`j@Qat^VZBX)Ozg1K#SL<+|f%g zikm8i^eL|0j#cluG4-!sPxw9s)B;kbYf4+Qd zPsU|0&03etMYoW;JKuJWn~N&O@=u7F;B);}BM;WQaSK*5n2|m>y^MlK!PHOH*jN1n zMFLbXrDx{a%F)b4Zb2gJZFUtRdb(|K0R{Uq3VRck^FJeD+FCsCvov{{j|hkU^_Qh1 zBZtg5^ZDlKZh1++K@^)UzTo*s+b4}$N~e!M_iwI29|te%+6y~rY=l1?a{ZS4QP~5C zD5j<0lpd&YlT!(-w#eH~>gG--Em}=^iP(Zj%UsV~d&jULCg<&e-5FVB2PH!`2tsDh zL!-E*^QW$^Zhphjd)9Jz+0g^C2(9skOt#V2mpkh```0Tm4)RKRJbN9nZ6 z+#kO|vJz`At`r+>m=A8T@9phjS60?VsH#=iYF8()2(<0O8{!m&AeQdtU%9t(G}&h0 z{HBg53Zzz1z^X#U7dQ-d^U`vI=UmC%OJM%)S0uJOeUGRE^^Ut1#>xNc#BjjbZkQJ- zBAwaE9{DIWo29QcP=_(c#?pTC-Iq4se;FG;qO+JNsGTi|9AT6HkE^!;i|YHrMh65%Fc1k*6r>wLx)lKd>1GINhoQT{K%}LH z4uPRYKwyR;1VlQO7KV`SZUnr0{Qd9q-TUpwIkC@~k>{+l*IxTwYrV^1@Jh;1hUJ2K zf%Ri;7lQ$%>6n<^pL?$7yDgd0Y$IRv-LUl=HP|9s5C1~(5 za#E)CvY9_dtENKHbY{bPhVDo$GSJ`ImQJ6e{j5ahQhd=O0xpnXwDCPW(tVOCL^!9; zaVut`R0&m_Yj9kya!~1iuDjwfv$XT@qmMxoyBD-lXHPU4osUy_etI_{%i=1`NyjT( zi_Oc2h(6zmIeFe&dZBqf~FX zX^$ zMH^R^rUfsB;pki0CV!*i!xoXDAyL6~MhSmPybarPPVz0FtEJN0TYVNPWI|!WgQ+d2 zu=OZ1YVYK-TdPx8|2qQ=Wes-n&IH~gdLU$NaHNuEYG7cn#qh38x|&oQy_ z1)hNch_?o@BP*-}G787G7Yb@vPq$vF)PkgHh-6$7RCwJE zrUybwuyg{^Dg@aOS;7gR*ztiWjM?*foOpdN|1=mZm1H%@AIj?d2hB2oTk*LFw4{)5 zup?vwHOldLC0@mTYx?sFuzh#g31-71kdmgEw~l` zGa3-WFrIM5%1iUUpgcfJ{muBE%^xLeTgO{JPq_O^k}L7~n320KlQ#EDV%IFTP?Dd! zf~3kQ{X}K_t9JuOsuH(+C-0`g>hu?*N=<%1(HH9@C+EumFcER!$$)wGu;i#N*96L$ z4pqUwx0IQ1HR)wrtf2DNMlM=VBg0dZ=!m;oO0e$J7tjJfz!|J+j58f)T0NDdIpUtP z+ftJ9kk%TQT+`PJu$9yAUrcq+K>q%5W%bry2xSnT?ai&EP96`ZTBzWLjB_IMfzyVK z8t-61;B`BTeawufA8Pgi)CWOka{tK5mq|$G)WLIga3~{s>Rwr>Bq7^xRmF&A%VO zp+I|fW9@9ER^=o!rlq*jKtpvrY5?c;+oxW9TI1WIRDV4zGqj~YD7?uXw*kX7n0?yY z4e~IX*~t3~X|fG-=)@@DFr}!8v{wU2l*6X_UcLM11Z-jmtzTUC^QgIdvCC6f44ybl=FnBE4xpFWP2Vf^Kg#fo~dyP&!?l*Z!@1nXFflYjPR{DbMU@{$;+Eu zJLECOj+C5)N$I5uKUqDKFq=}UJuA@`mu68~d?evm=NH(P`Id84v%Y9WzX>?rxacou z?o9311L#RVW({>F9VLTFdd)^XRnmByG)ky;UqG`+%dX!j;72EJRBlb$6$;avV4^Od zQtQfc#nLll$#qqq{CpNMTGf!L&54;aCdxrnG%~J<1&C1j#mcK8!h!~3qmHqh?uqOA zMzyMNvp;;ptfk^SkTwa_eCJxRuW6VwW1?|hk$nxRkcTOfW>21XvChe(+Njn^c|I|> z&Oed4ApvcAF>_l{byCo(%({q)IwwvqV^=3D#OxYjc>J_OvXSYi-(ScllK|yJUdbC1 zWhy<3IXkyCnrpRSy2-hJ2g7|*(zh% zec!*z>^A*vn#WwxAh8hc<78$@-D?_My$Zb1msIZu>xDd$)yUb)TkHX`)hm$+6JnDDgSWQJI}n7eU{OU3H#@2ycX zR|50Xxt&@qy0k(a>BgJhsMR^F+71D{m91Rxv-*n@=h;4kiiDwi&AuF?SCHGY4FwMt z;8kjIyA!w%3!$Ou-Lo^EFBPOdswB<2xKE6CE=t40s|)n{4lorn7~|RU=pCMv^-W=E z?%#`lbTZ&gxa7W?~8q|V+~O6GciLB&9s zx~1t2HG||keAmytOICizF28*FgDWwCpBhAb9!j26w2bCgY{XD*xlYrvL@nsV{JgkR zwu#%55&M?3bAZN;W#yfTqVh|)w4>&9-p>ZP*S`t&nFJ0o4ZK?YSEvE6b@A3aC4>Oj z=}&_{kdolBG>~yG3-Bxa#b98RKa>T^8f1t;Kr9N-@!1dv@4J8YJN^P=Av+@xJ15B2 z4*|c%4nF@H_$EGYA8g2;0zx6uf4oG&c_hI0=OO$6Lh&iVHGtNI09_6Uxxt#?;e)nk zh$gd#qrls0+qo!WJ8~x57`;+CzbE4Ktu=#lkKar3bE~ASzg^*hixC)1H*{JWA$^e;p0i-m*=ibjqEqHMmFY{b z|I^Wgjf%Z=YJRZHt@Si?7VsXIg&sAixyH{3Ef+;>D4`p&ZV(~W<|qgDpSKPc*Wa}E zm+KCyeO_3FL$9^28tJTx3(b_@b5*VN6`wr|L8AT?4-N7*WRQTQ2PphFcFA(^I3Hno zReTdQiLIHp(p}vCM5SH>bwJ11&U$7_n+lwDUEgRZYdJXys>#L0Y#Z*CPNXS|m`dDx z^r*b@arEWObmjc_#)a2wLtftkSrp&8?CpJ3g^Nzr;izwI?Cuxe7kdH8 zH4|OUZ&mY_)XbKhqOT}@SDN`w0auCN91LyR%RfXPr2sN$bt}E{Sqg)UD-Y&&2X^0- zO7-4euAzHg^U{WndAP7X=;y}!D{^g-EbJ3i116~TXn(cXkm#kTxSlhtd-mua3y+;& z5BC6Dk6e4t{(7GxwNe4QBa+6~r@uS5$oV99I@*mtHm=+DQTmtpao_P*{X^nvbdO|c z60o6sMNKZtzB{f3zIDC+w@QZR3%**HrHl;>1jv!DRIQm%h~`eh8oc4k60Y>7ZdaS+ z>i{~&G?vyN=CkAZRjMr9qv_l9o{EltN!zsPyj*52o%nt7%?r<)CVf8F^q!caL zSa3m;n{q-l>J(mf-Ja7GuAAR`g?e}}Fz_-c1^F8-^@E91*-mZcq@M?cF}-SMkqcev z)OM(ykGKiV9zDvux8caiCs#J>Bc{$hr;{@XH^E*g(mx5m*l#WpqRhaR-e?T7NZ4H& zDX$BZkok3D$acE=7jpB{^9zLO<>FDVw7u&SPE~6?MJzP?=g{fb_dV;&9DaO0=`qgL zuh`)<%Fj%f;5=)1uDxp-NI>xyA~4z)9`7jbSVAe}m-SL~uTrxO-<8^h6Y^jPCP zXQ%tw3#(lEoqJ|UYP9cF_b)Qidn`Vy9S@u1D&Nz^ztFyQ&!f{6)lyR_+RYS?&?o3} zjsL1J%G}y%>*AW?Z8BPenaI7&x7;88oRBDy-|%e1G1}1g}k@EdRM$~ zGD0}{wyZgBq9Ptl(4ko-zT~Qw-40!<{yn33qwWhX@b1)N^ycE9^s<&(DH`rW%Vw$q zl^_0<@E6UVmQqovDz#p-)qys*5Q%nc@pntmG2C6eBMr6p;Rc`W=oSZ^I5%|5+(e5! zt1^uEHIuru?MyO;Cq|bY0DB?R`a5X+jGYqtnFC`*k%+oYb>*^a4L3JdyLH`l556f`o#}90XfI`MuZ2W@ZpcL!5k#nAQ&E^i|+$C z6n@zOZiHNx{rp~sl2jA#%OM~DRXBlzhKM~ILhucL8)zV&o(L>g2t#DG@ZSWJpAK;F zu>YS@c*MW{`>8l1S_&w+e`pK+-u3A#oi>hR2h-$1(VJBhC){o8tr>QE{F)1ME7399 zG@d>_X$Diq%f8-0eo1WWui#!~DP=Xa!)ABWJXGY2(RG1U0k%IZ@P_lY*3VIivU{^V zxJD3u2t9R7h5vXdcO|!f?=%IjvdXVoJ$*F*kA8-_+Ov5hvN2@lr{$_KHPc1XOiSCub zIx%w<`<4o4m$dE^oA~71K~OnJrQWLKOJeKF;jcf*&ZGA&9`07mrx_-e zdZxRBVz&q9w{yj2x&}`XC8amrq-fHXe;F3GX}3nPjA!J1RZrRfnEgwC*N^&QO8;hHr`5FnG_aF z?xQW-IPlaDW>+3CKyrnzEn9gk_zv z-n1XJ_4|3^<(k-4JqT9}8U(WtuhYEF>VT1quMPj8>M%6BbnV%jxY`}x%4JD7vcv&n z`kwc|WM~j=?JJGj^Qd+h!RqH;8eBH1SpBHokDing%%(mcX($O*-)_W5sdo_M0;(8g&9he#~hn(zOT)YeXT^F3RYy!$XNuZztnvh0qBOq;HdJ& z*I+LdT?crrfSr24YR8h}%3A){6fWhs{9z3e`6j;JK<+++!7RH>=G5p>-@C&*wcEa= zo3*;ew5cs8COzIdf2_)kjPEB0sPoeihtLjLa!t$`!(jIMy?obC_F0Oco(PnmezOg) zF!PSY4)X*K<9~O}6SrrPw|TM<@73$_$=5>SscOD|iIEadfIH{7l78wF9>?h~-`}RW zgw#l@j6am@8aK9UvBRin|N3?ubnh-jkT};ZF4S1E)$UHToZu2wSk%P!?Ao(4b;;eG zRgd+pJG^@^A!zXqFP$}e!!M=LF{ZkE`4$UoZwex)==6;q=hxAv zW&$@zEfGCTvokL5_U}Qc5VtAcPAGS|Hyd?ge6^W#$5|$n&hP>jgkax{rgRav==|;# z{)M_hkA#ApN<&unfN{1=ZfVY3;@LaPM#{rFm%p?U zbW@%;F~rn%(fh{UK#NM%^m1U<&lUFx&XQ;`R+}%wmRkF-pEULVOPaz%PN0FzUcC1H z=b`{LjPV&(01hJ206ST*0Sz!}yv95BAz+39U=oD*89Nakf5Kn;*JvRm+5bBP%ay0V z7XdsG_>~N3VA%r+27BO-_(zg~U+due{!b%9v@%y&(KGE3`!AKE{SoGNKT3|@o>|UU z3QnP(*_eQ7!b@_Z>vZcR6Tz`$lc5TGv5(i)V4iUG5^eAryVHsDnk!E%P!h^r*zCDG zsl6jzxrC|PbSNl2wB#{aTeKQhshY%8l)SK+8h0uua#D_3(c2#?S}h4EY*G?;!oZP& zRtLpVr)UG3v#t!G#Q^o@E`hGuyj6YbvEAa*KZ(3_80mr;z^HLOdS&Z=z2V%s+;+Xc zOvj182Va_~ILhjAt5(^jUL0~O+d>U*jpXKSXSekIcKwMuF$4Ab0Qjoz@UHie!4$mob!Wj~xb6ZSvqiAxA9V5`E>D-KGRMy0yK zL;}iG1#Nqvr&&V3(YF2WFb;S7AFeSfPsJl)ZD@TzkShTCREHxx&0ELx#AHX}w=fP#lrXgR41z*L0G?tBJdOd~z86?p1t=%0w zlHv=`OtCFlovzuf4DvIZ*>?$o+xB?{@Mv$}Iz`$yYN_iCjCbnA)ziN|FcVc(NX?&0 zO>RZy9fIr}dFgp{#3xeKyp0{@t~VR1WhhPe#9d4d%)Ksc*Zi3y^G<(ZVZL1=eZ6uo-paeW|stDa*mhbmy$Y3L1VEHBOX7*Vo0 z_)Hg#MD_d7f+X}MN8OoxCo*6>KDj)ja9_6C2~HdgnqP{^{k2>z07~e! z-Hm9A)Ou&y3F^b1^5|yNc%^qO{Ds_lllOaSd2iQmE;-DzskFXsibk(FeP>PtCN=fB zdr9R|wt4AzYfIW_jId+JV&xq}ZvQrcy!}wGh=IO9q^S9Cz#}iQp;|X)xCe(C^&5uP zdfXbuda|0#UXby9$h**ym@f-tZ!P-0|FwOVWi0H&kdEF?)M|{(z2aF#fpTYu08*-^ z*089EC=RdA&d#aGHB**FzhgHnWBJUor3Xt$+E%xS%FT*}d7t`$gz@;ZEgefL2YJ@X z72|tfW;2jvt5l|-kG}A`lvPlq?utKpA~^ ze`$U$s_8_b>KfaekoFCsNA3|8A$^ip{d@1+s_)+~Hq<@9Of_s8-1 zgoy2G1~sn~AK{Tpp16JD`{0>J-%x5=8U8~__JfXw|_F58)8@FysN%VAkvrG0B zl7fip{~94-FcBUf`nO>Ks+j@gBe638MV$@mQR6YDufWd$a4CGd0Rc$U8whDIF=IBq z4_^xPUkq3_smA|N`~TgG_g4_czXT`QfINZ`;9LI@J`|GP(!eL-5^RD?5=rU%5t_S75w%c8B7x+x+MpNc(wfDjnks}z|i z;&bb7K8tjfZWml|z_Jt}ae7$?hmQwqOC)?TMG@1U0bYIZO_Qk>Usvo7m)-;v)nBF9 zu+|)Rjc>I^q;w(Pqwc7}Xs&KjV6u34s#_~Z0g=d6c4;M$uIT05tEu8d2b8o8(i68U zoi&4=x*=KJFZI>`Skf4jJ>@gIx!d6NINynaf7nahqvn%fMvc+rptxIcrOyX0_4>R? z?-RQ7E{Sd^ma1u`{jmAHS%X3Tq(nbXb*kBPN!jRx?W~)3MG)tByzc84UJRW&&9xU< zuo|(rE{vSa8UNun`)nzpOBe@(tF(6yZM*KmA6$p4$K#Hpd8{h>#A{2e9Rhw_VcMJX zdvtM6Zt1>faa{N~PDOjA_C9bNZpOzC4+N?mNZSlU^8(nOB$%o^LQX14ZSbTtIL%r{ zoY0GPdrpey6}AfDP<9eh(3@WDSSml(NQ*-NfE?(zh)!=Jbd9zgi$joH`s0Zb)411p zIiT#RR|d0^DPqN}tlYqaGSvaATN*lGl?5J%L7%3Q>qtqlv>k=&@YsG0QBrgA{-%l< zl6AFeXnXH31i0^QZ*L{_wstBQH4LNeddHq2Y{^0^f{wl||7T?p!a;qD)h%bHFVGf>;61eFtQn=MVao z>1fOIdb;U`%f(8jKc4*>S31l)qEX9LODhqv;m99WI$}WvJzkcyFRHEjx&b?4jl%jC zU@i~5aja7+O%*pc%~BjKp5ajPQeKlAI!4qvb0);OV<&^wcWWifieJJgr+VG;$1|}l z8(-<_H1mLmN5?uKCSn^T}jg`z0@8;rBq|L-{38cS`<)S z;hJ_3=0~SuG3ybmc{PX3CQ8DZcNckJv)!yYgPSS=jv+!k?)C5MyK7UZHMLAUDJgF(=uho@CCurw*gUwjh?}XgwpEs7ZW+F@t8n` zTM?e|!==x({RlwVj)GtQIDANGzsRBW=LW2BuMMg0$pO{L#8ImrK^sZuwcHc)CdYRu zP;d)Q!RfnYk1~rIm2)sg=oNTrR<_Ctas~*8qY`a`SJkGUKcIhH)FhA2NweP@Wgh1X+TWu5kUC=8)zbZW#P)_b_6moL zpk3xQXPw8c3C8Ac5}3N3!17zz;ic8?UUO5+R%=U;P7>+*o=dq4zw;ao8}9b|8&V~I z>NDJ|!w)^bwv<2mvc13YW>AhD&V;xz=jmZRySREH9is}npUGQe1+d>i7a`$Cf(Jbvt?S=T_&x-+?JIWR@teO8 z^1qPi^P3-gbt@@W^wYwRC3||};?x7V_sg-86Fn0)MOy_$%QF`WV)T}oN?6sCS_KMW zDXme(MY!ET{ms&o9uuR{iIJhyfvMC0nN3^PG!@lr_c`6`ml>fdwt?Jj$CyI_hc?p& zR-QUUIjUcSx`gk>t^KU)wM{+JzlM2Cn7^v0jp}8%O#TkwYesx=S@mU(A3cw`xhnI< zw2x*X^mT?wO;13Eni^urO;R}LB6G2HQ{3$GMZx~k9=~>NYa9k1pV2m`Hn}{>)c@Wq zx|BBXgl6!-i)HRFB$xUV2^z%V#GhaL3+Xw4ooF>W55kO#q=XW8J(EQ3yK7rwT*rzP z8+WcZvm|Y-#|)PLehCjx&x|fDTT!gvAvK$%g&EuFnxH05&a!%=)|-z%pOk3#PgL#L zpGv>`<0^(2hsoFLp%fQ?WFQNM14aVqn@cIWZ0@?JZWmOFyU9>iwq{M86bZ2u3_ET; zv*gRatK~P!suk6x%scKoycPH+$ubV(kB(g~z}=wvgN*Pjdv~B;_OU8w!_jKg%MDX7 zSX$dp15bqetyBnpf66O?oSO|`Q^#&!a2m0$Or_EbC&jE!74+{HfFx7Hgasb7e*V;z zh>YXEkd3w3fUR`9!APu^(_2qn(Z!c>RpXOm`8mUGCFAE&HMWM4;>Gp44^pxn6=#9FXXB&PzuyNlvYIz94N-@Z?(&G5BB|;p{gHO z@93OlnKXv2s=%;;2VaaD9d7!ylo}OKr#g-opI_3{_40(G6D4-|3vwNxJM5b)6zWAU z#REFWD@Ttr7wGEq5t!1{O!eo3g}={@ie4qLmGAH-iv{A=adv~}LehFZ7Zov|BL2Xo z4fBg8%Wm^%dH8u>x4thj{SEtjeEZ@v2t#1b8?H6#=Xv71r7Yl)U-eafISw5j<^gk< z|B#hxBw{LuslUCKv%vzJ&XHBr^;#%k8RMy%OgvXoY907iMgoaM)8f|;J ze;wL!etg_}q$HQYVQ2aJHC=;#k^0r~&2{6(6=4_aq1}3lg$s~BsbI7=o-&sb(bD1v zTm7tR>$=<)(Y=56-cT@;=`@Qa+_FV8Wog0WY-dt2?tMU?=hnV3Tk%4rv1zKfj#JaSg8Yk6)8SC* zLxgigT3%N9>H^3SW1qwsrMmu7zAmjcKkBNt!4t3eqqk!d%taAU+OAf>kPc} zlum|IMtb?~;`Z=J!Lr6#;Vi02mgGNsHxI8W@s0F`EWk3d0ZZCP2C`ZP2t@lMfWh%e z40v@6fD}mflg|IZ6#%7>gAOjX>i>Zr!4UR4c!mBE(k+XJLjJ$)pKlkGnwiLE6bJ?g zKA=DY%3q68ixOz=e~1b`PzT?Lz=z zHkh~gj?E38)e0wbeN6tbr#hC_D?l)_*Kp5Q3T>+Adw#F*;<|-=6Glo% z()hIZ%M1PP;bt@_8dc{ud5AdeH;{bgD?e^? zg@sAVM?{2*Nw|bZJ$9sftl9ka+6$T>tv4;2Nz48{#*x))x3IOxE>oT-{x3?UfmzTi zUZ?jLV)e=m5$%dG((*XXvOb<@xAhdh!JMmG>5{9!eClX%b#}(w3t1ao;O8+juWh=D!{9(dQ&`elbco7 zCQ#}Jf?^yd#ZU>6h4}ZDH;g#_SBgLe-kNJn{r)t$`d`TS%Q{`*MuCEhw8!%UN+nts ziX#V|Ui;oP^_jzV=j!oJwHWn|oeNN$V|U*zaQWhvXH^!NMd?~1)PHv9hWZjT8N<=CXU>uLHWTCB`1A z4eHQYtEJEo9P8*CQ!r8Q`bzqpB1knI*c^hE4+GiX8rqY_snnF+{dpo8v&DWY+E`V& zkdUaWHxZ$x%5#7H=z1sbn%Y!^bEC?K)9V6Dj;*)cC4Dw#$$O*_giQj3k&4vBI%3ZOzcJo0Uae$c0ARTCdagK0b0 z5>HGu2?{o0he7KVpV3?vM$|%`+;t8{QZc?Ez5zFsJdAl)Sg7C*H?<6I@(uCtorJ;e zZA1(=S}r~Ouw8DP%a&giS?(rUJ+dU+KiAuqo+6%On(i~3u;M$WR=JxgX?@U6VbUvP zOYJAYJ;I5^k(4kZ+DTyw_4O|rxxMth-ayaIA!~E)RQZhy@pP&Ac2*tQw-(kyeJi+> z&eiqpyW)J2e==qT=LCNE)lc&o9SV419pImww->~89JqdMe(z=;LZU?Hf4m5^9(=%M z>L>VnVL{Ba`{%xMb~c)EP);=Ku?Xv!gkospgFAU5=9}*F6X#KP{BnKai@MvjJev~) z!(W;RCVTe3TfmMG#LLJ+I`C%qC0V?lC8tiqUj>-O|BPr-h(I~6 zJLfSmy^cL&17&;1~yD}|N{`W!yB zApJeI)HKT#IeA?eineeb=%2b*3RMjAZJd7Wnpndv9H+FJRsOR!lUkUxx#fGaS5A_> zc3Hs9tZ5aUlWoob%p?m{d+Z{XjPBSgS~s_Qc_u72ec&Dc?1q=;tcYpH$|`y1lIzE& zXvvpz6&u*TOvSF|yDHDcyrp~uqTy7k)e;USf>lS7Bj?in{C2qJdY{DPq2`|fmmcrV z?e08Eo5X$qSvR+B3x1vkN?++UD9^I?oYeC5mH}KZL;Mff8-@d~uASZ|`#h`LO>M`? zuK3Xz0N#mz;;b#+?7)+e(r*QCsm(<66 zdOmFN;9lQ`K)a7wL+OXO{IqGa{4odC)zQ$8iAbkf1YpWT3BJLQx(41|`9rVN?}r?4 zqmmMaV;v;zPYOQgEl`6P=O4MtT9Fk7zg*oH^88ZECU)E!$%b39PUr>el0;BO^|9DX z7Zx1oB-hbz2Y~YvHuAvshL%GE;2+3rBVVQsiJ;;3r{a-LoWXB_swe(eb+tXhv4- zx+)JQtZ+%|)5rV!g*Uvnr)sFp;;l7xoo~F!WrQvot+<)L#B|T#cEVTAvHg!dO9dR} z3IZ;5r$VMw*=K5Qb(IUfF!ge_Aj{E%6sEDIXdbr7J(_w8L zjQZ*|`kMjFm9!Id&$~qL6zLAdHOg7`+EN-XAkuH+Y6{A;O1gKh3}`RRx^HHre*f`u zwwqMt2478Qv5v3VZO-l)1rGF7?8JIgd!L0GMdp2Tsf7;%Wi{|?Dt6OEW4vl>JHbc-fqSWp9j^vsSz_d)l3=~E?t6V1=8QQLc)CmxigBT zO0^=YHW;UVDDONepOp?{?68C)`(PU2eXnVzmOA>HNeODi zbB|)Aq;#4rJ2V42J{^pX+iBG1V3~HunC43;nVh4EqF^}#XHPvdU~}0q{ph3$o^d10 zg9j~SO1jM9tK+zgkaKan%wqj7T0sZ;cLm-IOg0Ak7s9`msdjC~{Ym*wfnE{!`)T6v z2D6VfqAkUFFi#h-DNt)uzzTFc%@-{1ZWbtBOONzE>&84Xy`Te(1T98}qapDli+$Ct z@>)7p{_9`=Krs)xT;TWD+a5()D$(XY%@jkAd-18|ND3%)r1qz)Teu(;efJ5tB= z;`$e}*1!*I`V!s&X3b$2z{i^vK;M+YiKtsm^3LFP4YG% zM8te0kwCr}=B}Go5r4hX-rK29=2B#v#Z9Z|j@uU$?Nc34>D7O|Hu9eD%JsSp5K&!~ zRX7s3>{HU51@rOJD&g{*k3C!AfxrFf16V{8M`Me9Xp~r|Gcr?mU2rYcP~y3!ne}~KCPHQ99)6srj^P-cjA_J-7q@zTQlWy#omC6~ zu*R$M^7aSibGe}?wc+y~sQXC7$mj54kb|ChlG6TIQnawRpNF=zp=$L2WmhQXyWA-h zp@6g)yj|@sCn1UoC|So%^ogB4pLVZH#2KZ#tcMJkc8Ksm5k-dWKijugXt#DZV>DZ} zw_M``#(9@&(pIY*Znl-_`21Y5I-Jn;mKf<#r=e-q?C9J*K#r6{HQ((>=t7vw4p`z=5`ypPh4Q);&e<46vohx)il+(~ z`=xoeG|~nHf`Sf3OohdN=*S8G@QDI+xENg{;U1I1)zsf(`xw^oqo3{3=g`_$n{$Lp zu2qb_#YR}2?z^fYJbbzxjwR^T{Y!Vj1jec)l8;&X6vZ-eG*WuVIUYBFMG=l~!lUnU zCfOH_rcmW2E+1dTz*Lm6fe?eb_hI8ZY=i1fzeM!_Q=ig0->Q<(GKR2IZ_715t{(R* zKHhQa;J3YIT61`RQ1)0p3Zv@%euI4?tEN`WUkP?E&JUR6DGg%R)Rw2h?xZJ{r8siH zc5a9c>7mT-)NwZciBr!|SD+vlgq*>*GNe_OeU=ve)oZBUU-0?7_0y=w6-JD9-!&9^*i6~Z?L zU)U=k>a1`h&@GGR*kYM7Eh2Y0zA%tXv zZy@X}5rn^3;=XmYCXdPD|Ds33d)EcJW~v$zKNXuu3rwm1T)$$sC(vG(u(R`{@<*0heAb|p*r2u^n_5eO z(Vxt6wS#j-wz~A~p+=itBJdmRInVUy{qe!AHJeY33OmdWy1L3?S>C z5i$wmBYIh3Ak}A5JYEvj4uDEYm9Ol~Bbdf83MVtJ@gKe>GQ`8IsOI>an?2VL8mZxH z<^EYJUg24bFtZiw&9m`*RLt%1B(?AHi>3SYliteX@%jz#b5kM~vhq8(clgqL^DG-u z$3VGC&ly)7{iFdM_Gn)HF-=zhuX<<%mD1k5;XCXrzt;j{{QguD+y63=AdO=iH9s*! zc5LV7?x;ieI5*>cl}*KiK5e$=|89RaKl=7p~Ce>6}ELc2M43& z8tEwOM_NkqTE7}Yn|1dKpgy!&L;P}@&2>wD_o9&dRTy-$gIf;76N?^}jN)0KC;Y{S|tync^bF}in26qksYvL1LeASrh_ zmntWhx+kTyPuovD1+GCwUKrkaxyzFEGRrdoSqw}IXtrhlh*qg`Ei=R>) z-+}@Nfp;BU%Wl88&ubPZ@^Xzs0;Kegl|HNEtAGeR#CNoYXsA#>gA&yf=*oXIpfrTY zms=6(5|zJ%5I4Hm1<4Ylwq~IJ_0$>og0RxhOFoJ<_jGO%0=Q|OEWB2;ssO(l< z={l4B3yJF76+=}8IGK%7$Heuz+CWiVtrPvMPOZ~!8OccoARqYN;J41?N{VsvOQe)< z-2?^_g2OuuNuMaIT>WUJMaadhO_9x^NqYJD#9zom+*ztjXDDA9yzHgu2r$x97O z>n|uEuc})>P#?iHbG_D&1oClBn)ZeSRQ8Mz9-zAz@IH7*l`LUM1<+-Lq{PAhqOi0e z5if&_v+;{mVjvRyJz&|(@Q>#j91$~sl`GgmWc6h6LI6$n-!>R*86XUI7zn-*6M{bA zZ30#p5d@02+o(H0StE<&?w8WgGMPF3*j=%b>1(H(jTZuCm*(C4QxL1WJDH!CY!!G* z(tBEJ<*wd&%xcl2;@m=b2a!T(P@()iXDrOVtK!QulFzS6Q!YPeq~v0FrbQb5^mV%G z{?HBYdbRvgaWNUo67v){rDO#3!`+x zT%USf1@`P5$*I^0Q%7 z#3ioF!cZ_V7*s@9bXs&2b0fH!xLE!hKbN1eyvcb(8J#LA4xS6Riy14ByYy`N}1+c*M3bm0TY&JUHSk&@5hlI+62ra8Qgv(a_3U zY$%p=o&_XPxsC3}3PTObJcx!01j=#Mijo|!R4Bn82w{1z&=tlCx3BO`7IvilSlApd zXh@s$yzH5|X9r2|oty+MgNHBmWVs6=*Pklm1*Q?#dyf&W(2@3@r9Y%$Nr4o(={Dmu zH}C$tePziFX@CtK^%u%#D?dp3w3~H(g=<$D`8YR1g4*2Tmx3OYzx<^Y5Z4!havNd7 ziZ4&hDGj*^lvSvy?8yo2DY|Ywf#`y_8mOy}5Dt81Y#v0@^Pge^PaY(Df#{fTcnLj` z1xCcbd%#!#o&mi4AP^h8s{6ki2#UnVzK{U5CY$}AG{B(23*|K__+=76=KwbNbTD#& z6KT`hU+F#=KS?clbs{+`m{oL;;byFU9|&r%GsW?NDMv38iq`Hx%+`PMPSSHbn`^zv zQavgfEg=t6UO{f@R9R?qR%ug|X?zYP`b}=7)1&;M*xH7q<1H7b4Y904^zxc^5K9@Q zOS8MzY^VQ+HqKS?+9L@~mL{G~^ExY0Xty%Swa5q?;x7UfV;>kgD8A`VILiV(^G&zh z3Ie7L2I>Q9Ssm!3crKw%1chcL^@^}b>%I5J13iNKI@Z^^U60?x6Ap=Q=A;IOR9b|;l#QZ!zwYu=) z;E?{!m=MgaMdOSY2@nckjrt~Q=8P8~SS-H7_u*xSF93(n#$(4HgYPi_+6)LW14A}A zeGCB<9RGL2d*`2nw-t=WYY+w=a^RH#GnzGc8_2<}IzU%4fIVJ@p#Ndyp^fpbrBt}I zWvN-u9EfH$&Vr88>_~yRYQ^_4#f0Qnll8@v!3fmv#n>?S_xUf+0fT8W;$sNEz)zvy zWQ+(c%5Y@=$6GpisDUP8j@v_dl=&=-MbE=QeT6k<&)MG3nfH+kDsSK3boVt(QQRgE z@84SWEO>8f$!NYQ_k*W`fryekk4hjp;ok#*T(xF^JPjv-kTJYe*cYm@W;M5&Nt9<~ zzZFbQ$$TvsK1%@c3npcN3=lt5eab1I!1{dXF?WB}<-#-zI|>s6Gf$5N{lWV*pE^Uz zaR^2_M}@n>=iY=J&70J z^UnCC86FQ~!UT?4f9oLeSwKQ==@L=`0|)&*HmYIRd@Lo z+KS)~;m15${HzUuD7+#d)#1*&{E3!{*&;Hw&^leUU$ABJl1AK0^RLbBKwVpED#w0Y zq8G{DvfZ7eQFk7OW2rhxwGXK4nO(L9E|u2rEUjM@b{KM35%VOEd0k@ozt z2q7WC3l$rlSjsl&C0Z#`X{S={mPV!pH{&dA0D-oYfkRdJZyOWNJ^swki}B+8(0VnP zqXqPR(cQ81$OnJMQebZ%KJO_er0hyVYZ)+BaPqV3azwxB5a0;sxcnRp8_*-qKK=G2 zs^)zi1vJ&!8pkB*!=c<4dzdRnWKVZjr-|UQY)iJ4HpMSpq8Hf!gL>0M4xX1X&qwl0 z?olS=2-ipR69QejzJ!#-Z>Wg1nIkn*z`G4BrgzjZ0;|g*9ATQ~v`m68fsAaRx2i5D zIJ_=Y@|e+_MvRGkTAI;o2n{qm=f@A4TCR)RQty7y=d8T(U7isAfsp^*Qb$G0m~Uw< zulKyl(we065=E?`p?wQdo`Y@iM-nis6d=I_+#w9$RX~tHf`hMFmm5Y_v7aGC?3M7XT&|J~ zT*LzVZf4QK@nD#4z*dcEXfchSM@}b7-OZ{fbqw*V;<6m40n1KD1!qEAmpqgw8PUOE z-_{yy$OufnYY{fWB#(`1sVyzOO^5OocHdfsy&W3+a3Zq)=&~^P{NO_yVJ$LiFlXC9 zA5}zM3rQZcf6GYG`r4ix!pUE5O>21XXH@C}FBy4Uo7(qhMk!3syWdhbTUC%o#)b=A zV%GADU@YXfH+1I!c3G`FwaP#YEWY!AopJ-|C zbWc=`@epO7|~@?NH$uI6QaQYv?LHG5OoOT5(E$*Ymx$q{ZEE?%kR-cK+(+p z@~K|}n4Ji~qDkN*$sGnl%3$zj1V<8(S`hPdF_5=GY43cITk>5U%VJ9Pt+V~*F|MKh z?YL(uD$Xd(=Qzd$8dxBh(s-+&uR!wrMYr=XPn3P1X+G9hug%D!;~u|2v6|A$aDanE zkX7kHA2rt4r_vhQfA5||-ZK1Ed5>E4+UF`ubDxj4)-S$y2?{r@+PAo41e;cEKMXGR z{<+2t3}rDC-U92)wO_9?w`fbuI6?H>rhaB?T}ehQ_<0>+Y0*^m|5WuQ@K8Vh|LNp86kDp%zwM<^A2r1Ft;)A#>+ zZ{OeV|M<;=_so0VGdu71%x48)w+AU<32_ct*wT&D@_|qTBR=;?s{89>z5xjzcG^K z@fvnqDld^FJo4|SrtRMsLsr$I5r9k;?~tYCoG8UxC}l;6haD#uB^H|*3-f!?FbDyl z2+n>)*VIbo)(yiLBTMgG*dvRAp~Hapjnz_Wi! zNLxj zN;myTi4dxvH~Jd9Df}?%N*^e==KlC34JY?rdTYuriOFpbT|>U;miEzdzn(sv9Scznmy{?}d!|4#A>)hXFogcT<~pid@&51Nn(OQ{Ix-srXj5YoWm#tbU#jtVC67GTkd z*<)gg#8A;DM|emo{ABm;Lrj#Oi2p+)Y*TzTz+ua14Bl83#uNwkp%j4; zNiD((-(naOVufQpj+vR+VRk*-+LwE0yTL`nWu>+&F^ig~Gp`JN5wW{4zW233qx9iA znq#F)S4Y5x=Q5)w91SX~E~~VMNFB~D54d~VddYK##(8=Btg1fER;zZ&l*O+t>pZXS z%B=ON`yaVcb*Opiw}k$}flof~H<(QsHq5raI%9J>qRmOC)qm-1^U|trh~VP0t9q}d zABAw`f6zEJ^66g7q)el(%0k1Q-X}T!?PH$P^rhcfgY>Duw1~@5Z^~1ogW#>xSlTP( z%(kx@Hpl&LUpig+PH=ty``{V($1V#Y%huBVeomEb?Z2Q*Kd0(@#vv;@ttanHmfP5c zq)7WOZF+cn)i9~he@w&vP?%vtp?~{&OYYL3%&jLzRzDl#e`1zf*gzY<#Bg;%D9I?zS3U^32TfmdVoQ5PR<&%f@lJ?@|$K+~M=Ag(=_k z=^GC_-hHnyS(37D3=w>LD0IoMMQ>*Mz@n~`OyyvUbyJA5#%ajvTe#P3sx@hPEoGb8 zKANAeW#fncAc3VN3!^hWYy6{)>9l*~_j<3yKOFZ{NE>|R>)SagxkIi;X(lyX_R)Tq ziJ|d~p6<6M=Y-6zM0xT0`D{rzH^v!piq$4^S891Rac&}ptRg}wmQ#feP7E=#08JGr ztW;MKyxmFLL_1IwsF)%E^rER24nTq=#K9HTas!Y+$qcsG1(?kiLwH0q5r!=wb6_-N zi)<&67z74DZ16!m@t5J42-~6C^Rh)47M6|MqU*yUdXEGMBA_?uY3yKhWNJ*%)WQ*k z<4mx^)q$Gvc#77RG~}WRwnm=pp{n&;Br7e}{bk(Ns@yxeZ+!ATub<&-5Pup8+?h?}8 z>32rUjXN*@a0z^<(P{OVYfG3}aDP<*bgGo&pJTi*9&{lmcjQxDbBI*yr9khOgID!l z%pH_J8Yr&Q>bInEx)S#51}X{|N_l@b_M?>)EP``=d+2mPbn#TALS_Tq-CBkIT~|f7 zMtXdx#k%g_O)oX!N8?4WMlL5X~Q_!z@fWc%CG76TeGQ%q?yvZ(w0WgTKd%S ztWd$%+UW;mu&?V|uRS6`%%2RZACf<7S;!_pBn5n{` z;?C`LYOjxUypzdwsq>OK_%Uf`#z2&mlAc^*k>i-m*4O!J8R2=i{L61>FEtu2j84lm zL~PP|IMsUT>@TT^`Xa-)4F8$I8}DxaGiTV&SLk1{r+1|I&A_yaw13OIli}K9mse#= zV-GX@+vn_QbuO%O`}%=G|HR0R9VvRF<45;I93Js+KhR%1`)|((EOfZdpD`MdIZEO!HRljq6Td zBn%5b{*md1nLFk#mXxVvA*WYza?*X++^j6lqO5oe=zvTyW+o)TeIO`>=kN}~j<{_d zCL{n%2WcQAnVhzG1QcRhC~_BpcELx5Df|KM*_aBX38crvrb;}5#}idZ40I%qrWi2B zCc;TexLFuyq!!p>FQOeU5!F$GxP?KAVmJ&Jndng!iUbUg2ZgADE#Qym+(MCvNr&@l zvBJH{{1zVjuvGqJN^oWZT_p#t~Fl&g7 z5FkWFJkw0i2v?o>TvO;@_`c;fU-DczJ#xwD?7H8bE4xK}3wM)aP3gumUFB`>T z?1P=ZXmRXSR5!vG-;H&AYD50e?_laNH!}UeGUF(vEtErj-_61m&GoGZ*ypK?;xb%}M6Vrn{FdSeeme_?PtAqfYSf2W zX7$(nmMoRu7_L=5>v|QfzM|t_*D?gQbyxp`q_zjUdJZ>+ypy@A`P$oaRm#j|P=)Tc zNpJMY;E3hH#)m1@A&kavTKaZQ@OXPNnrhUaRG_I7v+uIDP`5ER{m8|O8n2YQC^(x6r)jY-Nm)v0+{z&8uh6Rh8s($sL^@!e*9q zVHQhX@$A{s1P8K%4K_`T5KEGjQ?Mn_z99I-Xo_46zy}=1SHS)FM1)C#z5572xd1L1 zC@Y{EU+|cqPsGN+?o#Ng5#R(S6MzB{o}wdHiUl(r5g^GmJDlfAa`J6%ApvhVI{ zAJ-i?rQ1k<5ZtWSJF3S$_%&JVTz|tZ8{JD&%4<(s7q`3oup701tKIDHZs+=ePvFPG;QP zt2}2`zC=wL?Yxpb8SL@-Ho|9R&AYJq8qv9mE8*W?wdZMC&3d(G9q$SSDx}h2wp#pE z#@CIJ>+#>dNb7K&d%oBm;L^r_@-BZzr}bTdFSU^@Z2nyi zd>Id{<~S65({XyzUzuex@~Ng{MxAfP#zsna;vT1t|ILuth}zP3K271Q(oXBfu6fm= z4?gwI8qbC=$o5XnT$^nezaXCdM*29_ddVlVVY>Fld#}b%dGS6T_jdBLk`L9?lJ@QO zlS+=r@11@0@J!G1mKJO2y6xrLo~<8H8nF1Tv1=eISucC3+03w7?r8DP8%HK5T=hR5 zpL?$r%w?VZb$nHBbYRd47qD;r>tbWbseVy)_K$qQ=MqGAEpSo?8`aw9GF=JR}g1TJwWKE*}nlnr21Z%c!e}80%%kcN@275MZFaP28 z620bp)9R8#*@cp=6Sqb;diC^HmFLNG4vv>e$}83+k|_=jF{%`ibh#sW#ArJLjYKt8 z#h4bj#v)0SGK{e)mTL78CI=DPXB-TVn9+2ABPJwN^90mgL;^Vt+9);^BRDp#A~1Ra zVGWoC9YCSfi`Zha5R6?S0BKn81lm75VggKpK_A1jW;jp}#U=n&Kru_;H0Cuh!}~8T z#?);wMFsvA{&+6+!(Bbw8dgwW!X-fDg=e zm!a2zl6yUz<=Xo?2Ft3ZR^(9+{YvTf zCi>d`+s{9h>kgL|yx8*iWM5&`h2^8?k?+&Eg@tncKE2vsOCl%pUr3g;8b)jgSaK_D zC=P2;#S5Ct^= ziC*=k1+{7cH8GaghVtumU7ZscxQgneYzb-EEeMG^SC~e7VCFzZRC4!U2|mY zK;DDsO93f11q*ir@{&KlIG|=hTep;7SlPZ?nMp~oJ&?K5nOnYq8TCW z?%`K!6#Kp`Q4eP&o_~Gyo+i6d`?JT z|I#b2wk!4NH|N4=Zy_jCb+w1T} zHifP_vAiB5Z=Kk%B>QBf_?_tR*sB7QsQdbF)~y^H#-}v|;&0J>)=a&FJLaoi422Hc z(i)sOvs--H_#^zi?=g~m{)4!yMRCd$O=l@q7^DZMRq{GeI}AR|2G%znR``8T-uYyk zmGV1xViuW}Td26WM|pS7#aBi$q8Y(!q55y%gy>b-=@d1TWJKOjlkyt5`tp9b`j6v> zY&>UO9+Q>U`j@I2he=4~va8v_cUG{Cq1oa0@76jK>}Lq~+{g9AQk2>fnQA z9V|aj-8-aO`B`-+xIXLSSJT-T7E6)kWx=ZE*g2f29dBkyEAdOL!_`epinTMflh2O& z3*I8VuyRY;VZH4$=8ExABYtE2-1>FTIPn_lx=!4t$z@{ZK2>Qq@w{ z#-iVfo4Y0GvvTFi%Fe-^Wj+1xM=#9 ze;}_DQ=w{{oc@JJ!9kSFBshqwBNpYH$z?otO9PaB>I7TSBvT8f@euqMk(kDr7?9w` z!?sugb)TYmB6bS}FV5h>4gpv}nCP});IKmgOAtf>C>@;yz*EpW0t!*e(9quzD8fzy zGTxX`fXBktmTW^2P=25j5WE!F^-==#(#Dc_w#)`}LUA|qG+}D8bi4*>99+p#diBSK zq+aOOpQMisNrBjQjr%F@!1(9tj(3;u7Up}~f96OMQyqH!=y`q|+1uwb|G|6lhr`0I z>yqln{u%s-yfX0k3)kw2vA1SxLK-`A4yT^>7V+Awp4jv}LS`i8$ELftBxn0dE4Ker z-t2Yci{*@hxA%C$u)@Nqy0Na+s^-wd_m0ic7utVtNNG(Bd{wSBm1v+}&C`uo*;m4) z`^GFezVl(ig6E+^E4y>?TJ8Tq(q$cK&kR0W6mnJiZ%m_}rH$99`1kTvB^=3_NTI*H zWud>mrN6z+;?wA|V3%P0C)S4-nfYC>;%%Su3C>sLs#O}mDrc#xFm3JPxSq;=tiJco zBC50qiFRsSQb>DF$n8H0b8R2n6UnpPqUUOSvf3NSqfvrKoOW2=Yv4)g-(S-nRKKq@ zAa(Wj#5NV!`#kR;-V!9*wtOtTXx>UQX)%W8-FR8M=+{P{jLAoUi}D(_Aap z$TIcql!K%Vq~`|b;Ze?%?Wga3GvB{4f!eam zYoYMS+2wEg54fC6rQMUMwWLCYLc8-f7e zDIi;0Me$g1MkWo1wPj^9GD-D_Eo*3kw{IWl>9OJr784Kn1C;h%m`)1N+`6O`- z=bc6ti>KdostrDfevl+U|Efhi{pNLE)};&A`)`@7?h4S(&gY-H{Pe=7nmhFqD|KO} z@mEg_nrL~0z3l7Jl zis)qh0XMt%KVY*7{F=_2c&+e2TG79$6G8b|o)Tj@-{e{xljcjA>+xDuyNB{&V1LC% zKu@VS;^N(B{PwGEKh7n+yZc3cG@bXp?Dx_EF!`OyAY?c7|SO zdN0|(b)7H#)Y=1`$*}ND>kU@@!)IsJtjtTJ!`hLD^_Ab%E5E2Wez0+Sa)qK8CKeEM z(ASh%@#-t4vA7z^svJ6~jx?FdeIci~G(;8QqNGBzj;30Yi|0-GT!lW0=il;;@_cKn z>gd&|shVDSwm{@YnDoZH($)s&lk22O9xJhRwLPj+lKQrZO;OzCseM)=k3=Je$vg0+ z3hhE69NZ16M+@?@S(5Y1nTK-HreZhF`gX-Vmai5R3MW@JpI%u%@R77|=5_b>L* zhk&kx=RBcHKHZluIk=aLNt!7w^rR-~JybNcm?T*AOr+vA=){=$5KR)(?8p|prdEMP zG%VHEc$m(UMlTnSDHcymGBMM!S0x-YiIucvCYTnOG8OS;CMOeM1qNe90R#<`&j3d- zwgnWBuXeEn0M76SbR7E^WTO;~5YaoDGy(`4%RmVIr~(nD)q!Y%58ycoM0pYT=*lY4 zw18!Wa2o^5fUzh#Fij*v7^Z!hJp0H*;VZ}GFbR^W99ZfNQO4MClG(%fAt{<}-zGsN zLE@PMN(nt5q2c0Xv=jOg_?Dlop4gCo>W)!g=i8p{S9`~Lx^|q_eEz9GZ0?PlOlULB zu3~5Me%;rwYX)-WFa@wOo=bKoW3R? zICg2&>sQcey~KM`Mt%?NLj6l_r##5bJtc8XSqQJ&+) zJ{%Kmx?i&Id1cG8*!_^1+;+v_`Y9`HF$?#WMp(1QC#ZQ&2z2qD^vGGV8g*=+7>zh| z%vEhLs;jGr(W`vBHB59wF1twbXiPwFtGCytF|ZyENisEiGT+<2``NRivEMtddRgvs zy^iykpFLcvXk~KP&Dl~d>QZ^u`_UUa=m}(#9f3a&#jiR>gc&8q9LPu;&FMEYApN;i z5PQM;5ciH74Z_{r*!1B|sjHNs~MbH?kbU$e10kJh>>BHV40f_hoI2jIy~3* z(6i=V1hoqmPX)P6KuMg%Yswm?;bW3aIi%DHV#3rkRBi+8*vLR1Ga&eX9EO4tH#-W{E~E|9XdV>R z?CPX|g&qb6rz*gKcZ!l^K;p&?&jf<_7kc=mH0duun0wQolO{okQ#sO4=^T(X_bZ(9 zJ@rhG_x1JB?wu->VIy4{v062hrW5$aO?Gg(e#ePuk3%U5F>8YR_e-}61#IBHkR7_q zBv)^_=9ET?&~9m^V(&`x;Wx*^d;;A)KPLWI8{gkJ?b^Y=QWMymd-SS+#)hTSft8u3 z-p&&;M%Kz|w0Sjul<#qEajJTFcUOki2DgWrN`YqNZbvVPSP6rLZjzb4$TwqpGU{6H0(-`X16E%e4XyUxxSkzIu)){{2-6?vSiwb_etyVD4ok| z_pI_2L+Hu-Z|!}WY$VpylsA?A{zr55qQezmjnO;H-%{#^x(ECV^6Ff+@mJf#Nzt4? zpD4bRGdVeYDW`Pp@+~7FdG#HyV=|t7h!b;sAzg5xB=PcfqfN*tzpAUUqwL1CCLyjL z25vFF7SAumzB%hQ`>79N+63d>vJ@|BuIcyibd& zO(8u7C-d|=L&Vs_Y9mdA9DB18!&3(%-y^@ zA?xVXw7#UwcF||QROZ(%NA7P*Cs$`Zd_UB)HsL)Eo5`<69OAYa{H-#7_PIvQJ^HCi-|C|mWoo~+I^JRVWGlm9?Yiuj*vh52Fo=>gntd@CeJ zZ_q2YrKM+%+O+g9&*i_!9le5^n68tk9DMXybm`D{vno6MfwiutTj7o0e_uO(wfo?y zDf_eoO$ml0vw~mq26kAr^6Ex>C@2*TJE0QUpy;~woxOvVW&J9DT}HQM$3ORDOWr$= zcj|BYa8!==Ze8P8VYQl4)v|iPUh{g#d}m}dBC04-zoboWX8EeC@z=@oMDd2_qF;yl znkuy--bcOl$Z8)7>0ae?v8!#?YrN-HXLha1*K6C)Z(h`{>sLSPzn(i?BUZNl#=1I3 zw=^XDv*+lgU$WN?%(P#v|FzMIPbG)a!Ijk?|9;4U)-gIi< z=cesp=jGnZoa$_<8Rh4w7UBrl5UD9TTlTKI)4=UwPISk1vxV20^vjzebpE-tynw)f zP|D6>YQ^?&KmTO@XGSTB$Z?6`MlIEZs}xhwvOH=QbXTn5biiVw#x;P@tAf7x0&8zDCdFy0lrITS&g3=RuF) z2@dX9zr|Bpr#KQ1o0T8CvBV`L)T{P5n>(!}ENHCktE`k}wunHR(|pjxyL`uH*GuhN zH_Pv@{ib8YJ0E#DY`*OZE8n?KN;&IU24B-tE7dl^u=$O#n@zV?y^PEAG)gFroLkAR zsMoPko;xQ~d!;Ld+<)k2kksZKTW{vb6q?lPd}vzTmF;v?-l4X`WV1%XsGHKi0tPEP zN=Hult^w@66=oxUq&A9|5E=Pv+lC5jd6Qp??Fw-2dK*j^6^(DrTGqRI>A_Q$jmKi6 z?m(gYSc>77UBh$DETimS8!N2$zS(RsXu6m)-Q}VzTc7ZKbBwj0`-;j^>Y{<$=gl*@ zE7l~Pqf2e)e@X8eU)HdT;_f|bS^D67&^wKl#l|SkbJ}9gq2Z;i=2KBz&GNnViy52j zg1XP3|6BlONKhE`IKJvk9w^w~GAkMjWwIFLn|B;3z-9_nT5c#FqkNJwKO`kgp{Z83!%Q(5+ zb1ZJ*7$NX1FQfl?n%uEJQrs2sWuxL^qM9d-6CYqL0yn-mhc2nR+zMH$cD zm~ZeGWsJOWpAGn=OqW^W+9n>{uuYrS?boKuT!P5y0lwa`<+Ce>zxj_KU*@B4 zKP>kges8o}eq-F;fNf5mv)*B*5whJ~E1Ex58!4f+eLtnl-|#OGNQPeGFEn_%#TmppSPc-PyOR+)B9jD6OT$vq@yI}Te_Ydpf%@%B#YFXZv5g@z6tXZ#H<@TeBJ4VUb+*tzB zVKx2L96kf`!-v&6`;Pq-5ERQPbnkTKcJErzJ{)B#lXm~MKoVc?`@>$oLcM~Xab9;; z4GfKvGmT<&NYty*P4#^y0zO>(l)NPsxEe%`k6tcf zJ#w*7l>nmFR;$1i0h%({LXF)}KWW0OI#+aBZ5b3=W5VMw1UDq2Nh6{`=o;{kL zH@@=7ja$E;58rH%$?axt(6yq`Z(ztbImd0#O+M`Pr>iWw*ljpMV5ayJhh0L1Ks)M3 z=XlrEw--qL-p4v&%GCU%;e7+oA;k+y2SvO(mWPkRA`q}-IaOjAHq&?+FNTAIP|>*z z=zIvsELy2-Tu6if=zpR1Q9cJtSF{f^MI*&QX$HeLC3a6J`sEEql;|SDBo!ZUf9qctCVeOmGC4Bm{!6 zKwv%)^0@apQivoDDacKw>@j6>f=FUT5MW4$A*D##a>$MZFP<CraN|w1Ye^&GJHNNd$-nSQY-6&ueAm#)1_L?y_@QTqtSc1?cY0FvyR~j z|AH4{)euPvj;=CkFX<xiYk_# zD=eNs`JaIR27Stw(y%WY#m*LE3PPTUrKV!3q+U!4o{StfWib>*lcUXaXe7|T#-OKU z!MCCYkN{IiaAA93L`h+im`r$i3V}U+hCcW|ZWcj`O>oRT+evWjiP-->VnE2eh9VLM zI$Yyaxm2c#i3)rpd??uJlHiJ-(1jo{8v$2vwnXSIY>7B_ZEc|dGlLWXbOo_I*u;3K zpOe7fOdO1PP<=2Kn})+1U*xf6mk6fUKv2m{9ulI+#$R|6v4@GU*kpvZ02GMbIKd5T zQYdI)|Lcqy5CqdZXg-)FBwl2pX2C$gCN!|qLsV5nY_Y!)VUTXHLkmL142{n58FNM-U>k5!4r&;4dMu2X*k1Y^b)kf5mu)1?!QEP~G$M2Nyn7G9$Qx-bMoAZ-6T!F=>sC%dX4 z{a=T&00vLu?X0pgW;`hRF5pDBl_(odg(X}j2pHDY@{HvlV<(Npbi!AF4lR?<0f_-B zO2mpL_Hr_*6jUz^%Z4ma;{MytkO2b1;KA>+9XDI7Qy>h~3cI=hwKCym%Q*&I!9m9@ zVoZXDXRvSa7(AL2FGso@gMpB6KJbu%b}tMjuW=$fTzGO%(Co+0#x6o_D8MH;XlRHkqNkqA-j3dZ8VG?oFZ4(*HnF<6P^WngRw$vQl~ zA^V_MEM6TJs_`(80(Ofbomc_`zC=78s+aVQ{cXs9=>e=|`And;W8u74uvx(-?tu=m zh=QSzG7)SHd_C%*vTnr^5e!;o;8+ZdqzD0FBIpM&5F8QT4?AHn2y!5k*lX#FAQ7Gd z=8o`f&;>vwSd#PD#e;PEFC{?&ww@DO22F~tyn_g+7(9_**cK0iQD_sWtXRm-!N72; zqa{Q6&;!S#au2~DLvK)rgBO9kB%B1)E(KxAY0`)eI5rz&P$sj5rrTlxlfEF8AT=Gt zA}0m%u}z0TjG|5v7DU8BVNfV~3q?`jyRdBt8Nj#go?V@UGN62@4jf7i7PbudAuM9Y zKy#zH5L7^;K7z=0G1&h9UU-1Au}hu8Xas=)jEN?U1^(pxh9g1{rrS6-|7Y_50eabM AxBvhE literal 0 HcmV?d00001 diff --git a/diyhrt.market/meds/groups/bicalutamide.html b/diyhrt.market/meds/groups/bicalutamide.html index 9df1f7cd8..01db4271e 100644 --- a/diyhrt.market/meds/groups/bicalutamide.html +++ b/diyhrt.market/meds/groups/bicalutamide.html @@ -360,6 +360,47 @@ + + + + + + + +
+
+ + TeaHRT Bicalutamide 50mg
+ TeaHRT +
+
+ +
+ + 100 pills + +
+ +
+ + $100.00
+ + $1.00 + per pill + +
+
+ +
+ + + + + Delisted from store +
@@ -402,52 +443,11 @@ - 22 days ago + 29 days ago - - -
- -
- - -
-
- - TeaHRT Bicalutamide 50mg
- TeaHRT -
-
- -
- - 100 pills - -
- -
- - $100.00
- - $1.00 - per pill - -
-
- -
- - - - - Delisted from store -
@@ -619,7 +619,7 @@ - 3 days ago + 10 days ago @@ -707,7 +707,7 @@ - 257 days ago + 264 days ago @@ -892,5 +892,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/combination-minoxidil.html b/diyhrt.market/meds/groups/combination-minoxidil.html index dd55bca54..37daef6fd 100644 --- a/diyhrt.market/meds/groups/combination-minoxidil.html +++ b/diyhrt.market/meds/groups/combination-minoxidil.html @@ -275,6 +275,47 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
+ +
+
+ + Open Gate Labs Combination Minoxidil/Finasteride 5%
+ Open Gate Labs +
+
+ +
+ + 5000mg + +
+ +
+ + $35.00
+ + $0.01 + per mg + +
+
+ +
+ + + + + In Stock + + + +
+
+
+ new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/cyproterone.html b/diyhrt.market/meds/groups/cyproterone.html index 0aeff5152..3459e4eda 100644 --- a/diyhrt.market/meds/groups/cyproterone.html +++ b/diyhrt.market/meds/groups/cyproterone.html @@ -503,7 +503,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 257 days ago + 264 days ago @@ -517,12 +517,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels + style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Cyproterone (Procur) 50mg
- United Pharmacies UK + 4NRX Pharmacy UK
@@ -564,12 +564,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
+ style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Cyproterone (Procur) 50mg
- 4NRX Pharmacy UK + United Pharmacies UK
@@ -644,7 +644,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 4 days ago + 11 days ago @@ -779,7 +779,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 165 days ago + 172 days ago @@ -842,7 +842,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
+ style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -870,9 +870,15 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
- + - In Stock + + + + 7 days ago + + + @@ -927,5 +933,5 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/dutasteride.html b/diyhrt.market/meds/groups/dutasteride.html index 9dda3e1a1..92a221de5 100644 --- a/diyhrt.market/meds/groups/dutasteride.html +++ b/diyhrt.market/meds/groups/dutasteride.html @@ -434,7 +434,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 2 days ago + 7 days ago @@ -563,7 +563,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 257 days ago + 264 days ago @@ -610,7 +610,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 22 days ago + 29 days ago @@ -739,7 +739,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 257 days ago + 264 days ago @@ -786,7 +786,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 22 days ago + 29 days ago @@ -833,7 +833,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 257 days ago + 264 days ago @@ -894,7 +894,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -922,9 +922,15 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
- + - In Stock + + + + 106 days ago + + + @@ -1138,7 +1144,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 18 days ago + 25 days ago @@ -1226,7 +1232,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 43 days ago + 50 days ago @@ -1314,7 +1320,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 43 days ago + 50 days ago @@ -1540,5 +1546,5 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-droppers.html b/diyhrt.market/meds/groups/estradiol-droppers.html index 9e3650f52..e36c2e172 100644 --- a/diyhrt.market/meds/groups/estradiol-droppers.html +++ b/diyhrt.market/meds/groups/estradiol-droppers.html @@ -399,5 +399,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-gels.html b/diyhrt.market/meds/groups/estradiol-gels.html index df90c18b4..b247aa139 100644 --- a/diyhrt.market/meds/groups/estradiol-gels.html +++ b/diyhrt.market/meds/groups/estradiol-gels.html @@ -311,7 +311,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 336 days ago + 343 days ago @@ -358,7 +358,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 349 days ago + 356 days ago @@ -372,7 +372,7 @@ The main downsides of transdermal gel are that some users may have issues with a + style="border-left-width: 0.2rem; border-left-color: #FCA8FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -400,9 +400,15 @@ The main downsides of transdermal gel are that some users may have issues with a
- + - In Stock + + + + 7 days ago + + + @@ -446,7 +452,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 70 days ago + 77 days ago @@ -625,5 +631,5 @@ The main downsides of transdermal gel are that some users may have issues with a const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-injections.html b/diyhrt.market/meds/groups/estradiol-injections.html index 17c08755e..80cae6a6e 100644 --- a/diyhrt.market/meds/groups/estradiol-injections.html +++ b/diyhrt.market/meds/groups/estradiol-injections.html @@ -313,7 +313,7 @@ The main downside to Injections besides practical difficulties with injecting an - 360 days ago + Over a year ago @@ -696,7 +696,7 @@ The main downside to Injections besides practical difficulties with injecting an - 329 days ago + 336 days ago @@ -779,47 +779,6 @@ The main downside to Injections besides practical difficulties with injecting an
- - - Delisted from store - - - -
-
-
- - -
-
- - TeaHRT Estradiol Enanthate 10mL
- TeaHRT -
-
- -
- - 400mg - -
- -
- - $75.00
- - $0.19 - per mg - -
-
- -
- - Delisted from store @@ -906,6 +865,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+
+ + +
+
+ + TeaHRT Estradiol Enanthate 10mL
+ TeaHRT +
+
+ +
+ + 400mg + +
+ +
+ + $75.00
+ + $0.19 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -1119,6 +1119,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + Silvermaple Labs Estradiol Undecylate
+ Silvermaple Labs +
+
+ +
+ + 400mg + +
+ +
+ + $90.00
+ + $0.22 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -1161,52 +1202,11 @@ The main downside to Injections besides practical difficulties with injecting an - 6 days ago + 13 days ago - - -
-
- - - -
-
- - Silvermaple Labs Estradiol Undecylate
- Silvermaple Labs -
-
- -
- - 400mg - -
- -
- - $90.00
- - $0.22 - per mg - -
-
- -
- - - - - Delisted from store -
@@ -1249,7 +1249,7 @@ The main downside to Injections besides practical difficulties with injecting an - 318 days ago + 325 days ago @@ -1427,7 +1427,7 @@ The main downside to Injections besides practical difficulties with injecting an - 358 days ago + Over a year ago @@ -1514,47 +1514,6 @@ The main downside to Injections besides practical difficulties with injecting an In Stock - - -
-
- - - -
-
- - TeaHRT Estradiol Valerate 10mL
- TeaHRT -
-
- -
- - 400mg - -
- -
- - $70.00
- - $0.18 - per mg - -
-
- -
- - - - - Delisted from store -
@@ -1596,6 +1555,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + TeaHRT Estradiol Valerate 10mL
+ TeaHRT +
+
+ +
+ + 400mg + +
+ +
+ + $70.00
+ + $0.18 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -1649,5 +1649,5 @@ The main downside to Injections besides practical difficulties with injecting an const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-patches.html b/diyhrt.market/meds/groups/estradiol-patches.html index 9e8b3b6f6..a6e454dd7 100644 --- a/diyhrt.market/meds/groups/estradiol-patches.html +++ b/diyhrt.market/meds/groups/estradiol-patches.html @@ -1042,12 +1042,12 @@ The main downsides with transdermal patches can be difficulty maintaining higher
+ style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Climara 100mcg
- United Pharmacies UK + 4NRX Pharmacy UK
@@ -1089,12 +1089,12 @@ The main downsides with transdermal patches can be difficulty maintaining higher
+ style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Climara 100mcg
- 4NRX Pharmacy UK + United Pharmacies UK
@@ -1315,5 +1315,5 @@ The main downsides with transdermal patches can be difficulty maintaining higher const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-pills.html b/diyhrt.market/meds/groups/estradiol-pills.html index acf62eb36..a055fe5b0 100644 --- a/diyhrt.market/meds/groups/estradiol-pills.html +++ b/diyhrt.market/meds/groups/estradiol-pills.html @@ -436,7 +436,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 257 days ago + 264 days ago @@ -1200,7 +1200,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 183 days ago + 190 days ago @@ -1340,5 +1340,5 @@ The main downside to oral pills is that much of the Estradiol is metabolised in const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-sprays.html b/diyhrt.market/meds/groups/estradiol-sprays.html index bd182dd44..9b2d81bd2 100644 --- a/diyhrt.market/meds/groups/estradiol-sprays.html +++ b/diyhrt.market/meds/groups/estradiol-sprays.html @@ -402,5 +402,5 @@ The main downsides of transdermal sprays are that some users may have issues wit const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/finasteride.html b/diyhrt.market/meds/groups/finasteride.html index ad7029d95..0f0ca4fe6 100644 --- a/diyhrt.market/meds/groups/finasteride.html +++ b/diyhrt.market/meds/groups/finasteride.html @@ -518,7 +518,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 257 days ago + 264 days ago @@ -647,7 +647,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 313 days ago + 320 days ago @@ -735,7 +735,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 308 days ago + 315 days ago @@ -864,7 +864,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 257 days ago + 264 days ago @@ -1206,7 +1206,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 257 days ago + 264 days ago @@ -1458,7 +1458,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 257 days ago + 264 days ago @@ -1721,5 +1721,5 @@ Though the exact mechanism is unknown Finasteride is also associated with signif const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/gnrh-agonists.html b/diyhrt.market/meds/groups/gnrh-agonists.html index a5d02177d..548c9fa53 100644 --- a/diyhrt.market/meds/groups/gnrh-agonists.html +++ b/diyhrt.market/meds/groups/gnrh-agonists.html @@ -284,7 +284,7 @@ Recently we've seen cheaper formulations come to market such as Buserelin i
+ style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -312,9 +312,15 @@ Recently we've seen cheaper formulations come to market such as Buserelin i
- + - In Stock + + + + 6 days ago + + + @@ -367,5 +373,5 @@ Recently we've seen cheaper formulations come to market such as Buserelin i const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-10.html b/diyhrt.market/meds/groups/minoxidil-10.html index cdcbcb3d0..a79d2813e 100644 --- a/diyhrt.market/meds/groups/minoxidil-10.html +++ b/diyhrt.market/meds/groups/minoxidil-10.html @@ -393,7 +393,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 2 days ago + 7 days ago @@ -654,5 +654,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-2.html b/diyhrt.market/meds/groups/minoxidil-2.html index ec011c846..3bef0be9e 100644 --- a/diyhrt.market/meds/groups/minoxidil-2.html +++ b/diyhrt.market/meds/groups/minoxidil-2.html @@ -434,7 +434,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 81 days ago + 88 days ago @@ -572,5 +572,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-5.html b/diyhrt.market/meds/groups/minoxidil-5.html index 95086055d..61406c78f 100644 --- a/diyhrt.market/meds/groups/minoxidil-5.html +++ b/diyhrt.market/meds/groups/minoxidil-5.html @@ -557,7 +557,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 257 days ago + 264 days ago @@ -1006,5 +1006,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/progesterone.html b/diyhrt.market/meds/groups/progesterone.html index 9e7cf5a81..181b83c00 100644 --- a/diyhrt.market/meds/groups/progesterone.html +++ b/diyhrt.market/meds/groups/progesterone.html @@ -398,7 +398,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 257 days ago + 264 days ago @@ -527,7 +527,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 18 days ago + 4 days ago @@ -746,7 +746,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 29 days ago + 36 days ago @@ -1129,7 +1129,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 13 days ago + 20 days ago @@ -1187,5 +1187,5 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/spironolactone.html b/diyhrt.market/meds/groups/spironolactone.html index de84c80d3..5e243b4d3 100644 --- a/diyhrt.market/meds/groups/spironolactone.html +++ b/diyhrt.market/meds/groups/spironolactone.html @@ -477,7 +477,7 @@ Spironolactone has been widely used particularly in the United States in transfe - 1 days ago + 8 days ago @@ -1166,5 +1166,5 @@ Spironolactone has been widely used particularly in the United States in transfe const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html index ef0ea6814..3642167f0 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html @@ -428,7 +428,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -471,55 +471,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1782,7 +1782,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1793,5 +1793,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html index 0a8999c1c..1c45b7016 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1465,7 +1465,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1476,5 +1476,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html index af07b306a..742f2e16f 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1625,7 +1625,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1636,5 +1636,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html index e16b48b78..db8ab9f8c 100644 --- a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1760,7 +1760,7 @@ - + @@ -1771,5 +1771,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html index 03bed4e36..0756f8460 100644 --- a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html @@ -362,7 +362,7 @@
- + @@ -405,55 +405,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1270,13 +1270,29 @@ - April 13, 2025, 4:41 a.m. + April 14, 2025, 10:42 a.m. £18.56 Preorders + + April 14, 2025, 4:41 a.m. + + + In Stock + + + + + April 13, 2025, 4:41 a.m. + + + Preorders + + + April 13, 2025, 2:40 a.m. @@ -1587,7 +1603,7 @@
- + @@ -1630,55 +1646,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2852,7 +2868,7 @@
- + @@ -2871,7 +2887,7 @@ - 257 days ago + 264 days ago @@ -2901,55 +2917,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4035,7 +4051,7 @@
- + @@ -4054,7 +4070,7 @@ - 3 days ago + 10 days ago @@ -4084,55 +4100,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4949,13 +4965,29 @@ - April 13, 2025, 4:41 a.m. + April 14, 2025, 10:42 a.m. £17.61 Out of Stock + + April 14, 2025, 4:41 a.m. + + + In Stock + + + + + April 13, 2025, 4:41 a.m. + + + Out of Stock + + + April 13, 2025, 2:40 a.m. @@ -5810,7 +5842,7 @@
- + @@ -5853,55 +5885,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6772,7 +6804,7 @@ - + @@ -6783,5 +6815,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html index 84e0a5386..fe2bf9fea 100644 --- a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -367,55 +367,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1297,5 +1297,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html index 717f65ea0..62688da17 100644 --- a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1280,7 +1280,7 @@ - + @@ -1291,5 +1291,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html index e3eff6fa1..7d747b288 100644 --- a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html @@ -340,7 +340,7 @@
- + @@ -389,55 +389,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1299,7 +1299,7 @@
- + @@ -1348,55 +1348,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2242,7 +2242,7 @@
- + @@ -2291,55 +2291,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3210,7 +3210,7 @@ - + @@ -3221,5 +3221,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-100mcg-x4.html b/diyhrt.market/meds/products/climara-100mcg-x4.html index 865888d3f..ba74af64f 100644 --- a/diyhrt.market/meds/products/climara-100mcg-x4.html +++ b/diyhrt.market/meds/products/climara-100mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3160,7 +3160,7 @@
- + @@ -3203,55 +3203,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4105,7 +4105,7 @@
- + @@ -4154,55 +4154,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5048,7 +5048,7 @@
- + @@ -5097,55 +5097,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5991,7 +5991,7 @@
- + @@ -6040,55 +6040,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6959,7 +6959,7 @@ - + @@ -6970,5 +6970,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-50mcg-x4.html b/diyhrt.market/meds/products/climara-50mcg-x4.html index f8ac91498..dbdcd480b 100644 --- a/diyhrt.market/meds/products/climara-50mcg-x4.html +++ b/diyhrt.market/meds/products/climara-50mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2936,7 +2936,7 @@
- + @@ -2979,55 +2979,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3873,7 +3873,7 @@
- + @@ -3922,55 +3922,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4816,7 +4816,7 @@
- + @@ -4865,55 +4865,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5759,7 +5759,7 @@
- + @@ -5808,55 +5808,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6727,7 +6727,7 @@ - + @@ -6738,5 +6738,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html index 007978451..e91ae7a14 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html @@ -343,7 +343,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -386,55 +386,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1368,7 +1368,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1387,7 +1387,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 11 days ago + 18 days ago @@ -1417,55 +1417,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2375,7 +2375,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2418,55 +2418,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3345,7 +3345,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3356,5 +3356,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html index 48719ff59..8f546b860 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html @@ -330,7 +330,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -373,55 +373,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1452,7 +1452,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -1463,5 +1463,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html index e5e66ad49..4ea140f98 100644 --- a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3213,7 +3213,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3224,5 +3224,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html index 359504516..0ab46099a 100644 --- a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3213,7 +3213,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3224,5 +3224,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html index 87426828a..4f9bfc8ce 100644 --- a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html @@ -143,7 +143,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);"> Inhouse Pharmacy @@ -310,7 +310,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
+ style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -321,7 +321,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -329,15 +329,21 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- - - - - -
- -
-
-
- -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- -
- -
-

- -

-
-
-
- - - - - - - - - - - - - - - - -
First SeenPriceState
March 5, 2024, 8:49 p.m.$72.78 - Out of Stock -
-
-
-
-
-
-
- -
-
-
-
- - -
-
- + @@ -3244,51 +2301,945 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi class="day bg-danger" data-bs-toggle="tooltip" data-bs-placement="top" - data-bs-title="Dec. 16, 2024"> + data-bs-title="Dec. 23, 2024"> + data-bs-title="Dec. 24, 2024"> + data-bs-title="Dec. 25, 2024"> + data-bs-title="Dec. 26, 2024"> + data-bs-title="Dec. 27, 2024"> + data-bs-title="Dec. 28, 2024"> + data-bs-title="Dec. 29, 2024"> + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ +
+

+ +

+
+
+
+ + + + + + + + + + + + + + + + +
First SeenPriceState
March 5, 2024, 8:48 p.m.$83.90 + Out of Stock +
+
+
+
+
+
+
+ +
+
+
+
+ + +
+ + + + + + + + +
+ + + +
+ +
+
+
+ +
+ + + + + + + + + + + + + + + + + +
+ + + + + + +
-
+

-

-
+
@@ -4105,8 +4105,8 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - + + @@ -4159,7 +4159,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -4170,5 +4170,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html b/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html index b1cbf04b0..1664cf74c 100644 --- a/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html @@ -368,7 +368,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -411,55 +411,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
March 5, 2024, 8:48 p.m.$83.90March 5, 2024, 8:49 p.m.$72.78 Out of Stock
- - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1321,7 +1321,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1364,55 +1364,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2274,7 +2274,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2317,55 +2317,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3243,7 +3243,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -3286,55 +3286,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4180,7 +4180,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -4223,55 +4223,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5142,7 +5142,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -5153,5 +5153,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html b/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html index 139b0cbfc..f95dc8ded 100644 --- a/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html +++ b/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html @@ -307,7 +307,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -326,7 +326,7 @@ Unlike many other medications on this site, these products are produced by priva - 22 days ago + 29 days ago @@ -699,6 +699,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -909,5 +958,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html b/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html new file mode 100644 index 000000000..f6b8bc01f --- /dev/null +++ b/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html @@ -0,0 +1,596 @@ + + + + + + + + + + + + + + + + + + + + + + + + + Open Gate Labs Combination Minoxidil/Finasteride 5% - DIYHRT.Market + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
+
+
+ + + + + + + + + + + +
+ + Login + Register + +
+
+
+
+ +
+ + + +
+ + +
+
+
+

Open Gate Labs Combination Minoxidil/Finasteride 5%

+
+
+ +
+
+ + +
+
    + + +
  • + Group: + +
  • + + + +
  • + Dosage form: +
    + + Spray + +
    +
  • + + + +
  • + Manufacturer: +
    + + Open Gate Labs + +
    +
  • + + + + + +
  • + Active ingredient: +
    + + Minoxidil + +
    +
  • + + + + + + + +
  • + Volume: +
    + + 60 ml + +
    +
  • + + + +
  • + Total active ingredient: +
    + + 5000 mg + +
    +
  • + + + +
  • + Concentration: +
    + + 83.33333333333333 mg/ml + +
    +
  • + + + + + + + + + + + + + +
  • + Dose per spray: +
    + + 5.0 mg + +
    +
  • + + + + +
+
+ + +
+ +
+

+ + +

This product is a combination medication and also contains 0.25% Finasteride.

+ + + + + +

Minoxidil is a medication commonly used to promote hair growth and has been proven effective at treating Androgenic Alopecia in cis men and promoting facial hair growth in transmasculine people. In combination with a 5-Alpha Reductase Inhibitor and a standard transfeminine HRT regimen, it can be highly effective in reversing hair lost prior to medical transition.

+

Applied as a topical solution it is regarded safe, though it has known hypotensive properties and can aggravate skin conditions such as Eczema, Dandruff and Scalp dryness.

+ + + + + +

Unlike many other medications on this site, these products are produced by private individuals, not pharmaceutical companies, and thus do not have the associated safety guarantees. While we only list providers with a positive reputation within the DIY community it's important to understand these risks so that you can make an informed decision.

+ + + + + +

+ This product is 60ml of liquid, at a concentration of + 83.33mg per ml, for a total of a 5000mg per bottle. + Each spray contains 5mg of Minoxidil. +

+ + + + + + +

+ +
+ + + +
+ +
+ +
+
+
+
+ + +
+
+ + + + + + + +
+ + + +
+
+
+
+
+ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + +
+ +
+ +
+

+ +

+
+
+
+ + + + + + + + + + + + + + + + + + + + + + +
First SeenPriceState
April 11, 2025, 5:41 a.m.$35.00 + In Stock +
April 4, 2025, 10:22 a.m. + Out of Stock +
+
+
+
+
+
+
+ +
+
+
+
+ +
+ +
+ +
+ + + + + + + + + + + + + + + + + + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-cypionate.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-cypionate.html index db5dbc67c..0aeb75225 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-cypionate.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-cypionate.html @@ -337,7 +337,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -723,6 +723,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -810,7 +859,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -821,5 +870,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-dropper.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-dropper.html index 89b0a4320..add95da94 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-dropper.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-dropper.html @@ -318,7 +318,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -704,6 +704,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -823,7 +872,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -834,5 +883,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-enanthate.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-enanthate.html index 0744b3965..075055b56 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-enanthate.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-enanthate.html @@ -329,7 +329,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -715,6 +715,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -866,7 +915,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -877,5 +926,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-spray.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-spray.html index 589dc3999..9ef9d2e10 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-spray.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-spray.html @@ -318,7 +318,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -704,6 +704,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -807,7 +856,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -818,5 +867,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-undecylate.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-undecylate.html index b9f2d262d..1e59363b5 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-undecylate.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-undecylate.html @@ -329,7 +329,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -715,6 +715,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -834,7 +883,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -845,5 +894,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-estradiol-valerate.html b/diyhrt.market/meds/products/open-gate-labs-estradiol-valerate.html index 7fa881e2c..b78fbeb42 100644 --- a/diyhrt.market/meds/products/open-gate-labs-estradiol-valerate.html +++ b/diyhrt.market/meds/products/open-gate-labs-estradiol-valerate.html @@ -414,7 +414,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -800,6 +800,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -935,7 +984,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -946,5 +995,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html b/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html index 30144abb1..d0deebba7 100644 --- a/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html +++ b/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html @@ -283,7 +283,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -302,7 +302,7 @@ Unlike many other medications on this site, these products are produced by priva - 13 days ago + 20 days ago @@ -675,6 +675,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="April 14, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -829,5 +878,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html b/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html index c01779176..30af9b4c4 100644 --- a/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html +++ b/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html @@ -139,7 +139,7 @@ Unlike many other medications on this site, these products are produced by priva + style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-danger);"> Open Gate Labs @@ -296,7 +296,7 @@ Unlike many other medications on this site, these products are produced by priva
+ style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -307,7 +307,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -315,15 +315,21 @@ Unlike many other medications on this site, these products are produced by priva
- - - @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/qr-codes.html b/diyhrt.market/qr-codes.html index ace49dbb6..334babdf0 100644 --- a/diyhrt.market/qr-codes.html +++ b/diyhrt.market/qr-codes.html @@ -174,5 +174,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/register.html b/diyhrt.market/register.html index dfaf2dea2..3c5859427 100644 --- a/diyhrt.market/register.html +++ b/diyhrt.market/register.html @@ -95,7 +95,7 @@ - +
Enter the same password again
@@ -143,5 +143,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/resources.html b/diyhrt.market/resources.html index 4e7f9d3da..5d5d5e37e 100644 --- a/diyhrt.market/resources.html +++ b/diyhrt.market/resources.html @@ -155,5 +155,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk.html b/diyhrt.market/stores/4nrx-pharmacy-uk.html index 917819925..9902bc36c 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk.html @@ -304,7 +304,7 @@ - 22 days ago + 29 days ago @@ -1737,5 +1737,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html index b23f4f58d..3ac728964 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html @@ -179,7 +179,7 @@

Leave a Review

- +
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)